: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Flying Publisher

The Angels Initiative

Stroke prevention

Hypertension

Free Subscription

Articles published in J Hypertens
Retrieve available abstracts of 819 articles:
HTML format

Single Articles

April 2023

WOODS AP, Feeney T, Papageorge MV, de Geus SWL, et al
Addressing diagnostic inertia following incidental adrenal mass discovery in patients with hypertension.
J Hypertens. 2023;41:680-682.
PubMed

GALLAGHER BD, Windish DM
State of ambulatory hypertension education in U.S. internal medicine residency programs: a needs assessment survey.
J Hypertens. 2023;41:678-679.
PubMed

CARNAGARIN R, Nolde JM, Yang J, Marques FZ, et al
Stagnating rates of blood pressure control in Australia: insights from opportunistic screening of 10 046 participants of the May Measurement Month campaigns.
J Hypertens. 2023;41:632-637.
PubMed Abstract available

March 2023

LACY PS, Jedrzejewski D, McFarlane E, Williams B, et al
Blood pressure measurement modalities and indexed left ventricular mass in men with low-risk hypertension confirmed by ambulatory monitoring.
J Hypertens. 2023 Mar 10. doi: 10.1097/HJH.0000000000003415.
PubMed Abstract available

LI D, Zhang S, Cao F, Han J, et al
The sustainable antihypertensive and target organ damage protective effect of transcranial focused ultrasound stimulation in spontaneously hypertensive rats.
J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003407.
PubMed Abstract available

XUE CC, Li C, Hu JF, Wei CC, et al
Retinal vessel caliber and tortuosity and prediction of 5-year incidence of hypertension.
J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003406.
PubMed Abstract available

UKOHA-KALU BO, Adibe MO, Ukwe CV
A qualitative study of patients' and carers' perspectives on factors influencing access to hypertension care and compliance with treatment in Nigeria.
J Hypertens. 2023 Mar 3. doi: 10.1097/HJH.0000000000003409.
PubMed Abstract available

GOULAS I, Evripidou K, Doundoulakis I, Kollios K, et al
Prevalence of masked hypertension and its association with left ventricular hypertrophy in children and young adults with chronic kidney disease: a systematic review and meta-analysis.
J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003402.
PubMed Abstract available

XIONG S, Yin S, Deng W, Zhao Y, et al
Predictive value of liver fibrosis scores in cardiovascular diseases among hypertensive population.
J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003394.
PubMed Abstract available

GAO Y, Liu B, Guo X, Nie J, et al
Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension.
J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003401.
PubMed Abstract available

WU S, Tian X, Chen S, Zhang Y, et al
Arterial stiffness and blood pressure in treated hypertension: a longitudinal study.
J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003400.
PubMed Abstract available

KUMAR SM, Anandraj J, Sivanatham P, Essakky S, et al
Control status of hypertension in India: systematic review and meta-analysis.
J Hypertens. 2023 Mar 2. doi: 10.1097/HJH.0000000000003381.
PubMed Abstract available

STERGIOU G, MacDonald T, Young R, Kyriakoulis KG, et al
Reply to 'Evening or morning dosing of antihypertensive medications: valid epidemiological findings for consensus statement'.
J Hypertens. 2023;41:525-526.
PubMed

KAWADA T
Evening or morning dosing of antihypertensive medications: valid epidemiological findings for consensus statement.
J Hypertens. 2023;41:525.
PubMed

NURKKALA J, Kauko A, FinnGen, Laivuori H, et al
Associations of polygenic risk scores for preeclampsia and blood pressure with hypertensive disorders of pregnancy.
J Hypertens. 2023;41:380-387.
PubMed Abstract available

MEDEIROS BM, Da Silva TLN, Bloch KV, Kuschnir MCC, et al
Adolescent blood pressure classification curves and cardiometabolic risk factors: a comparison of the Brazilian and American references.
J Hypertens. 2023;41:420-428.
PubMed Abstract available

AVILA-GANDIA V, Ramos-Campo DJ, Garcia-Sanchez E, Luque-Rubia AJ, et al
Training, detraining and retraining effects of moderate vs. high intensity exercise training programme on cardiovascular risk factors.
J Hypertens. 2023;41:411-419.
PubMed Abstract available

ZEIJEN VJM, Hirsch A, Betjes MGH, Daemen J, et al
Unilateral renal atrophy 4 years after renal sympathetic denervation: a case report.
J Hypertens. 2023;41:516-519.
PubMed Abstract available

KOBAYASHI A, Fujihara K, Yamada MH, Sato T, et al
Combined effects of blood pressure and glycemic status on risk of heart failure: a population-based study.
J Hypertens. 2023;41:470-475.
PubMed Abstract available

KANTAUSKAITE M, Furst G, Minko P, Antoch G, et al
How acute renal failure led to the diagnosis of aortic coarctation.
J Hypertens. 2023;41:520-524.
PubMed Abstract available

ZEIJEN VJM, Feyz L, Kardys I, Geleijnse ML, et al
Association between renal sympathetic denervation and arterial stiffness: the ASORAS study.
J Hypertens. 2023;41:476-485.
PubMed Abstract available

CHALMERS J, Mourad JJ, Brzozowska-Villatte R, De Champvallins M, et al
Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trials.
J Hypertens. 2023;41:508-515.
PubMed Abstract available

February 2023

PARATI G, Bilo G, Kollias A, Pengo M, et al
Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper *.
J Hypertens. 2023 Feb 16. doi: 10.1097/HJH.0000000000003363.
PubMed Abstract available

PARISE BK, Santos RB, Mesas AE, Silva WA, et al
Sleep irregularity and the association with hypertension and blood pressure levels: the ELSA-Brasil study.
J Hypertens. 2023 Feb 13. doi: 10.1097/HJH.0000000000003392.
PubMed Abstract available

CARDOSO CRL, Leite NC, Salles GF
Relative prognostic importance of aortic and brachial blood pressures for cardiovascular and mortality outcomes in patients with resistant hypertension and diabetes: a two cohorts prospective study.
J Hypertens. 2023 Feb 2. doi: 10.1097/HJH.0000000000003387.
PubMed Abstract available

KAWADA T
Cardiovascular disease risk in patients with type 2 diabetes and hypertension.
J Hypertens. 2023;41:365.
PubMed

CUSPIDI C, Gherbesi E, Faggiano A, Sala C, et al
Unmasking left ventricular systolic dysfunction in masked hypertension: looking at myocardial strain. A review and meta-analysis.
J Hypertens. 2023;41:344-350.
PubMed Abstract available

HOLWERDA SW, Gangwish ME, Luehrs RE, Nuckols VR, et al
Concomitantly higher resting arterial blood pressure and transduction of sympathetic neural activity in human obesity without hypertension.
J Hypertens. 2023;41:326-335.
PubMed Abstract available

REN R, Zhang Y, Yang L, Shi Y, et al
Sleep fragmentation during rapid eye movement sleep and hypertension in obstructive sleep apnea.
J Hypertens. 2023;41:310-315.
PubMed Abstract available

GHAZI L, Li F, Simonov M, Yamamoto Y, et al
Effect of intravenous antihypertensives on outcomes of severe hypertension in hospitalized patients without acute target organ damage.
J Hypertens. 2023;41:288-294.
PubMed Abstract available

BO Y, Yu T, Guo C, Chang LY, et al
Isolated systolic or diastolic hypertension and mortality risk in young adults using the 2017 American College of Cardiology/American Heart Association blood pressure guideline: a longitudinal cohort study.
J Hypertens. 2023;41:271-279.
PubMed Abstract available

WANG FZ, Qian P, Liu MY, Ding L, et al
Adrenomedullin in paraventricular nucleus attenuates adipose afferent reflex and sympathoexcitation via receptors mediated nitric oxide-gamma-aminobutyric acid A type receptor pathway in rats with obesity-related hypertension.
J Hypertens. 2023;41:233-245.
PubMed Abstract available

VAN TWIST DJL, Kietselaer BLJH
Intravenous antihypertensive drugs: a double-edged sword?
J Hypertens. 2023;41:220-222.
PubMed

LI Y, Haseler E, McNally R, Sinha MD, et al
A meta-analysis of the haemodynamics of primary hypertension in children and adults.
J Hypertens. 2023;41:212-219.
PubMed Abstract available

JONES L, Blair J, Hawcutt DB, Lip GYH, et al
Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions.
J Hypertens. 2023;41:203-211.
PubMed Abstract available

BRGULJAN-HITIJ J, McNally R, Sinigoj P, Hornstrup BG, et al
ESH Summer School 2022: great experience for participants and an important achievement for ESH organization.
J Hypertens. 2023;41:365-368.
PubMed

KAKALETSIS N, Ntaios G, Milionis H, Protogerou AD, et al
Time of blood pressure in target range in acute ischemic stroke.
J Hypertens. 2023;41:303-309.
PubMed Abstract available

PEWOWARUK RJ, Hein AJ, Hansen KM, Barnes JN, et al
Exercise increases arterial stiffness independent of blood pressure in older Veterans.
J Hypertens. 2023;41:316-325.
PubMed Abstract available

OMBONI S, Ballatore T, Rizzi F, Tomassini F, et al
Age-related patterns of ambulatory blood pressure in a large cohort of individuals referred to Italian community pharmacies: results from the templar project.
J Hypertens. 2023;41:336-343.
PubMed Abstract available

ZHOU TL, Reulen JPH, Van Der Staaij H, Stehouwer CDA, et al
Cardiovagal baroreflex sensitivity, blood pressure and blood pressure variability - the Maastricht study.
J Hypertens. 2023;41:254-261.
PubMed Abstract available

CAMPBELL NRC, Whelton PP, Orias M, Cobb LL, et al
It is strongly recommended to not conduct, fund, or publish research studies that use spot urine samples with estimating equations to assess individuals' sodium (salt) intake in association with health outcomes: a policy statement of the World Hyperte
J Hypertens. 2023 Feb 1. doi: 10.1097/HJH.0000000000003385.
PubMed Abstract available

SUN Y, Guo Y, Xu H, Zhao J, et al
The relationship between arginine vasopressin gene polymorphisms and plasma copeptin and hypertensive disorders of pregnancy: a nested case-control study.
J Hypertens. 2023 Feb 1. doi: 10.1097/HJH.0000000000003376.
PubMed Abstract available

KANG YY, Chen Y, Wu QH, Dong H, et al
Prevalence and clinical characteristics of renovascular hypertension associated with fibromuscular dysplasia in China.
J Hypertens. 2023 Feb 1. doi: 10.1097/HJH.0000000000003382.
PubMed Abstract available

January 2023

ALNAZER RM, Veldhuizen GP, de Leeuw PW, Kroon AA, et al
The effect of age, sex and BMI on the aldosterone-to-renin ratio in essential hypertensive individuals.
J Hypertens. 2023 Jan 31. doi: 10.1097/HJH.0000000000003377.
PubMed Abstract available

REN Y, Shi J, Liu S, Zhu W, et al
Transcription factor AP-2 gamma/Kruppel-like factor 10 axis is involved in miR-3656-related dysfunction of endothelial cells in hypertension.
J Hypertens. 2023 Jan 26. doi: 10.1097/HJH.0000000000003359.
PubMed Abstract available

HIRAI T, Ueda S, Ogura T, Katayama K, et al
Hyperkalemia by eplerenone or esaxerenone in the presence or absence of clarithromycin in hypertensive patients: a retrospective observational cohort study.
J Hypertens. 2023 Jan 20. doi: 10.1097/HJH.0000000000003372.
PubMed Abstract available

PEWOWARUK RJ, Colebank MJ, Spronck B, Korcarz CE, et al
Biomechanics models predict increasing smooth muscle tone as a novel therapeutic target for central arterial dysfunction in hypertension.
J Hypertens. 2023 Jan 18. doi: 10.1097/HJH.0000000000003370.
PubMed Abstract available

BAWAND R, Ghiasian M, Khazaei M, Samadyan M, et al
Effects of blood pressure unawareness and poor adherence to antihypertensive drugs on outcomes of cerebrovascular accidents among patients with their first-ever stroke.
J Hypertens. 2023 Jan 13. doi: 10.1097/HJH.0000000000003358.
PubMed Abstract available

BOULESTREAU R, Lorthioir A, Persu A, Sarafidis P, et al
Revisiting malignant hypertension: rationale and design of the 'HAMA cohort', on behalf of the ESH working group 'hypertension and the kidney'.
J Hypertens. 2023 Jan 10. doi: 10.1097/HJH.0000000000003357.
PubMed Abstract available

TAKASE M, Yamada M, Nakamura T, Nakaya N, et al
Association between lung function and hypertension and home hypertension in a Japanese population: the Tohoku Medical Megabank Community-Based Cohort Study.
J Hypertens. 2023 Jan 4. doi: 10.1097/HJH.0000000000003356.
PubMed Abstract available

Dynamic of bedside ultrasound venous and pulmonary congestion assessment in patients with arterial hypertension and decompensated heart failure: Erratum.
J Hypertens. 2023;41:200.
PubMed

CASIGLIA E, Tikhonoff V, Virdis A, Grassi G, et al
Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values.
J Hypertens. 2023;41:180-186.
PubMed Abstract available

BOTHE TL, Bilo G, Parati G, Haberl R, et al
Impact of oscillometric measurement artefacts in ambulatory blood pressure monitoring on estimates of average blood pressure and of its variability: a pilot study.
J Hypertens. 2023;41:140-149.
PubMed Abstract available

WALLE-HANSEN MM, Berge T, Vigen T, Myrstad M, et al
Systolic blood pressure at age 40 and cognitive function 25 years later: the Akershus Cardiac Examination (ACE) 1950 Study.
J Hypertens. 2023;41:132-139.
PubMed Abstract available

PAPADOPOULOU SL, Gkaliagkousi E, Dipla K, Koletsos N, et al
Relationship of 24-h ambulatory blood pressure variability with micro and macrovascular parameters and hypertension status.
J Hypertens. 2023;41:74-82.
PubMed Abstract available

RUS RR, Pac M, Obrycki L, Sagsak E, et al
Systolic and diastolic left ventricular function in children with primary hypertension: a systematic review and meta-analysis.
J Hypertens. 2023;41:51-62.
PubMed Abstract available

MALHAME I, Dong S, Syeda A, Ashraf R, et al
The use of loop diuretics in the context of hypertensive disorders of pregnancy: a systematic review and meta-analysis.
J Hypertens. 2023;41:17-26.
PubMed Abstract available

OBRYCKI L, Sarnecki J, Pac M, Derezinski T, et al
Accelerated vascular age in adolescents with primary hypertension.
J Hypertens. 2023;41:171-179.
PubMed Abstract available

KARELIUS S, Vahtera J, Suorsa K, Heinonen OJ, et al
Changes in ambulatory blood pressure during the transition to retirement.
J Hypertens. 2023;41:187-193.
PubMed Abstract available

December 2022

ROSSI GP, Barton M, Dhaun N, Rizzoni D, et al
Challenges in the evaluation of endothelial cell dysfunction: a statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors.
J Hypertens. 2022 Dec 23. doi: 10.1097/HJH.0000000000003314.
PubMed Abstract available

SCHRADER B, Conradi C, Luders S, Vaske B, et al
Health football beats them all: subgroup analysis of the 3F (Fit&Fun with Football) study on white coat hypertension, sustained hypertension, dippers, nondippers, and on pharmacologically un(treated) arterial hypertension.
J Hypertens. 2022 Dec 19. doi: 10.1097/HJH.0000000000003360.
PubMed Abstract available

NTINERI A, Theodosiadi A, Menti A, Kyriakoulis KG, et al
A novel professional automated auscultatory blood pressure monitor with visual display of Korotkoff sounds: InBody BPBIO480KV validation according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/Inter
J Hypertens. 2022 Dec 15. doi: 10.1097/HJH.0000000000003341.
PubMed Abstract available

LOVGREN T, Connealy B, Yao R, D Dahlke J, et al
Postpartum medical management of hypertension and risk of readmission for hypertensive complications.
J Hypertens. 2022 Dec 13. doi: 10.1097/HJH.0000000000003340.
PubMed Abstract available

CHOI M, Hwang JR, Sung JH, Byun N, et al
Hydroxychloroquine reduces hypertension and soluble fms-like kinase-1 in a Nomega-nitro-l-arginine methyl ester-induced preeclampsia rat model.
J Hypertens. 2022;40:2459-2468.
PubMed Abstract available

LU SY, Hong WZ, Tsai BC, Chang YC, et al
Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway.
J Hypertens. 2022;40:2502-2512.
PubMed Abstract available

ALI M, Hussein Z, Marshall JM
Young South Asian women in the United Kingdom show evidence of blunted endothelium-dependent dilatation: implications for future cardiovascular disease.
J Hypertens. 2022;40:2438-2448.
PubMed Abstract available

O'DRISCOLL JM, Edwards JJ, Coleman DA, Taylor KA, et al
One year of isometric exercise training for blood pressure management in men: a prospective randomized controlled study.
J Hypertens. 2022;40:2406-2412.
PubMed Abstract available

November 2022

SCHROEVERS JL, Eggink E, Hoevenaar-Blom MP, Van Dalen JW, et al
Antihypertensive medication classes and the risk of dementia over a decade of follow-up.
J Hypertens. 2022 Nov 18. pii: 00004872-990000000-00141.
PubMed Abstract available

ANDERSSON U, Nilsson PM, Kjellgren K, Hoffmann M, et al
PERson-centredness in Hypertension management using Information Technology: a randomized controlled trial in primary care.
J Hypertens. 2022 Nov 18. pii: 00004872-990000000-00139.
PubMed Abstract available

Renal denervation in the antihypertensive arsenal - knowns and known unknowns: Erratum.
J Hypertens. 2022;40:2322.
PubMed

MICHAEL N, Sadananthan SA, Yuan WL, Ong YY, et al
Associations of maternal and foetoplacental factors with prehypertension/hypertension in early childhood.
J Hypertens. 2022;40:2171-2179.
PubMed Abstract available

GNANENTHIRAN SR, Liu H, Tan I, Chan J, et al
Cuffless blood pressure devices: the gap between patient acceptability and need for validation.
J Hypertens. 2022;40:2317-2319.
PubMed

JONES ESW, Lee HY, Khan N, Charchar FJ, et al
Reduction of salt intake: time for more action.
J Hypertens. 2022;40:2130-2132.
PubMed

NOLDE JM, Hillis GS, Atkins E, Von Huben A, et al
Impact of various night-time period definitions on nocturnal ambulatory blood pressure.
J Hypertens. 2022;40:2271-2279.
PubMed Abstract available

LUGO-GAVIDIA LM, Burger D, Nolde JM, Carnagarin R, et al
Platelet-derived extracellular vesicles correlate with therapy-induced nocturnal blood pressure changes.
J Hypertens. 2022;40:2210-2218.
PubMed Abstract available

GAVISH B, Bursztyn M, Thijs L, Wei DM, et al
Predictive power of 24-h ambulatory pulse pressure and its components for mortality and cardiovascular outcomes in 11 848 participants recruited from 13 populations.
J Hypertens. 2022;40:2245-2255.
PubMed Abstract available

EDWARDS JJ, Wiles J, O'Driscoll J
Mechanisms for blood pressure reduction following isometric exercise training: a systematic review and meta-analysis.
J Hypertens. 2022;40:2299-2306.
PubMed Abstract available

BOUWMEESTER TA, van de Velde L, Galenkamp H, Postema PG, et al
Association between the reflection magnitude and blood pressure in a multiethnic cohort: the Healthy Life in an Urban Setting study.
J Hypertens. 2022;40:2263-2270.
PubMed Abstract available

October 2022

HORNE CE, Stayt LC, Schutz S, Smith CM, et al
Symptom experiences in hypertension: a mixed methods systematic review.
J Hypertens. 2022 Oct 17. pii: 00004872-990000000-00129.
PubMed Abstract available

HELLEPUTTE S, Spronck B, Sharman JE, Van Bortel L, et al
Central blood pressure estimation in type 1 diabetes: impact and implications of peripheral calibration method.
J Hypertens. 2022 Oct 10. pii: 00004872-990000000-00126.
PubMed Abstract available

WOLDSTAD C, Rusinek H, Sweeney E, Butler T, et al
Quadratic relationship between systolic blood pressure and white matter lesions in individuals with hypertension.
J Hypertens. 2022 Oct 5. pii: 00004872-990000000-00123.
PubMed Abstract available

MIDDELDORP ME, Ariyaratnam JP, Kamsani SH, Albert CM, et al
Hypertension and atrial fibrillation.
J Hypertens. 2022 Oct 5. pii: 00004872-990000000-00124.
PubMed Abstract available

KALA P, Gawrys O, Miklovic M, Vanourkova Z, et al
Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension.
J Hypertens. 2022 Oct 5. pii: 00004872-990000000-00121.
PubMed Abstract available

KEEHN L, Hall WL, Berry SE, Sanders TAB, et al
Reproducibility of sequential ambulatory blood pressure and pulse wave velocity measurements in normotensive and hypertensive individuals.
J Hypertens. 2022 Oct 3. pii: 00004872-990000000-00120.
PubMed Abstract available

Distinct transcriptomic profile of small arteries of hypertensive patients with chronic kidney disease identified miR-338-3p targeting GPX3 and PTPRS: Erratum.
J Hypertens. 2022;40:2084.
PubMed

ZHANG Z, Zhang X, Gui Y, Wang X, et al
Renal arteriovenous fistula complicated with malignant hypertension: a case report.
J Hypertens. 2022;40:2076-2080.
PubMed Abstract available

TSAI HR, Hsu HC, Wu CI, Lee WH, et al
Effects of postsystolic shortening and diastolic dyssynchrony on myocardial work in untreated early hypertension patients.
J Hypertens. 2022;40:1994-2004.
PubMed Abstract available

CHUANG KH, Yao RH, Jiang YN, Gui LX, et al
Attenuating effect of magnesium on pulmonary arterial calcification in rodent models of pulmonary hypertension.
J Hypertens. 2022;40:1979-1993.
PubMed Abstract available

PALATINI P, Mos L, Rattazzi M, Spinella P, et al
Blood pressure response to standing is a strong determinant of masked hypertension in young to middle-age individuals.
J Hypertens. 2022;40:1927-1934.
PubMed Abstract available

ALMANSOOR ZR, Saxton SN
Time-restricted feeding: a free and effective method of managing hypertension by ameliorating inflammation?
J Hypertens. 2022;40:1899-1901.
PubMed

HITIJ JB
A commentary on the article 'Antihypertensive drug treatment in white-coat hypertension: data from the Plaque Hypertension Lipid-Lowering Italian Study'.
J Hypertens. 2022;40:1897-1898.
PubMed

MESSERLI FH, Bavishi C, Brguljan J, Burnier M, et al
Renal denervation in the antihypertensive arsenal - knowns and known unknowns.
J Hypertens. 2022;40:1859-1875.
PubMed Abstract available

FINSTERER J
Blood pressure regulation is multifactorial in mitochondrial disorders.
J Hypertens. 2022;40:2081.
PubMed

OKUMURA K, Obayashi K, Tai Y, Yamagami Y, et al
Influence of depression on the association between colder indoor temperature and higher blood pressure.
J Hypertens. 2022;40:2013-2021.
PubMed Abstract available

WANG Y, Zhang WS, Hao YT, Jiang CQ, et al
Changes in blood pressure and cardiovascular disease in middle-aged to older Chinese: the Guangzhou Biobank Cohort Study.
J Hypertens. 2022;40:2005-2012.
PubMed Abstract available

STERNBACH TJ, Harper S, Li X, Zhang X, et al
Effects of indoor and outdoor temperatures on blood pressure and central hemodynamics in a wintertime longitudinal study of Chinese adults.
J Hypertens. 2022;40:1950-1959.
PubMed Abstract available

SHARP ASP, Tunev S, Schlaich M, Lee DP, et al
Histological evidence supporting the durability of successful radiofrequency renal denervation in a normotensive porcine model.
J Hypertens. 2022;40:2068-2075.
PubMed Abstract available

September 2022

FAN JF, Wang W, Tan X, Ye P, et al
Contribution of cyclooxygenase-2 overexpression to enhancement in tonically active glutamatergic inputs to the rostral ventrolateral medulla in hypertension.
J Hypertens. 2022 Sep 27. pii: 00004872-990000000-00119.
PubMed Abstract available

ANGELAKI E, Barmparis GD, Kochiadakis G, Maragkoudakis S, et al
Artificial intelligence-based opportunistic screening for the detection of arterial hypertension through ECG signals.
J Hypertens. 2022 Sep 27. pii: 00004872-990000000-00118.
PubMed Abstract available

LI C, Shang S, Liang W
Sleep and risk of hypertension in general American adults: the National Health and Nutrition Examination Surveys (2015-2018).
J Hypertens. 2022 Sep 20. pii: 00004872-990000000-00117.
PubMed Abstract available

SENDZIKAITE S, Sudikiene R, Lubaua I, Silis P, et al
Antihypertensive therapy of late arterial hypertension in children following successful coarctation correction.
J Hypertens. 2022 Sep 14. pii: 00004872-990000000-00115.
PubMed Abstract available

LIAN J, Shi X, Jia X, Fan J, et al
Genetically predicted blood pressure, antihypertensive drugs and risk of heart failure: a Mendelian randomization study.
J Hypertens. 2022 Sep 14. pii: 00004872-990000000-00114.
PubMed Abstract available

CHANDAK P, Kessaris N, Karunanithy N, Byrne N, et al
Utilizing 3D printing to facilitate surgical in-situ paediatric renal artery aneurysm repair for refractory hypertension.
J Hypertens. 2022 Sep 14. pii: 00004872-990000000-00113.
PubMed Abstract available

Hyperuricemia and risk of hypertension resistant to therapy: a systematic review and meta-analysis: Erratum.
J Hypertens. 2022;40:1845.
PubMed

LI C, Wang Q, Qing Y, Ma L, et al
Rho kinase inhibition on renal remodeling in an apatinib-induced hypertensive rat model.
J Hypertens. 2022;40:1838-1840.
PubMed

CALO LA, Stefanelli LF, Bertoldi G, Ravarotto V, et al
Rho kinase inhibition: from hypertension to cardiovascular-renal remodeling and more.
J Hypertens. 2022;40:1836-1837.
PubMed

LIU Y, Zhong C, Si J, Chen S, et al
The impact of Sacubitril/Valsartan on cardiac fibrosis early after myocardial infarction in hypertensive rats.
J Hypertens. 2022;40:1822-1830.
PubMed Abstract available

QU Y, Guo ZN, Zhang P, Ma HY, et al
Time course of beat-to-beat blood pressure variability and outcome in patients with spontaneous intracerebral haemorrhage.
J Hypertens. 2022;40:1744-1750.
PubMed Abstract available

CHAMBERS LC, Diaz-Otero JM, Fisher CL, Jackson WF, et al
Mineralocorticoid receptor antagonism improves transient receptor potential vanilloid 4-dependent dilation of cerebral parenchymal arterioles and cognition in a genetic model of hypertension.
J Hypertens. 2022;40:1722-1734.
PubMed Abstract available

LIU MM, Peng J, Xu RX, Guo YL, et al
Hypertension and clinical outcomes in patients with familial hypercholesterolemia.
J Hypertens. 2022;40:1713-1721.
PubMed Abstract available

LAU D, Ringrose J, McAlister FA, Fradette M, et al
Telemonitoring and protocolized case management for hypertensive community dwelling older adults (TECHNOMED): a randomized controlled trial.
J Hypertens. 2022;40:1702-1712.
PubMed Abstract available

HITIJ JB
Association of depressive symptoms and hypertension prevalence, awareness, treatment.
J Hypertens. 2022;40:1655-1657.
PubMed

JIN X, Narisawa M, Piao L, Cheng XW, et al
Protein tyrosine phosphatase receptor type D as a potential therapeutic target in pulmonary artery hypertension.
J Hypertens. 2022;40:1650-1654.
PubMed

LEE EK, Zhu M, Chan DC, Yip BH, et al
Comparing effect of definition of diurnal periods by diary, fixed periods, and actigraphy on ambulatory blood pressure parameters in a Chinese population.
J Hypertens. 2022;40:1815-1821.
PubMed Abstract available

BOGAERTS JMK, Poortvliet RKE, van der Klei VMGTH, Achterberg WP, et al
Disentangling the varying associations between systolic blood pressure and health outcomes in the very old: an individual patient data meta-analysis.
J Hypertens. 2022;40:1786-1794.
PubMed Abstract available

August 2022

GEWA CA, Onyango AC, Opiyo RO, Gittelsohn J, et al
Patterns and predictors of elevated blood pressure and hypertension among primary school children in urban Kenya.
J Hypertens. 2022 Aug 30. pii: 00004872-990000000-00111.
PubMed Abstract available

ARAUJO-CASTRO M, Paja Fano M, Gonzalez Boillos M, Pla Peris B, et al
Predictive model of hypertension resolution after adrenalectomy in primary aldosteronism: the SPAIN-ALDO score.
J Hypertens. 2022 Aug 24. pii: 00004872-990000000-00101.
PubMed Abstract available

LEE YH, Kim JS, Song SH, Song SH, et al
Impact of donor hypertension on graft survival and function in living and deceased donor kidney transplantation: a nationwide prospective cohort study.
J Hypertens. 2022 Aug 24. pii: 00004872-990000000-00103.
PubMed Abstract available

KWON CH, Lee HY, Lee JH, Kim M, et al
Optimal office blood pressure levels in younger (<50 years old) Korean hypertensive patients: a nationwide cohort study in South Korea.
J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00091.
PubMed Abstract available

GRONEWOLD J, Jokisch M, Schramm S, Himpfen H, et al
Periventricular rather than deep white matter hyperintensities mediate effects of hypertension on cognitive performance in the population-based 1000BRAINS study.
J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00086.
PubMed Abstract available

SALICE P, Mircoli L, Butera G, Burdick L, et al
Percutaneous cutting balloon angioplasty for the treatment of renovascular hypertension in children and adolescents.
J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00089.
PubMed Abstract available

HATA S, Ushigome E, Yoshimura T, Takegami M, et al
Maximum home blood pressure and cardiovascular outcomes in patients with type 2 diabetes: KAMOGAWA-HBP study.
J Hypertens. 2022 Aug 19. pii: 00004872-990000000-00088.
PubMed Abstract available

GAFFEY AE, Rosman L, Sico JJ, Haskell SG, et al
Military sexual trauma and incident hypertension: A 16-year cohort study of young and middle-aged men and women.
J Hypertens. 2022 Aug 18. pii: 00004872-990000000-00085.
PubMed Abstract available

STERGIOU G, Brunstrom M, MacDonald T, Kyriakoulis KG, et al
Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension.
J Hypertens. 2022 Aug 16. pii: 00004872-990000000-00084.
PubMed Abstract available

VELDHUIZEN GP, Alnazer RM, Kroon AA, de Leeuw PW, et al
Variability of aldosterone, renin and the aldosterone-to-renin ratio in hypertensive patients without primary aldosteronism.
J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00078.
PubMed Abstract available

KABIA AU, Li P, Jin Z, Tan X, et al
The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment.
J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00080.
PubMed Abstract available

IATRIDI F, Theodorakopoulou MP, Papagianni A, Sarafidis P, et al
Management of intradialytic hypertension: current evidence and future perspectives.
J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00071.
PubMed Abstract available

ZHENG X, Han L, Shen S
Hypertension, remnant cholesterol and cardiovascular disease: evidence from the China health and retirement longitudinal study.
J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00079.
PubMed Abstract available

LI J, Tong D, Song B, Xie F, et al
Inflammatory cytokines induce neutrophil extracellular traps interaction with activated platelets and endothelial cells exacerbate coagulation in moderate and severe essential hypertension.
J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00070.
PubMed Abstract available

KANG MY
Occupational risk factors for hypertension.
J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00074.
PubMed Abstract available

FALLO F, Di Dalmazi G, Beuschlein F, Biermasz NR, et al
Diagnosis and management of hypertension in patients with Cushing's syndrome: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00081.
PubMed Abstract available

COSTA TJ, Linder BA, Hester S, Fontes M, et al
The janus face of ketone bodies in hypertension.
J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00064.
PubMed Abstract available

LIN Y, Li YQ, Wang H, Wu HJ, et al
Increasing angiotensin-converting enzyme 1 regulated by histone 3 lysine 27 hyperacetylation in high-fat diet-induced hypertensive rat kidney.
J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00065.
PubMed Abstract available

GEORGE R, Thomas C, Joy CA, Varghese B, et al
Comparative efficacy and safety of oral nifedipine with other antihypertensive medications in the management of hypertensive disorders of pregnancy: a systematic review and meta-analysis of randomized controlled trials.
J Hypertens. 2022 Aug 9. pii: 00004872-990000000-00069.
PubMed Abstract available

FANG X, Ma L, Wang Y, Ren F, et al
Neutrophil extracellular traps accelerate vascular smooth muscle cell proliferation via Akt/CDKN1b/TK1 accompanying with the occurrence of hypertension.
J Hypertens. 2022 Aug 4. pii: 00004872-990000000-00062.
PubMed Abstract available

NAKAGAWA K, Chen R, Greenberg SM, Ross GW, et al
Forkhead box O3 longevity genotype may attenuate the impact of hypertension on risk of intracerebral haemorrhage.
J Hypertens. 2022 Aug 4. pii: 00004872-990000000-00061.
PubMed Abstract available

TABARA Y, Chin K
Sleep duration and sleep blood pressure: the Nagahama study.
J Hypertens. 2022;40:1624-1625.
PubMed

WARD NC, Carnagarin R, Nolde JM, Lugo-Gavidia LM, et al
Circulating short-chain fatty acids in hypertension: a reflection of various hypertensive phenotypes.
J Hypertens. 2022;40:1589-1596.
PubMed Abstract available

NARITA K, Hoshide S, Ae R, Kario K, et al
Simple predictive score for nocturnal hypertension and masked nocturnal hypertension using home blood pressure monitoring in clinical practice.
J Hypertens. 2022;40:1513-1521.
PubMed Abstract available

CUKA E, Simonini M, Lanzani C, Zagato L, et al
Inverse salt sensitivity: an independent risk factor for cardiovascular damage in essential hypertension.
J Hypertens. 2022;40:1504-1512.
PubMed Abstract available

JIMENEZ-BALADO J, Riba-Llena I, Nafria C, Pizarro J, et al
Silent brain infarcts, peripheral vascular disease and the risk of cardiovascular events in patients with hypertension.
J Hypertens. 2022;40:1469-1477.
PubMed Abstract available

SATOH M, Hirose T, Satoh H, Nakayama S, et al
Actual impact of angiotensin II receptor blocker or calcium channel blocker monotherapy on renal function in real-world patients.
J Hypertens. 2022;40:1564-1576.
PubMed Abstract available

July 2022

SAVARE L, Rea F, Corrao G, Mancia G, et al
Use of initial and subsequent antihypertensive combination treatment in the last decade: analysis of a large Italian database.
J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00054.
PubMed Abstract available

JONES S, Schultz MG, Park C, Tillin T, et al
Antihypertensive treatment effect on exercise blood pressure and exercise capacity in older adults.
J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00058.
PubMed Abstract available

CHAINOGLOU A, Sarafidis K, Chrysaidou K, Farmaki E, et al
Arterial stiffness and nocturnal hypertension in preterm children and adolescents.
J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00055.
PubMed Abstract available

MANCIA G, Facchetti R, Quarti-Trevano F, Grassi G, et al
Antihypertensive drug treatment in white-coat hypertension: data from the Plaque HYpertension Lipid-Lowering Italian Study.
J Hypertens. 2022 Jul 26. pii: 00004872-990000000-00056.
PubMed Abstract available

MAGHAJOTHI S, Subramanian L, Mani P, Singh M, et al
A common Matrix metalloproteinase 8 promoter haplotype enhances the risk for hypertension via diminished interactions with nuclear factor kappa B.
J Hypertens. 2022 Jul 25. pii: 00004872-990000000-00050.
PubMed Abstract available

XU J, Zhong Y, Yin H, Linneman J, et al
Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCgamma1 axis.
J Hypertens. 2022 Jul 14. pii: 00004872-990000000-00040.
PubMed Abstract available

SIMS BM, Goodlett BL, Allbee ML, Pickup EJ, et al
Time restricted feeding decreases renal innate immune cells and blood pressure in hypertensive mice.
J Hypertens. 2022 Jul 12. pii: 00004872-990000000-00037.
PubMed Abstract available

AGBAJE AO
Arterial stiffness precedes hypertension and metabolic risks in youth: a review.
J Hypertens. 2022 Jul 11. pii: 00004872-990000000-00039.
PubMed Abstract available

POUDEL B, Viera AJ, Shimbo D, Schwartz JE, et al
Comparison of the association of masked hypertension defined by the 2017 ACC/AHA BP guideline versus the JNC7 guideline with left ventricular hypertrophy.
J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00030.
PubMed Abstract available

ZHU Y, Tao Y, Wu C, Zeng Y, et al
Renal Farnesoid X Receptor improves high fructose-induced salt-sensitive hypertension in mice by inhibiting DNM3 to promote nitro oxide production.
J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00029.
PubMed Abstract available

SRIVASTAVA S, Vemulapalli B, Okoh AK, Kassotis J, et al
Disparity in hospital admissions and length of stay based on income status for emergency department hypertensive crisis visits.
J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00024.
PubMed Abstract available

THEODORAKOPOULOU MP, Karagiannidis AG, Alexandrou ME, Polychronidou G, et al
Sex differences in ambulatory blood pressure levels, control and phenotypes of hypertension in hemodialysis patients.
J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00031.
PubMed Abstract available

DU TOIT WL, Kruger R, Gafane-Matemane LF, Schutte AE, et al
Urinary metabolomics profiling by cardiovascular risk factors in young adults: the African Prospective study on Early Detection and Identification of Cardiovascular disease and Hypertension study.
J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00032.
PubMed Abstract available

FANG J, Zhang Z, Greenlund KJ
Association of depressive symptoms and hypertension prevalence, awareness, treatment and control among USA adults.
J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00035.
PubMed Abstract available

BIRUKOV A, Glintborg D, Schulze MB, Jensen TK, et al
Elevated blood pressure in pregnant women with gestational diabetes according to the WHO criteria: importance of overweight.
J Hypertens. 2022 Jul 6. pii: 00004872-990000000-00028.
PubMed Abstract available

SOHN CS, Chang JW, George B, Chen S, et al
Role of the angiotensin type 1 receptor in modulating the carotid chemoreflex in an ovine model of renovascular hypertension.
J Hypertens. 2022;40:1421-1430.
PubMed Abstract available

CAVAGNA P, Kramoh KE, Diop IB, Kouam Kouam C, et al
Barriers to up-titrated antihypertensive strategies in 12 sub-Saharan African countries: the Multination Evaluation of hypertension in Sub-Saharan Africa Study.
J Hypertens. 2022;40:1411-1420.
PubMed Abstract available

KYRIAKOULIS KG, Ntineri A, Niiranen TJ, Lindroos A, et al
Home blood pressure monitoring schedule: optimal and minimum based on 2122 individual participants' data.
J Hypertens. 2022;40:1380-1387.
PubMed Abstract available

AZUKAITIS K, Sinha MD, Obrycki L, Pac M, et al
Disparities between determinants of impaired vascular structure and function in young people with primary hypertension: a systematic review.
J Hypertens. 2022;40:1369-1379.
PubMed Abstract available

AN H, Jin M, Li Z, Zhang L, et al
Association of gestational hypertension and preeclampsia with nonsyndromic orofacial clefts in China: a large prospective cohort study.
J Hypertens. 2022;40:1352-1358.
PubMed Abstract available

TATSUMI Y, Satoh M, Asayama K, Murakami T, et al
Association of home and office systolic and diastolic hypertension with glucose metabolism in a general population: the Ohasama study.
J Hypertens. 2022;40:1336-1343.
PubMed Abstract available

CHEDIER B, Roderjan CN, Cavalcanti AH, de Souza F, et al
Prevalence and associated factors of obstructive sleep apnea in refractory hypertension.
J Hypertens. 2022;40:1327-1335.
PubMed Abstract available

ARIFEN N, Li Y, Srivastava AK, Anand-Srivastava MB, et al
Sirtuin1 inhibitor attenuates hypertension in spontaneously hypertensive rats: role of Gialpha proteins and nitroxidative stress.
J Hypertens. 2022;40:1314-1326.
PubMed Abstract available

ANTZA C, Stabouli S, Kotsis V
Practical guide for the management of hypertensive disorders during pregnancy.
J Hypertens. 2022;40:1257-1264.
PubMed Abstract available

KALAGARA R, Chennareddy S, Scaggiante J, Matsoukas S, et al
Blood pressure management through application-based telehealth platforms: a systematic review and meta-analysis.
J Hypertens. 2022;40:1249-1256.
PubMed Abstract available

June 2022

LIAO Y, Chu C, Wang Y, Zheng W, et al
Isolated diastolic hypertension in childhood and risk of adult subclinical target organ damage: a 30-year prospective cohort study.
J Hypertens. 2022 Jun 22. pii: 00004872-990000000-00010.
PubMed Abstract available

OGGERO S, Godec T, van Gorp R, Pinto LA, et al
Role of plasma extracellular vesicles in prediction of cardiovascular risk and alterations in response to statin therapy in hypertensive patients.
J Hypertens. 2022 Jun 22. pii: 00004872-990000000-00012.
PubMed Abstract available

STERGIOU GS, Mukkamala R, Avolio A, Kyriakoulis KG, et al
Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.
J Hypertens. 2022 Jun 17. pii: 00004872-990000000-00007.
PubMed Abstract available

POTHURU S, Chan WC, Ranka S, Acharya P, et al
Epidemiology and outcomes of hypertensive crisis in patients with chronic kidney disease: a nationwide analysis.
J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00003.
PubMed Abstract available

SMITH PJ, Andrew S, Hinderliter AL, Mabe S, et al
Lifestyle modification and cognitive function among individuals with resistant hypertension: cognitive outcomes from the TRIUMPH trial.
J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00005.
PubMed Abstract available

MARQUES-VIDAL P, Chekanova V, Vaucher J
Association between genetic risk of high SBP and hypertension control: the CoLaus|PsyColaus study.
J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00002.
PubMed Abstract available

BERILLO O, Huo KG, Richer C, Fraulob-Aquino JC, et al
Distinct transcriptomic profile of small arteries of hypertensive patients with chronic kidney disease identified miR-338-3p targeting GPX3 and PTPRS.
J Hypertens. 2022 Jun 13. pii: 00004872-990000000-00006.
PubMed Abstract available

Impact of early glomerular filtration rate decline in response to antihypertensive treatment on risk of end-stage kidney disease and cardiovascular outcomes: a systematic review and meta-analysis: Erratum.
J Hypertens. 2022;40:1248.
PubMed

RIETZ H, Pennlert J, Nordstrom P, Brunstrom M, et al
Prevalence, time-trends and clinical characteristics of hypertension in young adults: nationwide cross-sectional study of 1.7 million Swedish 18-year-olds, 1969-2010.
J Hypertens. 2022;40:1231-1238.
PubMed Abstract available

SADANANTHAN SA, Michael N, Tint MT, Thirumurugan K, et al
Associations of maternal periconceptional alcohol consumption with offspring prehypertension/hypertension at age 6 years: the Growing Up in Singapore Towards healthy Outcomes prospective mother-offspring cohort study.
J Hypertens. 2022;40:1212-1222.
PubMed Abstract available

FERMOYLE CC, Broxterman RM, La Salle DT, Ratchford SM, et al
Persistent vascular dysfunction following an acute nonpharmacological reduction in blood pressure in hypertensive patients.
J Hypertens. 2022;40:1115-1125.
PubMed Abstract available

ABRAHIN O, Abrahin RP, de Sousa EC, Cortinhas-Alves EA, et al
Inter-individual variations in response to aerobic and resistance training in hypertensive older adults.
J Hypertens. 2022;40:1090-1098.
PubMed Abstract available

ANTZA C, Farmakis I, Doundoulakis I, Akrivos E, et al
Reproducibility of masked hypertension and office-based hypertension: a systematic review and meta-analysis.
J Hypertens. 2022;40:1053-1059.
PubMed Abstract available

ALIMENTO ML, Palermo P, Italiano G, Antonioli L, et al
Can beta-blockers influence regular daily physical activity?
J Hypertens. 2022;40:1199-1203.
PubMed Abstract available

KOU C, Zhao X, Lin X, Fan X, et al
Effect of different treatments for obstructive sleep apnoea on blood pressure.
J Hypertens. 2022;40:1071-1084.
PubMed Abstract available

GUTTERIDGE DS, Tully PJ, Ghezzi ES, Jamadar S, et al
Blood pressure variability and structural brain changes: a systematic review.
J Hypertens. 2022;40:1060-1070.
PubMed Abstract available

AUNE A, Gerdts E, Kokorina M, Kringeland E, et al
Persistent cardiac organ damage in surgically and medically treated primary aldosteronism.
J Hypertens. 2022;40:1204-1211.
PubMed Abstract available

BUFFOLO F, Burrello J, Burrello A, Heinrich D, et al
DEVELOPMENT OF CLINICAL SCORING SYSTEM AND MACHINE LEARNING-BASED MODEL TO PREDICT DIAGNOSIS OF PRIMARY ALDOSTERONISM IN PATIENTS WITH HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ZHOU H, Wang X, Chen Z, Zhang L, et al
EFFECT OF A WEB-BASED MANAGEMENT PLATFORM ON HYPERTENSION CONTROL IN COMMUNITY: A RANDOMIZED CLINICAL TRIAL.
J Hypertens. 2022;40.
PubMed Abstract available

UAGBOE AA, Ogboye A, Munee MM, Rahman KJ, et al
LEVERAGING TECHNOLOGY TO SUPPORT PEOPLE LIVING WITH HYPERTENSION AND DIABETES DURING THE COVID-19 PANDEMIC.
J Hypertens. 2022;40.
PubMed Abstract available

LUQUE P, Castilla-Guerra L, Sanchez N, Delgado M, et al
THE IMPACT OF HYPERTENSION AND ANTIHIPERTENSIVE TREATMENTS ON PATIENTS WITH SARS-COV-2: A RETROSPECTIVE-COHORT STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

SHALAEVA E, Shamsutdinova M, Shadmanov A, Boymuradov S, et al
COVID-19 AND NEW ONSET HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

WEBER T, Kreutz R, Januszewicz A, Mayer C, et al
COVID-19 ASSOCIATED REDUCTION IN HYPERTENSION-RELATED DIAGNOSTIC AND THERAPEUTIC PROCEDURES IN EXCELLENCE CENTERS OF THE EUROPEAN SOCIETY OF HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

CANDUSSO G, Catena C, Soardo G, Baiano V, et al
NON-INVASIVE BIOCHEMICAL SCORES OF NAFLD AND CAROTID MORPHOFUNCTIONAL ALTERATIONS IN NEVER TREATED ESSENTIAL HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

AZUKAITIS K, Rus R, Sagsak E, Jankauskiene A, et al
SYSTOLIC AND DIASTOLIC LEFT VENTRICULAR DYSFUNCTION IN CHILDREN WITH PRIMARY HYPERTENSION: A SYSTEMATIC REVIEW.
J Hypertens. 2022;40.
PubMed Abstract available

MYETTE R, Obrycki L, Litwin M, Seeman T, et al
THE PREVALENCE AND IMPACT OF ISOLATED DIASTOLIC HYPERTENSION IN CHILDREN.
J Hypertens. 2022;40.
PubMed Abstract available

SKRZYPCZYK P, Ofiara A, Szyszka M, Wabik A, et al
CIRCADIAN BLOOD PRESSURE PROFILE IN PEDIATRIC PATIENTS WITH PRIMARY HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SKRZYPCZYK P, Pawlik K, Bujanowicz A, Wroniewicz T, et al
LIPID INDICES, ARTERIAL DAMAGE AND ALBUMINURIA IN PEDIATRIC PATIENTS WITH UNTREATED PRIMARY HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SZYSZKA M, Skrzypczyk P, Ofiara A, Wabik A, et al
COMMON CAROTID ARTERY ELASTICITY, INTIMA-DIAMETER RATIO, AND TENSILE STRESS IN PEDIATRIC PATIENTS WITH PRIMARY HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ARNOLDI C, Capellini S, Zuccotti L, Paini A, et al
RELATIONSHIP BETWEEN COGNITIVE IMPAIRMENT AND HYPERTENSION MEDIATED ORGAN DAMAGE: THE VOBARNO STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

DE LA COLINA AN, Vasiliadis HM, Berbiche D, Bherer L, et al
IMPACT OF SEX AND ANTIHYPERTENSIVE MEDICATION ON GLOBAL COGNITION IN PRIMARY CARE OLDER ADULTS.
J Hypertens. 2022;40.
PubMed Abstract available

SUKHAREVA A, Falkovskaya A, Baev AE, Mochula OV, et al
MRI IN THE ASSESSMENT OF CEREBRAL INJURY AND CEREBROPROTECTIVE EFFECTS OF RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

TRIANTAFYLLOU G, Triantafyllou A, Dipla K, Zafeiridis A, et al
ASSOCIATION OF CEREBRAL OXYGENATION DURING EXERCISE WITH TARGET ORGAN DAMAGE IN HYPERTENSIVE AND NORMOTENSIVE INDIVIDUALS.
J Hypertens. 2022;40.
PubMed Abstract available

LIAKOS C, Karpanou E, Markou M, Grassos C, et al
SYNERGISTIC EFFECT OF HIGH HOMOCYSTEINE AND LOW VITAMIN B12 LEVELS ON CARDIOVASCULAR AND STROKE RISK OF HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

NGUYEN K, Abrahams N, Jewkes R, Mhlongo S, et al
EXPOSURES TO INTIMATE PARTNER VIOLENCE AND NON-PARTNER SEXUAL VIOLENCE ARE ASSOCIATED WITH HYPERTENSION IN SOUTH AFRICAN WOMEN.
J Hypertens. 2022;40.
PubMed Abstract available

PALATINI P, Mos L, Rattazzi M, Vriz O, et al
ORTHOSTATIC HYPERREACTIVITY AND THE CARDIOVASCULAR RISK IN JUVENILE AND MIDDLE-AGE HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

THEODORAKOPOULOU M, Iatridi F, Alexandrou ME, Karpetas A, et al
THE INFLUENCE OF AMBULATORY BLOOD PRESSURE ON THE ASSOCIATIONS OF INTRADIALYTIC HYPERTENSION WITH FUTURE CARDIOVASCULAR EVENTS AND MORTALITY IN HEMODIALYSIS PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

KHOMOVA I, Khramkova A, Shavarova E, Ezhova N, et al
ASSOCIATIONS BETWEEN EPICARDIAL FAT AND LEFT VENTRICULAR GEOMETRY IN YOUNG NON-OBESE HYPERTENSIVES.
J Hypertens. 2022;40.
PubMed Abstract available

NARITA K, Hoshide S, Kario K
SIMPLE PREDICTIVE SCORE FOR NOCTURNAL HYPERTENSION AND MASKED NOCTURNAL HYPERTENSION USING HOME BLOOD PRESSURE MONITORING IN CLINICAL PRACTICE.
J Hypertens. 2022;40.
PubMed Abstract available

QUARTI-TREVANO F, Seravalle G, Dell'Oro R, Facchetti R, et al
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS).
J Hypertens. 2022;40.
PubMed Abstract available

RATTAZZI M, Saladini F, Mos L, Fania C, et al
BLOOD PRESSURE RESPONSE TO STANDING IS A STRONG PREDICTOR OF MASKED HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SERAVALLE G, Facchetti R, Vanoli J, Dell'oro R, et al
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE.
J Hypertens. 2022;40.
PubMed Abstract available

CONSTANTINOS K, Stevens R, Hobbs FDR, McManus RJ, et al
PREDICTING THE RISK OF SYNCOPE IN PATIENTS WITH AN INDICATION FOR ANTIHYPERTENSIVE TREATMENT: DEVELOPMENT OF THE STRATIFY-SYNCOPE PREDICTION MODEL.
J Hypertens. 2022;40.
PubMed Abstract available

NADERI H, Ramirez J, Van Duijvenboden S, Aung N, et al
PREDICTING THE PATTERN OF ANATOMICAL LEFT VENTRICULAR HYPERTROPHY USING ELECTROPHYSIOLOGICAL BIOMARKERS FROM THE ECG QRS COMPLEX IN HYPERTENSIVE INDIVIDUALS FROM UK BIOBANK.
J Hypertens. 2022;40.
PubMed Abstract available

KJELDSEN SE, Zachs ES, Stokke IM, Wachtell K, et al
TIME-VARYING SERUM URIC ACID PREDICTS NEW-ONSET ATRIAL FIBRILLATION IN TREATED HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

BOGAERTS J, Gussekloo J, De Jong-Schmit B, Achterberg W, et al
THE DANTON STUDY - DISCONTINUATION OF ANTIHYPERTENSIVE TREATMENT IN OLDER PEOPLE WITH DEMENTIA LIVING IN A NURSING HOME: RESULTS OF A RANDOMIZED CONTROLLED TRIAL.
J Hypertens. 2022;40.
PubMed Abstract available

RANCEVIENE D, Azukaite J, Rysevaite-Kyguoliene K, Pauziene N, et al
IMPACT OF ARTERIAL HYPERTENSION VERSUS AGING TO THE STRUCTURES OF EPICARDIAC NERVES IN SPONTANEOUSLY HYPERTENSIVE RATS.
J Hypertens. 2022;40.
PubMed Abstract available

MENDEZ I, Saiz LC, Leache L, Gutierrez M, et al
BLOOD PRESSURE TARGETS AND MORTALITY IN HYPERTENSIVE PATIENTS WITH CHRONIC RENAL DISEASE. SYSTEMATIC REVIEW AND META-ANALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

BERGLUND J, Wijkman MO, Nilsson S
HIGHER PREVALENCE OF MASKED UNCONTROLLED HYPERTENSION WITH NEW EUROPEAN BLOOD PRESSURE TARGETS IN AN ELDERLY PRIMARY CARE POPULATION.
J Hypertens. 2022;40.
PubMed Abstract available

BURTSEV Y, Boytsov S, Karpov Y, Khomitskaya Y, et al
EFFECTIVENESS AND TOLERABILITY OF BISOPROLOL/PERINDOPRIL SINGLE-PILL COMBINATION IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND CONCOMITANT HYPERTENSION WHO HAD A HISTORY OF MIOCARDIAL INFARCTION.
J Hypertens. 2022;40.
PubMed Abstract available

GRECA E, Wireko AA, Abdul-Rahman T, Kacimi SEO, et al
ANTI-INFLAMMATORY EFFECTS AND PPAR GAMMA-ACTIVATING PROPERTIES OF TELMISARTAN IN PATIENTS WITH THE HYPERTENSION'S ON METABOLIC SYNDROME: METANALYSIS OF RCT.
J Hypertens. 2022;40.
PubMed Abstract available

KOVAL S, Penkova M, Mysnychenko O, Reznik L, et al
AMBULATORY BLOOD PRESSURE MONITORING PARAMETERS IN HYPERTENSIVE PATIENTS WITH ABDOMINAL OBESITY IN THE DYNAMICS OF OLMESARTAN/ AMLODIPINE THERAPY.
J Hypertens. 2022;40.
PubMed Abstract available

LEITE V, Abecasis F, Beirao P, Cunha V, et al
INTENSIVE SYSTOLIC BLOOD PRESSURE TARGET IN OLDER HYPERTENSIVE PATIENTS - IS IT BENEFICIAL?
J Hypertens. 2022;40.
PubMed Abstract available

PEI Y, Yu J
EFFECT OF SACUBITRIL-VALSARTAN ON EARLY RENAL FUNCTION AND VASCULAR FUNCTION IN PATIENTS DURING PERIMENOPAUSE WITH HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

BARRAGAN ACP, Leiva VG, Espejel LD
REACHING OF THERAPEUTICS GOALS IN PATIENTS WITH HYPERTENSION AND DIABETES MELLITUS. DO MULTIPLE THERAPY WORKS?
J Hypertens. 2022;40.
PubMed Abstract available

ZBYSHEVSKAYA E, Makeeva T, Gumerova V, Erinchek V, et al
VASCULAR STIFFNESS AS AN TARGET OF OPTIMAL ANTIHYPERTENSIVE THERAPY.
J Hypertens. 2022;40.
PubMed Abstract available

ZHUANG C, Wang W, Sun R, Qi M, et al
SACUBITRIL/VALSARTAN IMPROVES SEXUAL FUNCTION AND FIBROSIS OF THE CLITORAL AND VAGINAL TISSUES IN FEMALE SPONTANEOUSLY HYPERTENSIVE RATS.
J Hypertens. 2022;40.
PubMed Abstract available

AJOSE A, Odukoya OO, Akodu B
PERCEIVED STRESS, DEPRESSION AND MEDICATION ADHERENCE AMONG HYPERTENSIVE PATIENTS ATTENDING A SECONDARY CARE HOSPITAL IN LAGOS, NIGERIA.
J Hypertens. 2022;40.
PubMed Abstract available

JUG J, Prkacin I
ADHERENCE TO THE ANTIHYPERTENSIVE THERAPY - A VIEW FROM THE FAMILY MEDICINE PERSPECTIVE.
J Hypertens. 2022;40.
PubMed Abstract available

PAPPACCOGLI M, Georges CM, Petit G, Ritscher S, et al
DRUG ADHERENCE AND PSYCHOLOGICAL FACTORS MATTER IN PATIENTS WITH RESISTANT HYPERTENSION - YES BUT WHICH ONES?
J Hypertens. 2022;40.
PubMed Abstract available

BUFFOLO F, Sconfienza E, Burrello J, Losano I, et al
ESTIMATE OF ANTI-HYPERTENSIVE DRUG ADHERENCE THROUGH SERIAL MEASUREMENTS OF ALDOSTERONE-TO-RENIN RATIO.
J Hypertens. 2022;40.
PubMed Abstract available

COELHO J, Guimaraes M, Dos Santos J, Vaz A, et al
ADHERENCE TO ANTIHYPERTENSIVE DRUG TREATMENT IN BRAZIL: SYSTEMATIC REVIEW AND META-ANALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

HALVORSEN LV, Gognstad S, Soraas CL, Agnes C, et al
IMPLICATIONS OF CYP2D6 POLYMORPHISMS FOR THERAPEUTIC DRUG MONITORING IN PATIENTS WITH HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

LEE EK, Poon P, Bo Y, Zhu MT, et al
GLOBAL BURDEN, REGIONAL DIFFERENCES, TRENDS, AND HEALTH CONSEQUENCES OF MEDICATION NON-ADHERENCE IN PATIENTS WITH HYPERTENSION DURING 2010-2020: A SYSTEMATIC REVIEW AND META-ANALYS.
J Hypertens. 2022;40.
PubMed Abstract available

LEITE V, Coelho RP, Abecasis F, Beirao P, et al
HYPERTENSIVE CRISIS AT THE EMERGENCY DEPARTMENT OF A CENTRAL HOSPITAL.
J Hypertens. 2022;40.
PubMed Abstract available

LOPES S, Diniz F, Oliveira J, Mesquita-Bastos J, et al
RESISTANT HYPERTENSION PATIENTS' PERSPECTIVES ABOUT AN AEROBIC EXERCISE PROGRAM: INSIGHTS FROM THE ENRICH TRIAL.
J Hypertens. 2022;40.
PubMed Abstract available

MONTEALEGRE L, Navarro G, Amador E, Arteta M, et al
BELIEFS IN HEALTH AND ADHERENCE TO TREATMENT IN HYPERTENSIVE PATIENTS IN BARRANQUILLA- COLOMBIA.
J Hypertens. 2022;40.
PubMed Abstract available

MONTEALEGRE L, Amador E, Pulido T, Cabrera C, et al
MAIN FACTORS THAT DETERMINE ADHERENCE TO PHARMACOLOGICAL TREATMENT IN HYPERTENSIVE PATIENTS. SYSTEMATIC REVIEW.
J Hypertens. 2022;40.
PubMed Abstract available

OLIVERAS A, Galceran I, Camps C, Faura A, et al
MEDICATION NON-ADHERENCE IN UNCONTROLLED HYPERTENSION: SELECTIVE DETECTION AND EFFICIENCY AND EFFECTIVENESS OF A PROGRAM TO IMPROVE COMPLIANCE (ATHAN TRIAL).
J Hypertens. 2022;40.
PubMed Abstract available

PEETERS L, Kappers MHW, Hesselink DA, Net JBV, et al
RESISTANT HYPERTENSION IMPROVED AFTER 3 AND 6 MONTHS BY MEASURING DRUG LEVELS TO IDENTIFY NON-ADHERENCE.
J Hypertens. 2022;40.
PubMed Abstract available

RENNA N, Diez E, Vissani S, Farez B, et al
ASSESSMENT OF ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN A POPULATION OF ARGENTINA DURING THE COVID-19 PANDEMIC.
J Hypertens. 2022;40.
PubMed Abstract available

RIETZSCHEL E, Descamps O, De Sutter J, Philips JC, et al
ATHERO: AN OBSERVATIONAL CROSS-SECTIONAL EVALUATION OF ATHEROSCLEROTIC RISK CONTROL IN THE BELGIAN POPULATION TREATED WITH AT LEAST ONE ANTIHYPERTENSIVE AND ONE LIPID-LOWERING DRUG.
J Hypertens. 2022;40.
PubMed Abstract available

POLACZYK M, Olszanecka A, Wojciechowska W, Rajzer M, et al
MULTIPLE DRUG INTOLERANCE IN PATIENTS WITH ARTERIAL HYPERTENSION: PREVALENCE AND DETERMINING FACTORS.
J Hypertens. 2022;40.
PubMed Abstract available

TARNOVSKI L, Frkanec S, Frkanec S, Katic L, et al
THE PHARMACISTS' AND MOBILE APPLICATIONS' ROLE IN THE TREATMENT OF HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

FRAGOULIS C, Prentakis AG, Kontogianni E, Polyzos D, et al
DEPENDENCY RELATIONSHIP OF EXERCISE AND MEDICATION ADHERENCE IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

YOUSSEF G, Mohamed M, Remisy DE, Hamid MA, et al
REASONS OF NON-COMPLIANCE TO OFFICE VISITS IN HYPERTENSIVE PATIENTS: RESULTS FROM THE REGISTRY OF SPECIALIZED HYPERTENSION CLINICS.
J Hypertens. 2022;40.
PubMed Abstract available

HUANG JF, Zhang DY, An DW, Li MX, et al
ANTIHYPERTENSIVE TREATMENT IN MASKED HYPERTENSION FOR TARGET ORGAN PROTECTION (ANTI-MASK): A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
J Hypertens. 2022;40.
PubMed Abstract available

BAGADIA L
A RANDOMIZED CONTROLLED TRIAL OF INDIVIDUALIZED HOMOEOPATHIC TREATMENT TO REDUCE ANGER & THEREBY REDUCING HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

FILHO GG, Inuzuka S, Vitorino P, Sousa ALL, et al
PHARMACOLOGICAL TREATMENT OF ARTERIAL HYPERTENSION GUIDED BY PERIPHERAL OR CENTRAL BLOOD PRESSURE: COMPARISON OF THE TWO STRATEGIES IN THE INCIDENCE OF INTERMEDIATE OUTCOMES.
J Hypertens. 2022;40.
PubMed Abstract available

KONRADI A, Hassan H, Lefay D, Isachenko E, et al
CLINICAL EFFICACY AND SAFETY OF AMLODIPINE/BISOPROLOL/PERINDOPRIL SINGLE-PILL AND FREE COMBINATION THERAPY IN PATIENTS WITH UNCONTROLLED ESSENTIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

JARAI Z, Amon T, Baracsi-Botos V, Meszaros A, et al
TELMISARTAN/AMLODIPINE SINGLE-PILL COMBINATION THERAPY TO ACHIEVE BLOOD PRESSURE GOAL VALUES IN HYPERTENSIVE PATIENTS IN GPS' PRACTICE - AN OBSERVATIONAL STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

KAM E, Lee P, Poon P, Yu CP, et al
CONTROLLED-RELEASED ORAL MELATONIN SUPPLEMENTATION FOR HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

GUO Q, Lin J, Peng F, Chai D, et al
CARDIOVASCULAR OUTCOMES OF INITIAL BETA-BLOCKER + CALCIUM CHANNEL BLOCKER THERAPY VS OTHER DUAL THERAPIES IN CHINESE PATIENTS WITH NEWLY DIAGNOSED HYPERTENSION: A REAL-WORLD STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

LOPES S, Mesquita-Bastos J, Garcia C, Oliveira J, et al
ACUTE AEROBIC EXERCISE-INDUCED DECREASE IN BLOOD PRESSURE IS ASSOCIATED WITH CHRONIC BLOOD PRESSURE CHANGES IN PATIENTS WITH RESISTANT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

MIKHAILOVA O, Elfimova E, Khachatryan N, Litvin A, et al
PRESCRIBED ANTIHYPERTENSIVE AGENTS IN PATIENTS WITH AND WITHOUT ITS "ESCAPE'' PHENOMENON.
J Hypertens. 2022;40.
PubMed Abstract available

MOURAD JJ, Jamet P, Huguet M, Loubiere M, et al
TRIPLE ANTIHYPERTENSIVE THERAPY TYPE AND USE IN FRENCH GENERAL PRACTICE AND CARDIOLOGY IN 2021.
J Hypertens. 2022;40.
PubMed Abstract available

RADCHENKO G, Sirenko Y, Torbas O
THE OPEN-LABEL MULTICENTRAL STUDY OF ANTIHYPERTENSIVE FIXED-DOSE COMBINATION EFFECTIVENESS IN UKRAINE.
J Hypertens. 2022;40.
PubMed Abstract available

SHEPPARD J, Koshiaris C, Stevens R, McManus R, et al
THE ASSOCIATION BETWEEN ANTIHYPERTENSIVE TREATMENT AND SERIOUS ADVERSE EVENTS BY AGE AND FRAILTY: AN OBSERVATIONAL COHORT STUDY OF 3.8 MILLION PATIENTS FOLLOWED UP FOR 10 YEARS.
J Hypertens. 2022;40.
PubMed Abstract available

SHUPENINA E, Vasyuk Y, Namazova G
OBSERVATIONAL PROSPECTIVE STUDY OF AZILSARTAN MEDOXOMIL/ CHLORTALIDONE COMPARED WITH IRBESARTAN/ HYDROCHLOROTHIAZIDE COMBINATION THERAPY IN OBESE HYPERTENSIVES (PUZZLE).
J Hypertens. 2022;40.
PubMed Abstract available

FRAGOULIS C, Polyzos D, Konstantinidis D, Mavroudis A, et al
GENDER AS A RISK FACTOR FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH HYPERTENSIVE CRISES AFTER 12-MONTH FOLLOW-UP: A GREEK REGISTRY.
J Hypertens. 2022;40.
PubMed Abstract available

KOUREMETI M, Iliakis P, Konstantinidis D, Polyzos D, et al
EPLERENONE VS IRBESARTAN AS FIRST LINE THERAPY IN OBESE HYPERTENSIVE PATIENTS: PRELIMINARY RESULTS FROM HEBRO STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

YU X, Xu R
DAPAGLIFLOZIN'S EFFECT ON SERUM HOMOCYSTEINE IN PATIENTS WITH HYPERTENSION COMPLIACTED WITH INSULIN RESISTANCE.
J Hypertens. 2022;40.
PubMed Abstract available

BOULESTREAU R, Tillement J, Lucas L, Cremer A, et al
IS HEADACHE AT ADMISSION ASSOCIATED WITH HIGHER RATE OF RECENT BRAIN MRI INJURY DURING MALIGNANT HYPERTENSION CRISIS?
J Hypertens. 2022;40.
PubMed Abstract available

LUIS CG, Linero PL, Moreno MDCF, Fito MS, et al
TRENDS IN ANTIHYPERTENSIVE MEDICATION USE AFTER ISCHEMIC STROKE (1999-2020).
J Hypertens. 2022;40.
PubMed Abstract available

PINTO D, Rato ND, Garcia C, Teixeira M, et al
ADHERENCE TO PHYSICAL ACTIVITY IN OLDER ADULTS WITH HYPERTENSION: LESSONS FROM THE HOLDAGE RANDOMIZED CONTROLLED TRIAL.
J Hypertens. 2022;40.
PubMed Abstract available

NUNEZ URQUIZA JP, Marti A, Cervantes N, Reza APS, et al
EVALUATION OF BLOOD PRESSURE CONTROL AND THE EFFECTIVENESS OF DIFFERENT ANTIHYPERTENSIVES BY MEANS OF THE STRESS TEST.
J Hypertens. 2022;40.
PubMed Abstract available

SENER YZ, Durukan BN, Ozcan EB, Kutukcu EC, et al
EFFECTS OF LEFT VENTRICULAR MASS INDEX AND LEFT VENTRICULAR GEOMETRY ON 6 MINUTE STEPPER TEST RESULTS IN PATIENTS WITH HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

NEMER CB, Chedier B, de Hollanda Cavalcanti A, Nejm Roderjan C, et al
IMPACT OF LONG-TERM USE OF CPAP TREATMENT ON BLOOD PRESSURE AMONG REFRACTORY HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA.
J Hypertens. 2022;40.
PubMed Abstract available

RODERJAN CN, de Souza F, Chedier B, de Hollanda Cavalcanti A, et al
EFFECT OF LONG-TERM USE OF CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT ON ARTERIAL STIFFNESS IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND RESISTANT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

DENISOVA A, Solntseva T, Sivakova O, Chazova I, et al
FACTORS ASSOCIATED WITH AN INCREASED RISK OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

FERRAO D, Silva C, Matos M, Ferreira S, et al
VASCULITIS AND RENOVASCULAR HYPERTENSION - A CASE REPORT.
J Hypertens. 2022;40.
PubMed Abstract available

VARETA G, Georgianos P, Vaios V, Sgouropoulou V, et al
PREVALENCE OF APPARENT-TREATMENT RESISTANT HYPERTENSION IN PERITONEAL DIALYSIS PATIENTS ASSESSED WITH THE USE OF 24-HOUR AMBULATORY BLOOD PRESSURE MONITORING.
J Hypertens. 2022;40.
PubMed Abstract available

IONOV M, Emelyanov I, Vakhrushev A, Alieva A, et al
RADIOFREQUENCY RENAL SYMPATHETIC DENERVATION WITH MULTIELECTRODE CATHETERS IN PATIENTS WITH RESISTANT HYPERTENSION: EARLY PROCEDURAL RESULTS.
J Hypertens. 2022;40.
PubMed Abstract available

KVAPIL T, Vaclavik J, Kocianova E, Benesova K, et al
SHOULD ALL SECONDARY CAUSES OF HYPERTENSION BE SCREENED IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION?
J Hypertens. 2022;40.
PubMed Abstract available

MANUKYAN M, Falkovskaya A, Mordovin V, Zyubanova I, et al
A CLINICAL CASE OF SECONDARY HYPERTENSION IN A 20-YEAR-OLD FEMALE WITH COARCTATION OF THE AORTA.
J Hypertens. 2022;40.
PubMed Abstract available

MANUKYAN M, Falkovskaya A, Mordovin V, Zyubanova I, et al
SYSTEMIC VASCULAR RESISTANCE AS A PREDICTOR OF ANTIHYPERTENSIVE EFFICIENCY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
J Hypertens. 2022;40.
PubMed Abstract available

MATOVA O, Mishchenko L, Talaeva T
CARDIOVASCULAR AND KIDNEY OUTCOMES IN TREATED RESISTANT HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

DE CARVALHO FORTES C, Chedier B, Roderjan CN, Viegas B, et al
CHANGES IN CLINICAL PROFILE OF REFRACTORY HYPERTENSIVES AFTER THE INTRODUCTION OF SPIRONOLACTONE.
J Hypertens. 2022;40.
PubMed Abstract available

CHEDIER B, Souza F, Viegas B, Carlos FOC, et al
PROGNOSTIC OF PATIENTS WITH REFRACTORY HYPERTENSION IN A COHORT OF RESISTANT HYPERTENSIVES.
J Hypertens. 2022;40.
PubMed Abstract available

RAMIK Z, Vaclavik J, Kvapil T, Jelinek L, et al
LONG TERM EFFECT OF RESISTANT ARTERIAL HYPERTENSION ON RENAL FUNCTION IN COMPARISON TO NON-RESISTANT ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SHALIMOVA A, Isayeva G, Buriakovska O, Vovchenko M, et al
DISTURBANCES OF THE CIRCADIAN RHYTHM AND BLOOD PRESSURE LEVELS IN OBESE PATIENTS WITH TRUE AND PSEUDO-RESISTANT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SOLNTSEVA T, Denisova A, Sivakova O, Chazova I, et al
STATE OF TARGET ORGANS DAMAGE AND PREVALENCE OF CLINICAL ASSOCIATED CONDITIONS IN PATIENTS WITH A HYPERTENSIVE CRISIS AND UNCONTROLLED HYPERTENSION. (PILOT STUDY).
J Hypertens. 2022;40.
PubMed Abstract available

SUKHAREVA A, Falkovskaya A, Baev AE, Mochula OV, et al
MRI POTENTIAL FOR PREDICTION OF THE ANTIHYPERTENSIVE EFFECT OF RFA IN PATIENTS WITH TREATMENT-RESISTANT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

TABBALAT R, Al-Hayek T, Al Ani H, Barghouthi H, et al
PRIMARY ALDOSTERONISM: INITIAL EXPERIENCE FROM A NEWLY ESTABLISHED ESH HYPERTENSION CENTER OF EXCELLENCE - WORK IN PROGRESS.
J Hypertens. 2022;40.
PubMed Abstract available

KUZIOR A, Hernandez-Lazaro A, De Leon-Durango R, Rios-Gomez C, et al
EXTREMELY HIGH DIRECT PLASMA RENIN IN A YOUNG WOMAN WITH NEGATIVE IMAGING FOR RENOVASCULAR HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

BOSCH A, Poglitsch M, Kannenkeril D, Ott C, et al
ANGIOTENSIN PROFILES IN PATIENTS WITH HYPERTENSION AND TYPE 2 DIABETES WITH COMBINATION THERAPY OF EMPAGLIFLOZIN AND LINAGLIPTIN VERSUS METFORMIN AND INSULIN GLARGINE.
J Hypertens. 2022;40.
PubMed Abstract available

BOULESTREAU R, Lorthioir A, Persu A, Cremer A, et al
MALIGNANT HYPERTENSION HAMA COHORT: WHERE DO WE STAND IN 2021?
J Hypertens. 2022;40.
PubMed Abstract available

VISCHER A, Socrates T, Glinz D, Mayr M, et al
ASSOCIATION OF BASELINE ALDOSTERONE/RENIN WITH MAGNITUDE OF BLOOD PRESSURE REDUCTION FROM FIRST-LINE TREATMENT IN TREATMENT-NAIVE HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

BEKBERGENOVA Z, Derbissalina G, Umbetzhanova A, Batarbekova S, et al
EVALUATION OF THE QUALITY OF SCREENING FOR HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

BEKBERGENOVA Z, Derbissalina G, Umbetzhanova A, Batarbekova S, et al
INFLUENCE OF FACTORS ON SYSTOLIC BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION IDENTIFIED DURING SCREENING.
J Hypertens. 2022;40.
PubMed Abstract available

BEKBERGENOVA Z, Derbissalina G, Umbetzhanova A, Batarbekova S, et al
THE INFLUENCE OF HEREDITY ON LIFESTYLE CHANGES AND PARTICIPATION IN SCHOOL OF CHRONIC PATIENTS IN PATIENTS WITH HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

HUMBERT X, Rabiaza A
PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS ARE INFLUENCED BY THE CHARACTERISTICS OF GENERAL PRACTITIONERS AND THEIR PATIENTS: A CROSS-SECTIONAL STUDY IN NORMANDY (FRANCE).
J Hypertens. 2022;40.
PubMed Abstract available

JUG J, Lang VB, Prkacin I
ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSIVE CRISIS.
J Hypertens. 2022;40.
PubMed Abstract available

MOURAD JJ, Jamet P, Huguet M, Suhl J, et al
ANTIHYPERTENSIVE TREATMENT INITIATION IN FRANCE: WHAT DID GENERAL PRACTITIONERS PRESCRIBE IN 2021?
J Hypertens. 2022;40.
PubMed Abstract available

GUIMIL PD, Herranz ED, Gonzalez ER, Testillano LM, et al
WOMEN WITH HYPERTENSIVE STATES OF PREGNANCY FOLLOW IN NEPHROLOGY: CHARACTERISTICS AND EVOLUTION AFTER DELIVERY.
J Hypertens. 2022;40.
PubMed Abstract available

SOCRATES T, Wenker C, Blaschke C, Vischer A, et al
FEASIBILITY, ACCEPTANCE AND SAFETY OF A HOME BASED TELEMONITORING STRATEGY IN WOMEN WITH POSTPARTUM HYPERTENSION. INTERIM ANALYSIS OF THE SWISS REGISTER FOR WOMEN WITH PPHT.
J Hypertens. 2022;40.
PubMed Abstract available

DA SILVA IV, Santos AC, Matos A, Ferreira J, et al
AQUAPORIN-3 AND HEPARANASE GENETIC POLYMORPHISMS MAY MODULATE ANGIOGENESIS INFLUENCING THE RISK OF HYPERTENSIVE DISORDERS IN WOMEN.
J Hypertens. 2022;40.
PubMed Abstract available

STIRBAN R, Dragoi D, Grigore C, Balaceanu B, et al
IT IS SOMETHING MAKING THE DIFFERENCE BETWEEN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME VERSUS HYPERTENSIVE PATIENTS WITHOUT METABOLIC SYNDROME IN SARS-COV-2 INFECTION?
J Hypertens. 2022;40.
PubMed Abstract available

CANTU SM, Lee HJ, Mikusic NLR, Kouyoumdzian NM, et al
ALTERATION OF RENAL DOPAMINERGIC SYSTEM IN RATS FED WITH HIGH FAT DIET: A POSSIBLE MECHANISM PROMOTING ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

GASPAR L, Mesarosova D
PECULIARITIES OF TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH METABOLIC SYNDROME.
J Hypertens. 2022;40.
PubMed Abstract available

KOKAEVA I, Zhernakova Y, Blinova N, Elfimova E, et al
ENDOTHELIAL COMPLICATIONS IN HYPERTENSIVE PATIENTS WITH OBESITY OR NORMAL BODY WEIGHT AFTER COVID-19.
J Hypertens. 2022;40.
PubMed Abstract available

KOVAL S, Snihurska I, Yushko K
CHANGES IN THE COMPOSITION OF THE GUT MICROBIOTA IN THE OBESE HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

MASTROGIANNIS K, Lazaridis A, Triantafillou A, Koletsos N, et al
CORRELATION OF COGNITIVE STATUS WITH IMPAIRED SKIN MICROVASCULAR REACTIVITY IN NEWLY DIAGNOSED UNTREATED HYPERTENSIVES.
J Hypertens. 2022;40.
PubMed Abstract available

ZAMMANIS I, Konstantinidis D, Tatakis F, Drogkaris S, et al
THE ROLE OF MICROCIRCULATION ON BLOOD PRESSURE AND HEART RATE RESPONSE DURING EXERCISE STRESS TESTING IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

YAROVOY S, Chazova I, Danilov N, Matchin Y, et al
POSITIVE PULMONARY ARTERY REMODELING AFTER A SERIES OF BALLOON PULMONARY ANGIOPLASTIES IN A PATIENT WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

PINTO D, Rato ND, Garcia C, Teixeira M, et al
EFFECTS OF HOME-BASED ISOMETRIC HANDGRIP OR AEROBIC EXERCISE TRAINING IN OLDER ADULTS WITH PRE-HYPERTENSION AND HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

MANTA E, Thomopoulos C, Konstantinidis D, Tatakis F, et al
EFFECT OF DIETARY APPROACHES TO STOP HYPERTENSION DIET OR MEDITERRANEAN DIET ON BLOOD PRESSURE IN INDIVIDUALS WITH OR WITHOUT HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

PRATISTITA PTP, Marbun MB
THE ROLE OF DIETARY APPROACHES TO STOP HYPERTENSION (DASH DIET) ON BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SPRONCK B, Caulk AW, Ramachandra AB, Murtada SI, et al
DIFFERENTIAL AORTIC REMODELING EFFECTS OF NOREPINEPHRINE- AND ANGIOTENSIN II-INDUCED HYPERTENSION IN MICE.
J Hypertens. 2022;40.
PubMed Abstract available

MCDERMOTT EA, Mensah EA, Fantin F, Okorie M, et al
WHITE-COAT HYPERTENSION: SIZE OF THE WHITE-COAT EFFECT IS STRONGLY ASSOCIATED WITH CENTRAL ARTERIAL STIFFNESS.
J Hypertens. 2022;40.
PubMed Abstract available

REKOVETS O, Sirenko Y, Torbas O, Kushnir S, et al
DINAMICS OF ARTERIAL STIFFNESS USING CAVI INDEX DEPENDS ON ADDED STATIN TO FIXED COMBINATION ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SALADINI F, Rattazzi M, Faggin E, Palatini P, et al
CAROTID ELASTICITY IS IMPAIRED IN STAGE 1 HYPERTENSIVE PATIENTS EVEN IF BLOOD PRESSURE IS WELL CONTROLLED BY TREATMENT.
J Hypertens. 2022;40.
PubMed Abstract available

THEODORAKOPOULOU M, Alexandrou ME, Iatridi F, Faitatzidou D, et al
COMPARISON OF AMBULATORY CENTRAL HEMODYNAMICS AND ARTERIAL STIFFNESS IN HEMODIALYSIS PATIENTS WITH AND WITHOUT INTRADIALYTIC HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

JAQUES DA, Vollenweider P, Bochud M, Ponte B, et al
AGING AND HYPERTENSION IN KIDNEY FUNCTION DECLINE: A 10-YEAR POPULATION-BASED STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

MAHMOUD NB, Hamouda M, Maatoug J, Salem MB, et al
HYPERTENSION AS A RISK FACTOR FOR MORTALITY AND THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE AFTER AN EPISODE OF ACUTE KIDNEY INJURY WITH FULL RECOVERY.
J Hypertens. 2022;40.
PubMed Abstract available

BEZRODNA L, Mishchenko L, Serbenjuk K, Matova O, et al
EARLY MARKERS OF THE KIDNEYS DAMAGE IN PATIENTS WITH RESISTANT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

DE LEEUW PW, Houben AJ, Kroon AA
RENAL EXTRACTION EFFICIENCY FOR PAH IS COMPARABLE IN ESSENTIAL HYPERTENSION AND RENAL FIBROMUSCULAR DYSPLASIA.
J Hypertens. 2022;40.
PubMed Abstract available

HENDRIKS-BALK M, Damianaki A, Polychronopoulou E, Brito W, et al
RENAL MICROPERFUSION RESPONSE TO A COLD PRESSURE TEST IS DECREASED IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

KNEZEVIC T, Padjen I, Laganovic M, Ivkovic V, et al
TRAJECTORIES OF BLOOD PRESSURE, TREATMENT PATTERNS AND HYPERTENSION CONTROL IN PATIENTS WITH LUPUS NEPHRITIS - DATA FROM A RETROSPECTIVE COHORT STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

LEIBA A, Rappoport V, Hausmann M
ACUTE RENAL FAILURE PROGRESSING TO ESRD IN A PATIENT WITH UNTREATED HIGH GRADE HYPERTENSION - THE MALIGNANT NATURE OF "BENIGN'' NEPHROSCLEROSIS.
J Hypertens. 2022;40.
PubMed Abstract available

MARTINEZ-ARROYO O, Ortega A, Solaz E, Martinez F, et al
DECREASED URINARY LEVELS OF SIRT1 AS NON-INVASIVE BIOMARKER OF EARLY RENAL DAMAGE IN HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SCHASTLIVENKO A, Vykhrystenka L
HIGH INCIDENCE OF CHRONIC KIDNEY DISEASE IN THE BELARUSIAN POPULATION PARTICULARLY IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

DZHURYAK V, Sydorchuk A, Voroniuk K, Sydorchuk L, et al
ALDOSTERONE SYNTHASE CYP11B2 (-344C/T) GENE POLYMORPHISM INFLUENCES RISK OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

TAKENAKA T
CENTRAL AND BRACHIAL PULSE PRESSURE PREDICTS CARDIOVASCULAR AND RENAL EVENTS IN TREATED HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

ANNA M, Alexandru C, Marcel A, Nicolae C, et al
THE EFFECT OF RENAL DENERVATION ON THE CIRCADIAN BLOOD PRESSURE PATTERN IN PATIENTS WITH RESISTANT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

FALKOVSKAYA A, Mordovin V, Pekarskiy S, Manukyan M, et al
FEATURES OF CHANGES IN THE LEVELS OF MATRIX METALLOPROTEINASES AND THEIR INHIBITORS IN DIABETIC PATIENTS WITH RESISTANT HYPERTENSION AFTER RENAL DENERVATION.
J Hypertens. 2022;40.
PubMed Abstract available

FALKOVSKAYA A, Mordovin V, Pekarskiy S, Manukyan M, et al
THE EFFECT OF RENAL DENERVATION ON CEREBRAL BLOOD FLOW IN DIABETIC PATIENTS WITH RESISTANT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

FALKOVSKAYA A, Mordovin V, Pekarskiy S, Manukyan M, et al
THE EFFECT OF RENAL DENERVATION ON PERIPHERAL AND CEREBRAL VASOREACTIVITY IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
J Hypertens. 2022;40.
PubMed Abstract available

MANUKYAN M, Falkovskaya A, Mordovin V, Zyubanova I, et al
LEPTIN AS A PREDICTOR OF CARDIOPROTECTIVE EFFICIENCY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT HYPERTENSION AND TYPE 2 DIABETES MELLITUS.
J Hypertens. 2022;40.
PubMed Abstract available

BOUHANICK B, Amar J, Amar L, Courand PY, et al
ANTIPLATELET AND ANTICOAGULANT THERAPY DURING ANGIOPLASTY PROCEDURES FOR ATHEROMATOUS OR FIBROMUSCULAR DYSPLASIA RENAL ARTERY STENOSIS: A SURVEY OF PRACTICES IN EUROPEAN SOCIETY OF HYPERTENSION EXCELLENCE CENTRES (ESH-EC) IN FRANCE.
J Hypertens. 2022;40.
PubMed Abstract available

YOUSSEF G, Mesalm MH, Reda G, Bakhoum S, et al
EFFECT OF AN ELECTRO-STIMULATOR DEVICE ON THE AVERAGE 24-HOUR BLOOD PRESSURE IN PATIENTS WITH MILD AND MODERATE HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ZHIPENG Z, Xiaoping C
PATIENT PREFERENCE FOR RENAL DENERVATION THERAPY IN HYPERTENSION: A CROSS-SECTIONAL SURVEY IN CHENGDU, CHINA.
J Hypertens. 2022;40.
PubMed Abstract available

ZHAO S, Yu S, Tang J, Maimaitiaili R, et al
INFLAMMATORY MARKERS AND HYPERTENSION-MEDIATED ORGAN DAMAGE IN COMMUNITY-DWELLING ELDERLY INDIVIDUALS: THE NORTHERN SHANGHAI STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

HAJRI SE, Messaoudi Y, Ernez S, Bouraoui H, et al
LONGITUDINAL LEFT VENTRICULAR FUNCTION IN HYPERTENSIVE SUBJECTS WITH NORMAL EJECTION FRACTION: NEW INSIGHT BY SPECKLE TRACKING ECHOCARDIOGRAPHY.
J Hypertens. 2022;40.
PubMed Abstract available

FARHAN HA, Ybeer HF
GLOBAL LOGITUDINAL STRAIN IN HYPERTENSIVE DISORDERS DURING PREGNANCY AS A PREDICTOR FOR EARLY DETECTION OF SUBCLINICAL LEFT VENTRICULAR DYSFUNCTION.
J Hypertens. 2022;40.
PubMed Abstract available

HENDRIKS-BALK M, Da Costa S, Polychronopoulou E, Damianaki K, et al
DIFFERENCES IN BOLD MRI SIGNAL INTENSITY BETWEEN HYPERTENSIVE PATIENTS AND HEALTHY VOLUNTEERS.
J Hypertens. 2022;40.
PubMed Abstract available

KOCIANOVA E, Kamasova M, Hanajikova B, Jelinek L, et al
LEFT ATRIAL VOLUME INDEX (LAVI) AS A PREDICTOR OF PAROXYSMAL ATRIAL FIBRILLATION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

LIU Y, Sun Q, Fu T, Pan Y, et al
THE IMPACT AND INTERACTION OF METABOLIC ELEMENTS ON LEFT ATRIAL STIFFNESS IN HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

OUABDESSELAM S, Mokhtar OA, Bendiab NTS, Henaoui L, et al
THE TRIGLYCERIDE- GLUCOSE INDEX: AN INDEPENDENT FACTOR OF A SUBCLINICAL LEFT VENTRICULAR DYSFUNCTION IN TREATED HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

SHAVAROV A, Kobalava Z
DISSOCIATION BETWEEN LEFT ATRIAL AND LEFT VENTRICULAR CHANGES IN HYPERTENSIVE PATIENTS WITH ATRIAL CARDIOMYOPATHY.
J Hypertens. 2022;40.
PubMed Abstract available

BENDIAB NT, Henaoui L, Benkhedda S
HYPERTENSIVE HEART DISEASE, WHAT ARE THE FACTORS PRECIPITATING ITS EARLY ONSET?
J Hypertens. 2022;40.
PubMed Abstract available

ZERVAKIS S, Marketou M, Danelatos C, Maragkoudakis S, et al
RIGHT VENTRICULAR LONGITUDINAL SYSTOLIC STRAIN AS A PREDICTION MARKER OF NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION IN ESSENTIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

KRAMER T, Hoenemann J, Weis H, Jordan J, et al
EFFECTS OF ACUTE NORMOBARIC HYPOXIA-INDUCED PULMONARY HYPERTENSION ON ELECTROCARDIGRAPHIC MEASURES IN POST-MYOCARDIAL INFARCTION PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

EZHOVA N, Bazdyreva E, Shavarova E, Khomova I, et al
LEFT ATRIAL RESERVOIR FUNCTION DECLINES IN HYPERTENSIVE SUBJECTS WITH DYSLIPIDEMIA.
J Hypertens. 2022;40.
PubMed Abstract available

PAFFER MT, Paffer PT, Procopio A, Ribeiro F, et al
RENAL SYMPATHETIC DENERVATION AS TREATMENT FOR REFRACTORY HYPERTENSION: CASE REPORT.
J Hypertens. 2022;40.
PubMed Abstract available

VRIZ O, Rudski L, Frumento P, Limongelli G, et al
RIGHT HEART PULMONARY CIRCULATION UNIT RESPONSE TO EXERCISE IN PATIENTS WITH SYSTEMIC ARTERIAL HYPERTENSION. INSIGHTS FROM THE RIGHT-NET STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

RIBEIRO C, Neiva R, Silva D, Correia-De-Sa P, et al
REDUCTION OF HEART RATE VIA P2X4 RECEPTOR ACTIVATION AS A PROMISING TREATMENT STRATEGY IN PULMONARY ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ABDULLAEVA G, Kevorkov A, Yusupova K, Khamidullaeva G, et al
THE RELATIONSHIP OF ARTERIAL AND MYOCARDIAL STIFFNESS WITH LEFT VENTRICLE DIASTOLIC DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SAHOO SK, Pathni AK, Krishna A, Sharma B, et al
ESTIMATES ON MEDICATION COST OF DRUG DOSE SPECIFIC TREATMENT PROTOCOL FOR HYPERTENSION MANAGEMENT IN PUBLIC AND PRIVATE HEALTHCARE SECTORS IN INDIA.
J Hypertens. 2022;40.
PubMed Abstract available

OUAIL DE, Tebbani M, Bouali F
THE CHRONOLOGY OF ONSET OF TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

LEE HY
CLINICAL CHARACTERISTICS AND OUTCOME OF KOREAN HYPERTENSION COHORT.
J Hypertens. 2022;40.
PubMed Abstract available

MEAZZA R, Rossi M, Guareschi A, Iaci G, et al
VASCULAR OR CARDIAC? DIFFERENT TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTS WITH OR WITHOUT CHRONIC KIDNEY DISEASE.
J Hypertens. 2022;40.
PubMed Abstract available

FLORIDO CF, Pierin AMG
COHORT STUDY IN PATIENTS WITH HYPERTENSIVE CRISIS: CHARACTERISTICS AND FOLLOW-UP AFTER 30 DAYS.
J Hypertens. 2022;40.
PubMed Abstract available

MAMDOUH H, Alnakhi W, Hussain H, Ibrahim G, et al
PREVALENCE AND ASSOCIATED RISK FACTORS OF HYPERTENSION AND PRE-HYPERTENSION AMONG THE ADULT POPULATION: FINDINGS FROM THE DUBAI HOUSEHOLD SURVEY, 2019.
J Hypertens. 2022;40.
PubMed Abstract available

STEFFEN HM, Nhlema A, Phiri S, Kasper P, et al
PREVALENCE AND INCIDENCE OF ARTERIAL HYPERTENSION OVER 36 MONTHS IN AMBULATORY HIV INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY IN LILONGWE, MALAWI.
J Hypertens. 2022;40.
PubMed Abstract available

CONG DT, Ngoc HC
HEALTH-RELATED QUALITY OF LIFE AND ASSOCIATED FACTORS AMONG HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

CRUZ PV, Ang W, Calatrava J
EFFICACY AND SAFETY OF SACUBITRIL/VALSARTAN (LCZ696) IN HYPERTENSION CONTROL AND ADVERSE CARDIOVASCULAR EVENT REDUCTION AMONG ASIANS: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

ZHANG W, Liu CY, Bilo G, Soranna D, et al
EFFICACY AND SAFETY OF NIFEDIPINE GASTROINTESTINAL THERAPEUTIC SYSTEM VERSUS RAMIPRIL IN CHINESE AND EUROPEAN PATIENTS WITH HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

GALLO G, Forte M, Tocci G, Cotugno M, et al
ASSOCIATION OF NDUFC2 POLYMORPHIC VARIANTS WITH LEFT VENTRICULAR HYPERTROPHY IN HUMAN HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

OTMANE A, Makrelouf M, Zenati A
APO E GENE POLYMORPHISM (C112R, R158C) AND LIPID PROFILE IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

ANDELOVA K, Bacova BS, Sykora M, Pavelka S, et al
SPONTANEOUSLY HYPERTENSIVE RATS EXHIBIT ENHANCED CARDIAC CONNEXIN-43 AND REDUCED PRO-FIBROTIC MARKERS IN RESPONSE TO COLD ACCLIMATION.
J Hypertens. 2022;40.
PubMed Abstract available

CAMARGO L, Samji S, Lilla S, Zanivan S, et al
PROTEOMIC PROFILE OF CYSTEINE OXIDATION IN VASCULAR SMOOTH MUSCLE CELLS IN HUMAN HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

NAWRES BT, Sabra A, Meriem BS, Manel BS, et al
POST PARTUM HYPERTENSIVE EMERGENCY REVEALING ATYPICAL HEMOLYTIC AND URAEMIC SYNDROME IN TWO SISTERS.
J Hypertens. 2022;40.
PubMed Abstract available

PODPALOVA O, Kaliadka M, Babenka A, Mrochek A, et al
TELOMERE LENGTH IS NEGATIVELY ASSOCIATED WITH BMI, R WAVE IN AVL AND IL-6 LEVEL IN PATIENTS WITH NEW CASES OF HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

REPCHUK Y
OBESITY AND VITAMIN D RECEPTOR (VDR, RS2228570) GENE POLYMORPHISM ASSOCIATION IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

REPCHUK Y, Sydorchuk L, Semianiv M, Voronyuk K, et al
THE CHANGES IN VITAMIN D AND IONIZED CALCIUM LEVELS IN PATIENTS WITH ESSENTIAL HYPERTENSION DEPENDING ON THE AGT GENE (RS699) POLYMORPHISM.
J Hypertens. 2022;40.
PubMed Abstract available

SEMIANIV M
25(OH)D AS A RISK FACTOR OF ESSENTIAL ARTERIAL HYPERTENSION CONSIDERING THE GENES POLYMORPHISM AGTR1 (RS5186) AND VDR (RS2228570).
J Hypertens. 2022;40.
PubMed Abstract available

SHORIKOVA D, Shorikov E, Shorikov P, Ismael O, et al
POLYMORPHISMS NOS3-T-786C IN MACROANGIOPATHIES IN PATIENTS WITH COMBINED HYPERTENSION AND TYPE DIABETES MELLITUS 2.
J Hypertens. 2022;40.
PubMed Abstract available

STRAUSS-KRUGER M, Kruger R, Vuren EJV, Jacobs A, et al
IDENTIFYING A METABOLOMICS PROFILE ASSOCIATED WITH MASKED HYPERTENSION IN TWO INDEPENDENT COHORTS: DATA FROM THE AFRICAN-PREDICT AND SABPA STUDIES.
J Hypertens. 2022;40.
PubMed Abstract available

SYDORCHUK A, Voroniuk K, Sydorchuk L, Semianiv M, et al
LINKAGE BETWEEN NOS3 (RS2070744) AND GNB3 (RS5443) GENES' POLYMORPHISM, CAROTID ARTERIES STRUCTURAL CHANGES AND ENDOTHELIAL DYSFUNCTION IN ESSENTIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SYDORCHUK A, Voronyuk K, Sydorchuk L, Repchuk Y, et al
ARE METABOLIC DISORDERS IN HYPERTENSIVE PATIENTS ASSOCIATED WITH GNB3 (RS5443) GENETIC POLYMORPHISMS?
J Hypertens. 2022;40.
PubMed Abstract available

DZHURYAK V, Sydorchuk L, Repchuk Y, Semianiv M, et al
DEPENDENCE OF METABOLIC DISORDERS ON ALDOSTERONE SYNTHASE CYP11B2 (-344C/T) GENE POLYMORPHISM IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

DZHURYAK V, Sydorchuk A, Sydorchuk L, Sydorchuk R, et al
ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE POLYMORPHISM (894G>T, 786T>C) CONTRIBUTE TO HYPERTENSION RISK AND LIPIDS PROFILE DISORDERS.
J Hypertens. 2022;40.
PubMed Abstract available

ALGHAMDI R, Muhammad F, Osman H, Salim F, et al
THE PHARMACOKINETIC PARAMETERS DATA OF THE 20 MOST COMMONLY PRESCRIBED ANTIHYPERTENSIVE MEDICATIONS.
J Hypertens. 2022;40.
PubMed Abstract available

ARTEMIEVA M, Biriukova N, Kuropatkina T, Medvedeva N, et al
GONADOECTOMY REDUCED THE DEGREE OF DEVELOPMENT OF RENOVASCULAR HYPERTENSION IN FEMALE RATS CAUSED BY STOP OF HIGH-SALT DIET.
J Hypertens. 2022;40.
PubMed Abstract available

MAZZA A, Bregola G, Cavazzin E, Dell'avvocata F, et al
COST-EFFECTIVENESS OF POLYPILL TREATMENT IN HIGH-RISK HYPERTENSIVE SUBJECTS WITH HYPER-CHOLESTEROLAEMIA.
J Hypertens. 2022;40.
PubMed Abstract available

SYKORA M, Kratky V, Tribulova N, Kopkan L, et al
INHIBITION OF RAS COMPONENTS ATTENUATES PROGRESSION OF MYOCARDIAL REMODELING IN BOTH NORMOTENSIVE AND HYPERTENSIVE RATS IN EXPERIMENTAL HEART FAILURE.
J Hypertens. 2022;40.
PubMed Abstract available

VARBIRO S, Josvai A, Hetthessy J, Matrai M, et al
ADDITIVE DAMAGE IN THE CONTRACTILITY OF INTRAMURAL CORONARY ARTERIOLES IN A RAT MODEL OF ANDROPAUSAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

BENDOUDOUCH H, Dahmani I, Mahdi Z, Benali M, et al
RESTING ELECTROCARDIOGRAM ABNORMALITIES IN PATIENTS WITH ARTERIAL HYPERTENSION AND THEIR ASSOCIATION WITH CARDIOVASCULAR RISK FACTORS.
J Hypertens. 2022;40.
PubMed Abstract available

ABDREBBI SB, Meguenni K
EPIDEMIOLOGY OF ARTERIAL HYPERTENSION IN A UNIVERSITY HOSPITAL CENTER IN NORTH-WEST OF ALGERIA.
J Hypertens. 2022;40.
PubMed Abstract available

ABDREBBI SB, Meguenni K
HYPERTENSION, THE MAIN RISK FACTOR FOR STROKE IN A UNIVERSITY HOSPITAL CENTER IN NORTHWEST ALGERIA.
J Hypertens. 2022;40.
PubMed Abstract available

RUF R, Grinshtein Y, Shabalin V
A COMBINATION OF HYPERTENSION AND A HIGH ATHEROGENIC INDEX OF PLASMA AS AN INDICATOR OF A CORONARY HEART DISEASE RISK.
J Hypertens. 2022;40.
PubMed Abstract available

RUF R, Grinshtein Y, Shabalin V
THE INTERRELATION OF HYPERTENSION AND HYPERURICEMIA THE PRISM OF SCORE2.
J Hypertens. 2022;40.
PubMed Abstract available

BENTZEL S, Ohman O, Abdulla K, Manhem K, et al
HIGH BLOOD PRESSURE IN THE EMERGENCY DEPARTMENT. A TOOL FOR DETECTION OF HYPERTENSION? A FOLLOW-UP STUDY OF UNSELECTED PATIENTS ATTENDING AN EMERGENCY DEPARTMENT.
J Hypertens. 2022;40.
PubMed Abstract available

BIRULINA Y, Buyko E, Ivanov V, Dzyuman A, et al
MORPHOFUNCTIONAL ABNORMALITIES WITHIN THE AORTA AS A PREDICTOR OF ARTERIAL HYPERTENSION IN METABOLIC SYNDROME.
J Hypertens. 2022;40.
PubMed Abstract available

SHAMSUDDIN S, Davis K, Moorhouse L, Mandizvidza P, et al
ASSOCIATION BETWEEN PSYCHOLOGICAL DISTRESS AND LATER REPORTS OF HYPERTENSION AMONG ADULTS IN EAST ZIMBABWE.
J Hypertens. 2022;40.
PubMed Abstract available

EASON S, Sayers M
A COMPARISON OF EUROPEAN AND AMERICAN GUIDELINES TO GAUGE THE PREVALENCE OF HYPERTENSION IN 16-19 YEAR OLD BLOOD DONORS.
J Hypertens. 2022;40.
PubMed Abstract available

FRKANEC S, Katic L, Strbac T, Trobonjaca A, et al
ELECTROCARDIOGRAM CHANGES IN PREHYPERTENSIVE SUBJECTS - EPIDEMIOLOGY OF HYPERTENSION IN CROATIA-1 (EH UH-1) STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

FRKANEC S, Katic L, Strbac T, Tarnovski L, et al
EPIDEMIOLOGY OF HYPERTENSION IN CROATIA (EHUH STUDY) -ECG FINDINGS AND CARDIOVASCULAR MORTALITY DATA AFTER 17 YEARS OF FOLLOW-UP.
J Hypertens. 2022;40.
PubMed Abstract available

VARETA G, Georgianos P, Vaios V, Sgouropoulou V, et al
PREVALENCE, PHENOTYPES AND CONTROL OF HYPERTENSION IN END-STAGE KIDNEY DISEASE PATIENTS UNDERGOING PERITONEAL DIALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

GEORGIANOU E, Markakis K, Georgianos P, Zografou I, et al
PREVALENCE AND CONTROL OF HYPERTENSION IN DIABETIC PATIENTS WITH VERSUS WITHOUT CHRONIC KIDNEY DISEASE.
J Hypertens. 2022;40.
PubMed Abstract available

LEROUX D, Cloutier L
GEOGRAPHICAL ANALYSIS OF HYPERTENSION IN CANADIAN POPULATION.
J Hypertens. 2022;40.
PubMed Abstract available

LEWANDOWSKA K, Lipski D, Pawlak-Chomicka R, Uruski P, et al
THE PREVALENCE OF WHITE-COAT EFFECT AND REVERSE WHITE-COAT EFFECT IN TREATED HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

MIRADA M, Pessana F, Acuna MIR, Ramirez A, et al
ARTERIAL HYPERTENSION (HT) IS ONE OF THE MOST PREDICTIVE RISK FACTORS FOR TYPE 2 DIABETES (DM2). THE FINDRISC IS VALIDATED FOR THE EARLY DETECTION OF SUFFERING FROM DM2.
J Hypertens. 2022;40.
PubMed Abstract available

MOURAD JJ, Jamet P, Huguet M, Bourbia S, et al
ANTIHYPERTENSIVE TREATMENT PRESCRIBING BEHAVIOURS IN FRENCH GENERAL PRACTICE IN 2021.
J Hypertens. 2022;40.
PubMed Abstract available

PALMU J, Tikkanen E, Havulinna AS, Vartiainen E, et al
COMPREHENSIVE BIOMARKER PROFILING OF HYPERTENSION IN 36,985 FINNISH INDIVIDUALS.
J Hypertens. 2022;40.
PubMed Abstract available

REPCHUK Y, Sydorchuk L
LIPIDS' METABOLISM AND ANGIOTENSINOGEN GENE (AGT, RS699) POLYMORPHISM ASSOCIATION IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

DE PAULA ARAUJO T, Borges LGS, Barroso WKS, Batista SR, et al
WHAT ARE THE FACTORS ASSOCIATED WITH UNCONTROLLED BLOOD PRESSURE IN BRAZILIAN HYPERTENSIVE PATIENTS?
J Hypertens. 2022;40.
PubMed Abstract available

SHIN JH, Kim BS, Kim HJ, Yu MY, et al
IMPACT OF THE ESTIMATED GLOMERULAR FILTRATION RATE ON LONG-TERM MORTALITY IN PATIENTS WITH HYPERTENSIVE CRISIS VISITING THE EMERGENCY DEPARTMENT.
J Hypertens. 2022;40.
PubMed Abstract available

SHIN JH, Kim BS, Kim HJ, Yu MY, et al
IMPACT OF PROTEINURIA ON LONG-TERM MORTALITY IN PATIENTS WITH HYPERTENSIVE CRISIS VISITING THE EMERGENCY DEPARTMENT.
J Hypertens. 2022;40.
PubMed Abstract available

SHIN JH, Kim BS, Kim W, Kim HJ, et al
CLINICAL IMPLICATIONS OF CARDIAC TROPONIN-I IN PATIENTS WITH HYPERTENSIVE CRISIS VISITING THE EMERGENCY DEPARTMENTS.
J Hypertens. 2022;40.
PubMed Abstract available

TARNOVSKI L, Frkanec S, Katic L, Strbac T, et al
POOR HYPERTENSION CONTROL AND DISAPPEARANCE OF MEDITERRANEAN LIFE STYLE ON THE CROATIAN ADRIATIC ISLANDS. HUNT ON THE SILENT KILLER (HSK) - OPPORTUNISTIC PUBLIC HEALTH ACTION.
J Hypertens. 2022;40.
PubMed Abstract available

VAY-DEMOUY J, Blacher J, Olie V
LACK OF LIFESTYLE MODIFICATIONS IN GLOBAL HYPERTENSION MANAGEMENT.
J Hypertens. 2022;40.
PubMed Abstract available

OUAIL DE, Tebbani M, Bouali F
INTEREST OF MEASURING THE INTIMA MEDIA THICKNESS IN THE EVALUATION OF HYPERTENSIVE.
J Hypertens. 2022;40.
PubMed Abstract available

SYDORCHUK A, Voroniuk K, Sydorchuk L, Repchuk Y, et al
ENDOTHELIUM DYSFUNCTION PATHWAY AND CAROTID INTIMA-MEDIA THICKNESS IN HYPERTENSIVE PATIENTS: ROLE OF NOS3 (RS2070744) AND GNB3 (RS5443) GENES' POLYMORPHISMS.
J Hypertens. 2022;40.
PubMed Abstract available

YUAN Y, Sun W, Kong X
COMPARISON BETWEEN DISTINCT INSULIN RESISTANCE INDICES IN MEASURING THE DEVELOPMENT OF HYPERTENSION: THE CHINA HEALTH AND NUTRITION SURVEY.
J Hypertens. 2022;40.
PubMed Abstract available

YUAN Y, Sun W, Kong X
RELATIONSHIP BETWEEN METABOLICALLY HEALTHY OBESITY AND THE DEVELOPMENT OF HYPERTENSION: A NATIONWIDE POPULATION-BASED STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

CHEN J, Yu J
MTOR INHIBITOR IMPROVES TESTOSTERONE-INDUCED MYOCARDIAL HYPERTROPHY IN HYPERTENSIVE RATS.
J Hypertens. 2022;40.
PubMed Abstract available

VACLAVIK J, Hartmann I, Hruska F, Kocianova E, et al
HYPERTENSION OUTCOMES OF ADRENALECTOMY FOR UNILATERAL PRIMARY ALDOSTERONISM.
J Hypertens. 2022;40.
PubMed Abstract available

ANDERSSON U, Kjellgren K, Hoffmann M, Wennersten A, et al
PERSON-CENTREDNESS IN HYPERTENSION MANAGEMENT USING INFORMATION TECHNOLOGY (PERHIT): A RANDOMISED CONTROLLED TRIAL IN PRIMARY HEALTH CARE.
J Hypertens. 2022;40.
PubMed Abstract available

GIRERD X, Canipel L, Hanon O, Pathak A, et al
EVALUATION OF A DIGITAL THERAPY FOR UNCONTROLLED HYPERTENSIVE PATIENTS FOLLOWED BY GENERAL PRACTITIONERS IN FRANCE.
J Hypertens. 2022;40.
PubMed Abstract available

MAIMAITIAILI R, Li Y, Zhang Y, Feng T, et al
SIMPLIFIED REGIMEN FOR THE MANAGEMENT OF HYPERTENSION WITH TELEMEDICINE AND BLOOD PRESSURE SELF-MONITORING (SIMPLE): STUDY PROTOCOL FOR A RANDOMIZED CONTROLLED TRIAL.
J Hypertens. 2022;40.
PubMed Abstract available

OGBOYE A, Rahman KMJ, Odukwe A, Mobisson N, et al
DIGITAL INTERVENTIONS TO DRIVE SELF-MANAGEMENT IN PEOPLE WITH HYPERTENSION IN NIGERIA.
J Hypertens. 2022;40.
PubMed Abstract available

JACOBS M, Ogboye A, Mobisson N
HARNESSING HUMAN-CENTRED DESIGN APPROACHES TO BUILD A CHATBOT FOR PEOPLE LIVING WITH HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ZANINI C, Teixeira D, Pereira D, Sousa ALL, et al
MUSIC THERAPY WITH HYPERTENSIVE PATIENTS DURING THE PANDEMIC PERIOD - ONLINE MEETINGS AS PART OF MULTIPROFESSIONAL TREATMENT.
J Hypertens. 2022;40.
PubMed Abstract available

PAPAVASILEIOU M, Aravantinos D, Karamanou A, Moustakas G, et al
PROGNOSTIC VALUE OF THE GLYCOSYLATED HEMOGLOBIN TO THE MACE IN HYPERTENSIVE NON DIABETIC PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

DOAN L
SGLT2I - A POTENTIAL ANTIHYPERTENSIVE AGENT IN HYPERTENSION PATIENTS WITH TYPE 2 DIABETES MELLITUS.
J Hypertens. 2022;40.
PubMed Abstract available

GEORGIANOU E, Markakis K, Georgianos P, Zografou I, et al
THE ASSOCIATION OF EGFR AND ALBUMINURIA WITH SYSTOLIC HYPERTENSION IN PATIENTS WITH DIABETES.
J Hypertens. 2022;40.
PubMed Abstract available

KOTZE-HORSTMANN L, Hill J, Kengne AP, Peer N, et al
MANAGEMENT OF DYSLIPIDAEMIA AND HYPERTENSION BY GLYCAEMIC STATUS IN URBAN SOUTH AFRICANS.
J Hypertens. 2022;40.
PubMed Abstract available

PAPADAKIS JA, Ioannou P, Theodorakopoulou V, Papanikolaou K, et al
INCREASED INCIDENCE OF IMPAIRED FASTING GLUCOSE (IFG) AMONG HYPERTENSIVE PATIENTS NAIVE TO HYPOLIPIDEMIC TREATMENT.
J Hypertens. 2022;40.
PubMed Abstract available

PAPAZOGLOU S, Toutouzas K, Tsioufis K
DO INCREASED LEVELS OF TRIGLYCERIDES CONSIST AN INDEPENDENT RISK FACTOR DEFINING THE SEVERITY OF CARDIOMYOPATHY IN T2DM PATIENTS WITH KNOWN HYPERTENSION ?
J Hypertens. 2022;40.
PubMed Abstract available

WANG Q, Tian L, Sun R, Qi M, et al
EFFECTS OF SGLT-2 INHIBITORS ON 24H AMBULATORY BLOOD PRESSURE IN PATIENTS WITH TYPE 2 DIABETIC AND HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

CHALAKOVA T, Tsochev K, Yotov Y, Bocheva Y, et al
ARTERIAL HYPERTENSION IN PATIENTS WITH LONG DURATION TYPE 1 DIABETES MELLITUS.
J Hypertens. 2022;40.
PubMed Abstract available

ZHURAVLYOVA L, Rogachova T, Sokolnikova N, Filonenko M, et al
THE EFFECT OF DAPAGLIFLOZIN ON THE LEVEL OF SYSTOLIC BLOOD PRESSURE AND GLYCEMIC CONTROL IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES.
J Hypertens. 2022;40.
PubMed Abstract available

FEJES I, Roka R, Abraham G, Varkonyi T, et al
EFFECT OF HYPERTENSION AND RAS INHIBITORS TO ADULT PATIENTS (OVER 18 YEARS OLD) WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV2) INFECTION WHO WERE ADMITTED TO HOSPital.
J Hypertens. 2022;40.
PubMed Abstract available

LOZADA MC, Medina H Jr, Sucaldito MSF, Santos LE, et al
ASSOCIATION OF IN-PATIENT OUTCOMES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR USE AMONG HYPERTENSIVE PATIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19).
J Hypertens. 2022;40.
PubMed Abstract available

POLYZOS D, Konstantinidis D, Drogkaris S, Tatakis F, et al
SURGICAL MASKS AND UNATTENDED BLOOD PRESSURE CHANGES IN TREATED HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

STIRBAN R, Grigore C, Dragoi D, Balaceanu B, et al
PARTICULARITIES OF HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME, ADMITTED FOR SARS-COV-2 INFECTION TO A CLINICAL EMERGENCY HOSPITAL.
J Hypertens. 2022;40.
PubMed Abstract available

STIRBAN R, Grigore C, Dragoi D, Balaceanu B, et al
NEW ONSET OF HYPERTENSION IN PATIENTS ADMITTED FOR INFECTION WITH SARS-COV-2 VIRUS.
J Hypertens. 2022;40.
PubMed Abstract available

KYYA Y, Barnett O, Halkevych M, Labinska O, et al
RED BLOOD CELL COLOUR VARIATION AS A MARKER OF CALCIUM DISTRIBUTION: WHAT ROLE DOES IT HAVE IN HEART FAILURE PATIENTS WITH HYPERTENSION AND LONG COVID?
J Hypertens. 2022;40.
PubMed Abstract available

DENISOVA A, Sivakova O, Solntseva T, Chazova I, et al
EFFECT OF CORONAVIRUS INFECTION ON PATIENTS WITH CONTROLLED AND UNCONTROLLED ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

TSOUTSOULI V, Sachla Z, Efstathiou K, Foutsitsakis D, et al
COVID-19 RELATED CHANGE IN DAILY LIFE OF HYPERTENSIVE PATIENTS MAY AFFECT HYPERTENSION MANAGEMENT.
J Hypertens. 2022;40.
PubMed Abstract available

RODRIGUES FF, Sa J
COVID-19 INFECTION AND ARTERIAL HYPERTENSION - A RECIPROCAL INTERACTION?
J Hypertens. 2022;40.
PubMed Abstract available

GAVRILA A
THE PROGNOSTIC VALUE OF THE BIOLOGICAL PROFILE OF INFLAMMATION AND COAGULATION AT HYPERTENSIVE PATIENTS AFTER COVID-19.
J Hypertens. 2022;40.
PubMed Abstract available

HAZARAPETYAN L, Grigoryan S, Zeveian P
THE FEATURE OF ATRIAL FIBRILLATION OCCURRENCE AND PROGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION, WHO HAVE UNDERGONE COVID-19.
J Hypertens. 2022;40.
PubMed Abstract available

DELALIC D, Jug J, Varahabhatla V, Prkacin I, et al
ARTERIAL HYPERTENSION FOLLOWING COVID-19.
J Hypertens. 2022;40.
PubMed Abstract available

KOH JH, Kang MJ
ASSOCIATION BETWEEN DEPRESSION DISORDER AND INCIDENTAL HYPERTENSION IN COVID 19 POSITIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

MAKEEVA T, Zbyshevskaya E, Bitakova F, Erinchek V, et al
CLINICAL AND MORPHOLOGICAL FEATURES OF KIDNEY DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION DIED OF SARS-COV-2 INFECTION.
J Hypertens. 2022;40.
PubMed Abstract available

MAKEEVA T, Zbyshevskaya E, Bitakova F, Butaev T, et al
RISK FACTORS FOR POST-COVID-19 SYNDROME DEVELOPMENT IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

MONTEALEGRE L, Amador E, Pulido T, Rebolledo R, et al
FACTORS THAT INFLUENCE THE SURVIVAL RATE IN PATIENTS WITH COVID-19 WITH A PREVIOUS DIAGNOSIS OF HYPERTENSION AND/OR DIABETES: A SYSTEMATIC REVIEW.
J Hypertens. 2022;40.
PubMed Abstract available

OLIE V, Grave C, Tuppin P, Lesuffleur T, et al
IMPACT OF THE COVID-19 PANDEMIC ON THE INITIATION OF ANTIHYPERTENSIVE DRUG THERAPY IN FRANCE.
J Hypertens. 2022;40.
PubMed Abstract available

KARIORI M, Fragoulis C, Polyzos D, Leontsinis I, et al
IMPACT OF HYPERTENSION AS AN ADDITIONAL RISK FACTOR IN CARDIORESPIRATORY STATUS OF POST SARS-COV-2 INFECTED SUBJECTS.
J Hypertens. 2022;40.
PubMed Abstract available

KARIORI M, Fragoulis C, Chrysochoou C, Leontsinis I, et al
CARDIOPULMONARY EXERCISE TEST AND ECHOCARDIOGAPHIC FINDINGS IN HOSPITALISED POST SARS-COV-2 PATIENTS: THE EFFECT OF ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

VINTILA AM, Horumba M, Miron P, Balan R, et al
ARTERIAL HYPERTENSION SEVERITY INFLUENCE ON COVID19 SEVERITY AND ICU ADMISSION.
J Hypertens. 2022;40.
PubMed Abstract available

WOJCIECHOWSKA W, Terlecki M, Klocek M, Januszewicz A, et al
IMPACT OF ARTERIAL HYPERTENSION AND ANTIHYPERTENSIVE PHARMACOTHERAPY ON IN-HOSPITAL MORTALITY IN COVID-19 PATIENTS: THE CRACOV-HHS STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

YUFEREVA Y, Shevchenko O, Ginzburg L, Zakirzyanov A, et al
COVID-19 IMPACT ON THE PREVALENCE OF SUBCLINICAL HYPERTENSION AMONG PRACTICALLY HEALTHY MEDICAL STUDENTS.
J Hypertens. 2022;40.
PubMed Abstract available

JAIN R, Hosseini J, Shoghli R
COVID19 INFECTION IN CORONARY ARTERY DISEASE WITH DIABETES AND HYPERTENSION IN VALVULAR SURGERY PATIENTS IN TERTIARY HEART CENTRE.
J Hypertens. 2022;40.
PubMed Abstract available

VINTILA AM, Horumba M, Miron P, Balan R, et al
ARTERIAL HYPERTENSION AND COVID19 IN HOSPITAL MORTALITY.
J Hypertens. 2022;40.
PubMed Abstract available

SOLIMENE MC, Drager L, Bortolotto L
GENDER-RELATED DIFFERENCES IN CORONARY ARTERY DISEASE IN PATIENTS WITH RESISTANT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

GHRAB A, Chamtouri I, Louati M, Abdallah W, et al
SMOKING PARADOX IN HYPERTENSIVE ST SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS: 25-YEAR POPULATION-BASED STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

SAKALIDIS A, Dimitriadis K, Dri E, Soulaidopoulos S, et al
HYPERTENSIVE PATIENTS WITH ANGINA AND NON-OBSTRUCTIVE CORONARY ARTERY DISEASE ARE CHARACTERIZED BY INCREASED SYMPATHETIC NERVOUS SYSTEM ACTIVATION.
J Hypertens. 2022;40.
PubMed Abstract available

SAKALIDIS A, Dimitriadis K, Dri E, Soulaidopoulos S, et al
ARTERIAL STIFNESS AND SYMPATHETIC OVERDRIVE IN HYPERTENSIVE PATIENTS WITH ANGINA AND NON-OBSTRUCTIVE CORONARY ARTERY DISEASE.
J Hypertens. 2022;40.
PubMed Abstract available

TSYGANKOVA O, Ponkin S, Veretyuk V
EFFECT OF MOBILE APPLICATIONS FOR PHYSICAL ACTIVITY TRACKING ON EXERCISE TOLERANCE IN PATIENTS WITH HYPERTENSION AND CORONARY ARTERY DISEASE.
J Hypertens. 2022;40.
PubMed Abstract available

PAPAVASILEIOU M, Karamanou A, Moustakas G, Aravantinos D, et al
PROGNOSTIC VALUE OF THE REMNANT CHOLESTEROL AND OTHER LIPID PARAMETERS TO THE MACE IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

PAPAVASILEIOU MV, Doumas M, Karamanou A, Moustakas G, et al
ASSOCIATION OF SERUM URIC ACID LEVELS AND ATHEROMATOSIS OF CAROTID ARTERIES IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

DE SOUSA A, Magalhaes FG, da Silva SB, Inuzuka S, et al
ASSOCIATION BETWEEN THE PRESENCE OF COMORBIDITIES AND CARDIOVASCULAR OUTCOMES IN A HYPERTENSIVE LATIN AMERICAN POPULATION.
J Hypertens. 2022;40.
PubMed Abstract available

DUNAIEVA I, Bilovol O, Knyazkova I, Kirienko O, et al
THE EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN COMORBID PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

FEDORISHINA O, Protasov K, Torunova A
THE RELATIONSHIPS BETWEEN ANXIETY AND BLOOD PRESSURE DYNAMICS UNDER THE ANTIHYPERTENSIVE TREATMENT.
J Hypertens. 2022;40.
PubMed Abstract available

KRYVOSHEI V, Filippova A
THE STATE OF ELASTIC PROPERTIES OF ARTERIES IN PATIENTS WITH CHRONIC PANCREATITIS IN COMBINATION WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

NEMCSIK J, Korosi B, Gyongyosi H, Batta D, et al
SIMILARITIES IN DEPRESSION AND ANXIETY BETWEEN WHITE-COAT AND RESISTANT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

OKPARA C, Mobisson N, Moosa M, Rahman KJ, et al
THE EFFECT OF A DIGITAL HEALTH INTERVENTION ON THE CONTROL OF HYPERTENSION AMONG PEOPLE LIVING WITH CANCER.
J Hypertens. 2022;40.
PubMed Abstract available

BATISTA SR, Vitorino PVO, Silva RR, Sousa ALL, et al
CARDIOMETABOLIC MULTIMORBIDITY AND ASSOCIATED FACTORS: THE FIRST BRAZILIAN REGISTRY OF PATIENTS WITH HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SIRENKO O, Kuryata O
ANDROGEN DEFICIENCY ASSOCIATES WITH INCREASED ADVANCED GLYCATED END PRODUCTS, GALECTIN-3 IN HYPERTENSIVE MEN WITH BENIGN PROSTATIC HYPERPLASIA.
J Hypertens. 2022;40.
PubMed Abstract available

BILALOVA D, Nigmatullina R, Mustafin A
ROLE OF SEROTONIN AND ITS METABOLITE 5-HIAA IN THE DEVELOPMENT OF PULMONARY HYPERTENSION. NEW APPROACHES TO TREATMENT AND NON-INVASIVE DIAGNOSTICS?
J Hypertens. 2022;40.
PubMed Abstract available

CHAINOGLOU A, Sarafidis K, Chrysaidou K, Farmaki E, et al
HYPERTENSION AND ARTERIAL STIFFNESS IN PRETERM CHILDREN AND ADOLESCENTS.
J Hypertens. 2022;40.
PubMed Abstract available

GOULAS I, Evripidou K, Doundoulakis I, Nika T, et al
PREVALENCE OF MASKED HYPERTENSION IN CHILDREN AND YOUNG ADULTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

KOS M, Mihalj M, Hamidovic N, Dumancic D, et al
ESTIMATION OF DAILY SALT INTAKE IN CHILDREN WITH ESSENTIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

OBRYCKI L, Pac M, Sarnecki J, Feber J, et al
VASCULAR AGE IN ADOLESCENTS WITH PRIMARY HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

PATERNO CA
THE IMPORTANCE OF THE SYMPTOMS FOR DIAGNOSING AND TREATING OF HYPERTENSION IN CHILDREN, ADOLESCENTS AND YOUNG-AGED, ASSESSED WITH APPLANATION TONOMETRY.
J Hypertens. 2022;40.
PubMed Abstract available

FERNANDEZ GAP
HYPERTENSIVE HEART DISEASE IN ADOLESCENCE. PRELIMINARY RESULTS OF THE PESESCAD-HTA STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

SHORT B, Moon K, Larkins NG, Hijazzi S, et al
ISRADIPINE FOR THE TREATMENT OF ACUTE SEVERE HYPERTENSION IN CHILDREN.
J Hypertens. 2022;40.
PubMed Abstract available

SKRZYPCZYK P, Bujanowicz A, Pawlik K, Wroniewicz T, et al
MEAN PLATELET VOLUME IS A PREDICTOR OF BLOOD PRESSURE NORMALIZATION IN PEDIATRIC HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

KOLLIAS A, Ntineri A, Zeniodi ME, Stambolliu E, et al
HYPERTENSION PHENOTYPES IN YOUNG INDIVIDUALS BASED ON COMBINED OR ISOLATED ELEVATION OF OFFICE, HOME AND AMBULATORY BLOOD PRESSURE MEASUREMENTS AND ASSOCIATION WITH ORGAN DAMAGE.
J Hypertens. 2022;40.
PubMed Abstract available

GULKEVYCH O, Mishchenko L, Logvynenko A, Matova O, et al
COGNITIVE IMPAIRMENT AND CAROTID INTIMA-MEDIA THICKNESS IN PATIENTS WITH RESISTANCE HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

BOULESTREAU R, Lucas L, Cremer A, Doublet J, et al
NEUROLOGICALLY ASYMPTOMATIC PATIENTS FREQUENTLY PRESENT CEREBRAL INJURIES DURING MALIGNANT HYPERTENSION: A MRI STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

GERMAN-SALLO M, Preg Z, Pal T, Andrassy K, et al
HEART RATE VARIABILITY AND BRAIN FUNCTIONING IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

ULBRICH P, Morton L, Briese M, Lammlin N, et al
STAGE-DEPENDENT RESPONSES OF VASCULAR AND PARENCHYMAL CELLS IN THE HYPERTENSIVE RAT BRAIN.
J Hypertens. 2022;40.
PubMed Abstract available

WOJCIECHOWSKA E, Gryglas P
CASE REPORT: HELLP-LIKE SYNDROME IN A 19-YEAR-OLD WOMAN WITH NOT WELL - CONTROLLED HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

GEORGIEVA N, Kinova E, Borizanova A, Shopov L, et al
ASSOCIATION BETWEEN ARTERIAL STIFFNESS AND LEFT VENTRICULAR FUNCTION IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

LIAKOS C, Karpanou E, Markou M, Grassos C, et al
SYNERGISTIC EFFECT OF HIGH HOMOCYSTEINE AND LOW VITAMIN B12 LEVELS ON THE PREVALENCE OF ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

CHEN J, Yu J
ASSOCIATION OF FREE ANDROGEN INDEX AND SEX HORMONE BINDING GLOBULIN AND LEFT VENTRICULAR HYPERTROPHY IN POSTMENOPAUSAL HYPERTENSIVE WOMEN.
J Hypertens. 2022;40.
PubMed Abstract available

DUARTE F, Santos I, Barrada MI, Oliveira L, et al
ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN OBESE HYPERTENSIVE PATIENTS - CAN WE CONSIDER A DIFFERENT APPROACH?
J Hypertens. 2022;40.
PubMed Abstract available

OTMANE A, Makrelouf M, Zenati A
ASSOCIATION BETWEEN URIC ACID AND METABOLIC SYNDROME IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

ABDELHALIM T, Nadia DD, Abdelghani BC
ARTERIAL HYPERTENSION, THE MOST FREQUENT CARDIOVASCULAR RISK FACTOR, BUT HITHERTO UNRECOGNIZED IN THE NOMADIC POPULATION OF SOUTHERN ALGERIA.
J Hypertens. 2022;40.
PubMed Abstract available

ALI U, Podpalov V
HIGH LEVEL OF THE AMOUNT OF ECG PEAKS SV1+RV5-V6 PREDICT NEW CASES OF HYPERTENSION IN THE ORGANIZED POPULATION OF THE PETROCHEMICAL INDUSTRY WORKERS.
J Hypertens. 2022;40.
PubMed Abstract available

PAPAVASILEIOU MV, Mytas D, Karamanou A, Moustakas G, et al
ASSOCIATION OF SERUM URIC ACID WITH LEFT VENTRICLE, LEFT VENTRICULAR FILLING PRESSURE AND LEFT ATRIAL SIZE IN HYPERTENSIVE PATIENTS WITHOUT ATRIAL FIBRILLATION.
J Hypertens. 2022;40.
PubMed Abstract available

BUILA N, Kabanda G, Nkodila A, Mundu G, et al
IMPACT OF ADAPTED PHYSICAL ACTIVITY ON BLOOD PRESSURE AND HYPERTENSION CONTROL IN MILITARY OF THE KINSHASA GARNISON.
J Hypertens. 2022;40.
PubMed Abstract available

VACCA A, Catena C, Soardo G, Spagnol F, et al
RELATIONSHIPS BETWEEN NAFLD BIOCHEMICAL SCORES AND LEFT VENTRICULAR GEOMETRIC PATTERN IN NAIVE ESSENTIAL HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

CHINNAAIAH K, Lo FA, Sule AA, Chin TJ, et al
INCREASE ARTERIAL STIFFNESS IN MOYAMOYA DISEASE PRESENTING WITH HYPERTENSION AND STROKE: A NOVEL FINDING IN A VERY RARE CASE IN SINGAPORE.
J Hypertens. 2022;40.
PubMed Abstract available

DE ROSA ML, Zuccarino M, Di Sarro E, Iovino MD, et al
THE IMPACT OF POLLUTION ON HYPERTENSION AND ECONOMY.
J Hypertens. 2022;40.
PubMed Abstract available

HAKO Y, Bika C, Okala C, Dissongo JI, et al
HYPERTENSION IN CAMEROONIAN RURAL AND URBAN PYGMIES AND BANTUS OF THE SOUTHERN REGION.
J Hypertens. 2022;40.
PubMed Abstract available

INUZUKA S, Filho GG, Vitorino P, Barroso A, et al
CARDIOVASCULAR RISK RECLASSIFICATION BY PULSE WAVE VELOCITY IN BRAZILIAN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

KLAUS KK, Lukas K, Bernhard G, Jutta S, et al
INCREASED IONIZED CALCIUM-MAGNESIUM-RATIO IN ELDERLY HYPERTENSIVES - RELATIONSHIP TO ARTHERIOSCLEROSIS.
J Hypertens. 2022;40.
PubMed Abstract available

LI Y, Xinhua T, Xiaoling X, Guoxiong C, et al
COMPARISON OF HYPERTENSION PREVALENCE AND ASSOCIATED RISK FACTORS IN MONKS AND COMMON RESIDENTS FROM ZHEJIANG PROVINCE, SOUTHEAST CHINA.
J Hypertens. 2022;40.
PubMed Abstract available

MALOBERTI A, Fumagalli S, Garofani I, Ghidini S, et al
RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

NAZ Q, Verma N, Serajuddin M, Patel ML, et al
ALPHA ADDUCIN GENE POLYMORPHISM IS MORE COMMON IN MALE AS COMPARE TO FEMALE IN ESSENTIAL HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

OOI IJ, Chia YC
PREVALENCE AND RISK FACTORS OF POSTURAL HYPOTENSION AMONG HYPERTENSIVE PATIENTS IN A PRIMARY CARE SETTING.
J Hypertens. 2022;40.
PubMed Abstract available

LONG NP, Kim NHT
STUDYING THE SITUATION OF CAROTID ATHEROSCLEROSIS OF HYPERTENSIVE PATIENTS IN THE NORTH OF BINH DINH PROVINCE VIETNAM 2019.
J Hypertens. 2022;40.
PubMed Abstract available

SAFRONENKO V, Chesnikova A, Sementsova N, Skarzhinskaya N, et al
INFLUENCE OF CONCOMITANT ATHEROSCLEROSIS OF THE ARTERIES OF THE LOWER EXTREMITIES ON THE PARAMETERS OF ARTERIAL STIFFNESS IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

SEMIANIV M, Sydorchuk L, Biletsky S, Petrynych O, et al
LIPID DISORDERS AND ESSENTIAL ARTERIAL HYPERTENSION RISK DEPENDING ON AGTR1 (RS5186) AND VDR (RS2228570) GENES POLYMORPHISM.
J Hypertens. 2022;40.
PubMed Abstract available

SURUNOVICH J, Podpalov V
HYPERTENSION AND COMORBIDITY AS MACE DEVELOPMENT RISK FACTORS IN THE EAST EUROPEAN REGION.
J Hypertens. 2022;40.
PubMed Abstract available

BACOVA BS, Benova TE, Sykora M, Zurmanova J, et al
CONTINUOUS EXPOSURE OF THE HYPERTENSIVE RATS TO LIGHT INCREASES THE RISK OF MALIGNANT CARDIAC ARRHYTHMIAS - OMACOR CARDIOPROTECTION.
J Hypertens. 2022;40.
PubMed Abstract available

TRIANTAFYLLIDI H, Benas D, Fabri A, Birmpa D, et al
SMOKING HABIT IS NOT RELATED WITH HYPERTENSION MEDIATED ORGAN DAMAGE IN YOUNG PATIENTS WITH FIRST DIAGNOSED AND NEVER TREATED ESSENTIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

TRIANTAFYLLIDI H, Birmpa D, Benas D, Fabri A, et al
ISOLATED DIASTOLIC HYPERTENSION IS NOT A BENIGN SITUATION REGARDING HYPERTENSION MEDIATED ORGAN DAMAGE IN PATIENTS WITH FIRST DIAGNOSED AND NEVER TREATED ESSENTIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

TRIANTAFYLLIDI H, Fabri A, Benas D, Birmpa D, et al
REDUCED ENDOTHELIAL GLYCOCALYX IS ASSOCIATED WITH HYPERTENSION BURDEN ONLY IN MALE SMOKERS WITH FIRST DIAGNOSED AND NEVER TREATED STAGE I AND II ESSENTIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

TRIANTAFYLLIDI H, Vlachos S, Benas D, Fabri A, et al
HEPATIC STEATOSIS INDEX IS INDEPENDENTLY RELATED TO HYPERTENSION MEDIATED ORGAN DAMAGE IN PATIENTS WITH FIRST DIAGNOSED AND NEVER TREATED ESSENTIAL HYPERTENSION AND SMOKING HABIT.
J Hypertens. 2022;40.
PubMed Abstract available

SIAFI E, Andrikou I, Thomopoulos C, Konstantinidis D, et al
THE PROGNOSTIC VALUE OF FATTY LIVER INDEX FOR CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

KAKOURI N, Andrikou I, Konstantinidis D, Siafi E, et al
SYMPATHETIC NERVOUS SYSTEM ACTIVITY AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
J Hypertens. 2022;40.
PubMed Abstract available

WANG Q, Zhang H, Wang W, Fan X, et al
EFFECT OF HYPOKALEMIA ON LEFT VENTRICULAR STRUCTURE AND FUNCTION IN PATIENTS WITH ESSENTIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

WANG Q, Zhang H, Wang W, Pei Y, et al
STUDY ON HYPERTENSION-RELATED TARGET ORGAN DAMAGE IN ESSENTIAL HYPERTENSION PATIENTS WITH HYPOKALEMIA.
J Hypertens. 2022;40.
PubMed Abstract available

WOZNICKA-LESKIEWICZ L, Posadzy-Malaczynska A
CARDIOVASCULAR RISK AND SUBCLINICAL VASCULAR ORGAN DAMAGE IN PATIENTS WITH AND WITHOUT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

LI C, Wang Q, Ma L, Wang W, et al
RHO KINASE BLOCKADE ALLEVIATE BLOOD PRESSURE ELEVATION AND INHIBIT VASCULAR REMODELING IN APATINIB-INDUCED HYPERTENSION-TO BE CONFERMED.
J Hypertens. 2022;40.
PubMed Abstract available

LI C, Wang Q, Ma L, Wang W, et al
RHO KINASE BLOCKADE ALLEVIATE BLOOD PRESSURE ELEVATION AND INHIBIT VASCULAR REMODELING IN APATINIB-INDUCED HYPERTENSION TO BE CONFERMED.
J Hypertens. 2022;40.
PubMed Abstract available

VAN DORST D, Colafella KM, Van Doorn L, Van Veghel R, et al
CYCLOOXYGENASE-2 INHIBITION AS A NEW TOOL TO COMBAT ANGIOGENESIS INHIBITOR-INDUCED HYPERTENSION AND RENAL TOXICITY.
J Hypertens. 2022;40.
PubMed Abstract available

WANG W, Zhan H, Wang Q, Zhuang C, et al
RHOA/ROCK PATHWAY PARTICIPATES IN THE STUDY OF RELATED MECHANISMS OF APATINIB IN THE TREATMENT OF BREAST CANCER-INDUCED HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

FERREIRA MJ, Silva GDC, Bernardes N, De Araujo AA, et al
DIURETIC ASSOCIATED WITH CONCURRENT EXERCISE PROMOTES ADDITIONAL PHYSICAL, AUTONOMIC AND INFLAMMATORY ADAPTATIONS IN HYPERTENSIVE RATS SUBMITTED TO OVARIAN HORMONE PRIVATION.
J Hypertens. 2022;40.
PubMed Abstract available

BILO G, Kyriakoulis K, Liu CY, Soranna D, et al
EFFECT OF NIFEDIPINE GITS OR RAMIPRIL ON BLOOD PRESSURE VARIABILITY IN PREVIOUSLY UNTREATED HYPERTENSIVE PATIENTS: RESULTS OF REVERENT RANDOMIZED TRIAL.
J Hypertens. 2022;40.
PubMed Abstract available

ILIC MD, Stojanovic S, Krstic I, Stojanovic M, et al
ASSOCIATION BETWEEN VARIABILITY IN SYSTOLIC BLOOD PRESSURE AND CARDIOVASCULAR EVENTS IN HYPERTENSIVE PATIENTS: 60 MONTHS FOLLOW UP.
J Hypertens. 2022;40.
PubMed Abstract available

KERRIDGE T, Gupta A
NOCTURNAL DIPPING PATTERN IN 24-HOUR AMBULATORY BLOOD PRESSURE RECORDINGS OF HYPERTENSIVE INDIVIDUALS IN THE BAY OF PLENTY (BOP).
J Hypertens. 2022;40.
PubMed Abstract available

KEZHUN L
EFFECT OF CHOLECALCIFEROL ON RATE OF MORNING BLOOD PRESSURE RISE IN WOMEN WITH ARTERIAL HYPERTENSION IN PREMENOPAUSAL AND EARLY POSTMENOPAUSAL PERIODS.
J Hypertens. 2022;40.
PubMed Abstract available

LIN Z, Zhang YH
ISCHEMIC REPERFUSION INJURY IN HYPERTENSIVE RAT HEART.
J Hypertens. 2022;40.
PubMed Abstract available

MOJAAT M, Ben Salah M, Salem MB, Handous I, et al
HYPERTENSION FOLLOWING LIVING KIDNEY-DONATION: BETTER SAFE THAN SORRY. A SINGLE-CENTER STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

SILVA S, Sousa AC, Sousa AL, Vitorino P, et al
BEHAVIOR OF PRESSURE VARIABILITY IN PATIENTS WITH ARTERIAL HYPERTENSION AND DIABETES MELLITUS WITH OR WITHOUT INSULIN USE AND THE INFLUENCE OF THE NUTRITIONAL STATE IN BRAZIL.
J Hypertens. 2022;40.
PubMed Abstract available

SOUSA AC, Magalhaes FG, Silva SB, Simeoni AR, et al
ASSOCIATION OF SHORT-TERM BLOOD PRESSURE VARIABILITY WITH DIABETES IN HYPERTENSIVE INDIVIDUALS.
J Hypertens. 2022;40.
PubMed Abstract available

KYRIAKOULIS K, Kollias A, Bilo G, Soranna D, et al
BLOOD PRESSURE VARIABILITY ASSESSED WITH OFFICE, HOME AND AMBULATORY MEASUREMENTS BEFORE AND AFTER ANTIHYPERTENSIVE DRUG TREATMENT: THE REVERENT TRIAL.
J Hypertens. 2022;40.
PubMed Abstract available

KOLLIAS A, Kyriakoulis K, Bilo G, Soranna D, et al
IDENTIFICATION OF HYPERTENSIVE PATIENTS WITH INCREASED BLOOD PRESSURE VARIABILITY USING DIFFERENT MEASUREMENT METHODS BEFORE AND AFTER TREATMENT: THE REVERENT TRIAL.
J Hypertens. 2022;40.
PubMed Abstract available

PAPADOPOULOU SL, Gkaliagkousi E, Dipla K, Koletsos N, et al
RELATIONSHIP OF 24-HOUR AMBULATORY BLOOD PRESSURE VARIABILITY WITH MICRO- AND MACROVASCULAR PARAMETERS AND HYPERTENSION STATUS.
J Hypertens. 2022;40.
PubMed Abstract available

VULIN A, Sucur N, Delic Z, Poljak JP, et al
SHORT-TERM BLOOD PRESSURE VARIBILITY AND LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

CARBONELL AMP, Anton PR, Carrasco RO, Suarez MJC, et al
CIRCADIAN PATTERN IN PATIENTS OLDER THAN 75 YEARS WITH HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ANDREEVA G, Deev A, Gorbunov V
PSYCHOLOGICAL AND QUALITY OF LIFE SCALE SCORES CORRELATED WITH THE WINTER INCREASE OF AMBULATORY BLOOD PRESSURE IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ANDREEVA G, Koshelyaevskaya Y, Smirnova M, Gorbunov V, et al
THE WHITE COAT EFFECT LEVEL CORRELATED WITH LIFESTYLE COMPONENTS AND SOCIO-DEMOGRAPHIC DATA IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ANDREEVA G, Koshelyaevskaya Y, Smirnova M, Gorbunov V, et al
WHITE COAT EFFECT LEVEL CORRELATED WITH THE ECHOCARDIOGRAPHIC PARAMETERS AND COMPOSITE ENDPOINT DATA IN TREATED PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ANDREEVA G, Gorbunov V, Lyusin D
THE PERSONAL TRAIT CORRELATED WITH THE NIGHT BLOOD PRESSURE LEVEL IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ANTZA C, Farmakis I, Doundoulakis I, Akrivos E, et al
REPRODUCIBILITY OF MASKED HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

ANTZA C, Farmakis I, Doundoulakis I, Akrivos E, et al
REPRODUCIBILITY OF WHITE COAT HYPERTENSION: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

GIRERD X, De Buyer P, Boualit R, Hanon O, et al
HOW MANY DAYS TO CONFIRM HYPERTENSION USING HOME BOOD PRESSURE MONITORING.
J Hypertens. 2022;40.
PubMed Abstract available

GIRERD X, Boualit R, Pathak A, Perruchod D, et al
ADVANTAGES AND LIMITATIONS OF USING THE AKTIIA CUFFLESS BRACELET FOR A HYPERTENSION SPECIALIST.
J Hypertens. 2022;40.
PubMed Abstract available

KOU C, Zhao X, Fan X, Wang Q, et al
EFFECT OF DIFFERENT TREATMENT OF HYPERTENSIVE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA ON BLOOD PRESSURE: A NETWORK META-ANALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

LEGRADY P, Fejes I, Czombos A, Abraham G, et al
UNATTENDED AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT VERSUS CLASSIC OFFICE AUTOMATED BLOOD PRESSURE MEASUREMENT IN A HYPERTENSION OUTPATIENT CLINIC.
J Hypertens. 2022;40.
PubMed Abstract available

LOGUNOVA N, Karpov Y, Khomitskaya Y
PREDICTORS OF BISOPROLOL ON-TREATMENT STATUS AT THE TIME OF INCLUSION OF HYPERTENSIVE PATIENTS IN THE STUDY: POST-HOC ANALYSIS OF THE TRICOLOR STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

LOGUNOVA N, Karpov Y, Khomitskaya Y, Kvasnikov B, et al
BASELINE CHARACTERISTICS, ANTIHYPERTENSIVE EFFECTIVENESS, AND TREATMENT ADHERENCE IN HYPERTENSIVE PATIENTS DEPENDING ON AGE: POST-HOC ANALYSIS OF THE TRICOLOR STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

RADOVANOVIC D, Schoenenberger-Berzins R, Muggli F, Gallino A, et al
COMPARISON OF OFFICE, HOME AND AMBULATORY BLOOD PRESSURE MEASUREMENT IN HYPERTENSIVE PARTICIPANTS IN THE POPULATION-BASED SWISS LONGITUDINAL COHORT STUDY (SWICOS).
J Hypertens. 2022;40.
PubMed Abstract available

RANCEVIENE D, Zigmantaite V, Jurevicius J, Pauziene N, et al
THE DESIGNING EXPERIMENT OF ESSENTIAL HYPERTENSION: THE CHOICE OF A CONTROL GROUP FOR SPONTANEOUSLY HYPERTENSIVE RATS.
J Hypertens. 2022;40.
PubMed Abstract available

SNINCAK M, Pella J, Hrabcakova P, Kolesar K, et al
MASKED ARTERIAL HYPERTENSION IN MIDDLE-AGE PATIENTS AND THE ELDERLY. PREVALENCE, CARDIOVASCULAR RISK FACTORS AND SOME LONG-TERM RISK TRENDS.
J Hypertens. 2022;40.
PubMed Abstract available

THEODORAKOPOULOU M, Alexandrou ME, Iatridi F, Karpetas A, et al
PERIDIALYTIC AND INTRADIALYTIC BLOOD PRESSURE MEASUREMENTS ARE NOT VALID ESTIMATES OF 44-HOUR AMBULATORY BLOOD PRESSURE IN PATIENTS WITH INTRADIALYTIC HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

TOBA A, Ishikawa J, Harada K
AUTOMATED OFFICE BLOOD PRESSURE MEASUREMENT ASSITED BY INSTRUCTIONAL VIDEO IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

KOUREMETI M, Konstantinidis D, Andrikou I, Terentes-Printzios D, et al
SYSTOLIC VERSUS DIASTOLIC BLOOD PRESSURE AS PREDICTORS OF CARDIOVASCULAR EVENTS AMONG TREATED HYPERTENSIVE PATIENTS: A 6-YEAR PROSPECTIVE STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

KALOS T, Dimitriadis K, Konstantinidis D, Siafi E, et al
PARAMETERS INDICATING DEVELOPMENT OF HYPERTENSION IN THREE-YEAR FOLLOW-UP STUDY OF SUBJECTS WITH HIGH NORMAL BLOOD PRESSURE.
J Hypertens. 2022;40.
PubMed Abstract available

PAPAVASILEIOU MV, Karamanou A, Aravantinos D, Moustakas G, et al
ROLE OF SERUM URIC ACID LEVELS AND CRP IN THE EXISTENCE OF ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

ARISIDO MW, Foco L, Gogele M, Melotti R, et al
ANALYSIS OF RAAS BIOMARKERS TO CLASSIFY ANTI-HYPERTENSIVE DRUG TREATMENTS IN THE GENERAL POPULATION: THE CHRIS STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

CZAJKOWSKA K, Zbroch E, Bielach-Bazyluk A, Koc-Zorawska E, et al
MID-REGIONAL PROADRENOMEDULLIN (MR-PROADM) AS A BIOMARKER IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERTENSION - STUDY CONTINUATION.
J Hypertens. 2022;40.
PubMed Abstract available

JEKELL A, Lundwall K, Spaak J, Kahan T, et al
VASCULAR BIOMARKERS IN RELATION TO INDICES OF AORTIC STIFFNESS AND RENAL FUNCTION IN PRIMARY HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ORTEGA A, Martinez-Arroyo O, Riffo-Campos AL, Perez-Hernandez J, et al
COMBINED EXOSOMAL AND PLASMA NON-CODING RNA SIGNATURE ASSOCIATED WITH URINARY ALBUMIN EXCRETION IN HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

CRUZ GD, Oliveira KB, Barroso WKS, Batista SR, et al
INCREASED PULSE WAVE VELOCITY AND ASSOCIATED FACTORS IN BRAZILIAN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

MANZANO-LISTA FJ, Sanz-Gomez M, Gonzalez-Moreno D, Vega-Martin E, et al
IMBALANCE IN BONE MORPHOGENIC PROTEINS 2 AND 7 IS ASSOCIATED WITH HYPERTENSION AND ARTERIAL STIFFNESS IN CHRONIC KIDNEY DISEASE.
J Hypertens. 2022;40.
PubMed Abstract available

BENDIAB NT, Bouanane S, Baba Ahmed FZ
EVALUATION OF PLASMA HOMOCYSTEINE LEVELS AND ERYTHROCYTE ANTIOXIDANT ENZYMATIC ACTIVITIES IN TYPE 2 DIABETICS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

BENDIAB NT, Bouanane S, Ahmed FZB
IMPACT OF POLYCYSTIC OVARIAN SYNDROME (PCOS) ASSOCIATED WITH HYPERTENSION ON SOME METABOLIC MARKERS.
J Hypertens. 2022;40.
PubMed Abstract available

VAZQUEZ-AGRA N, Marques-Afonso AT, Fernandez-Castro I, Lopez-Paz JE, et al
CORRELATION OF CAROTID INTIMA-MEDIA THICKNESS AND PULSE WAVE VELOCITY WITH HEMATOCRIT, PLATELET COUNT AND FIBRINOGEN LEVELS IN DIPPER AND NON-DIPPER HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

WANG K, Chu C, Wang Y, Yu Y, et al
ASSOCIATION OF SERUM RENALASE WITH THE RISK OF HYPERTENSION IN CHINESE ADULTS WITH NORMAL KIDNEY FUNCTION.
J Hypertens. 2022;40.
PubMed Abstract available

DU TOIT C, Tran T, Aryal S, Lip S, et al
INVESTIGATING THE QUALITY OF MACHINE LEARNING RESEARCH AND REPORTING IN HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

ARCHER L, Koshiaris C, Snell Ie K, Riley RD, et al
PREDICTING THE RISK OF FALLS IN PATIENTS WITH AN INDICATION FOR ANTIHYPERTENSIVE TREATMENT: DEVELOPMENT AND VALIDATION OF THE STRATIFY-FALLS PREDICTION MODEL.
J Hypertens. 2022;40.
PubMed Abstract available

ASLANOVA R, Lapshin A, Andriamanohery R, Abdulloev D, et al
DYNAMICS OF VENOUS CONGESTION (VEXUS) AND LIVER STIFFNESS BY TRANSIENT ELASTOGRAPHY IN PATIENTS WITH ARTERIAL HYPERTENSION AND DECOMPENSATED HEART FAILURE.
J Hypertens. 2022;40.
PubMed Abstract available

ASLANOVA R, Andriamanohery R, Abdulloev D, Montoya F C, et al
DYNAMIC OF BEDSIDE ULTRASOUND VENOUS AND PULMONARY CONGESTION ASSESSMENT IN PATIENTS WITH ARTERIAL HYPERTENSION AND DECOMPENSATED HEART FAILURE.
J Hypertens. 2022;40.
PubMed Abstract available

IONIN V, Elizaveta B, Viktorya P, Georgy B, et al
BIOMARKERS OF FIBROSIS AND INFLAMMATION IN PATIENTS WITH METABOLIC SYNDROME AND ATRIAL FIBRILLATION: WHAT ARE THE DIFFERENCES IN MOLECULAR MECHANISMS IN HYPERTENSION AND OBESITY?
J Hypertens. 2022;40.
PubMed Abstract available

MAZZA A, Baracca A, Schiavon L, Torin G, et al
IRON DEFICIENCY MANAGEMENT IN HYPERTENSIVE SUBJECTS WITH ACUTE HEART FAILURE: FROM CLINICAL TRIALS TO CLINICAL PRACTICE.
J Hypertens. 2022;40.
PubMed Abstract available

MZOUGHI K, Zairi I, Marwa C, Belkahla N, et al
HYPERTENSION AND QUALITY OF LIFE OF PATIENTS WITH HEART FAILURE.
J Hypertens. 2022;40.
PubMed Abstract available

PAPAKONSTANTINOU P, Andrikou I, Konstantinidis D, Tsioufis K, et al
PR INTERVAL DURATION AS A RISK FACTOR FOR NEW-ONSET ATRIAL FIBRILLATION IN PATIENTS WITH ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

PITTARAS A, Faselis C, Samuel IBH, Doumas M, et al
EXERCISE CAPACITY AND ATRIAL FIBRILLATION RISK IN 459,592 HYPERTENSIVES: A COHORT STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

SYCHOV O, Stasyshena O, Ilchyshyna O, Zinchenko Y, et al
THE COURSE OF ATRIAL FIBRILLATION AFTER A PREVIOUS INFECTION WITH COVID-19 DEPENDING ON THE PRESENCE OF ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

CARBONELL AMP, Anton PR, Carrasco RO, Suarez MJC, et al
EPISODES OF HYPOTENSION AND DEGREE OF HBP CONTROL IN THE ELDERLY WITH ANTIHYPERTENSIVE DRUG TREATMENT.
J Hypertens. 2022;40.
PubMed Abstract available

D'AMICO F, Grasso R, D'Amico R
PHYSICAL PERFOMANCE IN HYPERTENSE ELDERLY PEOPLE AND RISK OF FALL.
J Hypertens. 2022;40.
PubMed Abstract available

FERREIRA F, Freitas E, Souza D, Rodrigues C, et al
THE ACTION OF ANTIHYPERTENSIVES ON CENTRAL VESSEL STIFFNESS IN THE ELDERLY: A SUBSTUDY OF EVOUPIU (BRAZILIAN STUDY OF PULSE WAVE VELOCITY IN ELDERLY).
J Hypertens. 2022;40.
PubMed Abstract available

KANTOLA IM, Kantola T
THE CHANGE IN QUALITY OF LIFE IN DRUG TREATED HYPERTENSIVE PATIENTS AFTER 10 YEARS OF ANTIHYPERTENSIVE TREATMENT.
J Hypertens. 2022;40.
PubMed Abstract available

KISTERS KLAUS K, Sophia K, Uwe G
SERUM AND IONIZED MAGNESIUM IN ELDERLY HYPERTENSIVES.
J Hypertens. 2022;40.
PubMed Abstract available

MZOUGHI K, Bergaoui Z, Soltani C, Belkahla N, et al
ASSESSMENT OF THE KNOWLEDGE ABOUT HYPERTENSION IN THE TUNISIAN ELDERLY.
J Hypertens. 2022;40.
PubMed Abstract available

THANH HN, Trong KHP, Huu AN, Xuan GNT, et al
PREVALENCE OF HYPERTENSION AND DISTRIBUTION OF BODY MASS INDEX LEVELS AMONG OLDER ADULTS WITH TYPE 2 DIABETES MELLITUS IN VIETNAM: A MULTICENTRE STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

RIVASI G, Tortu V, D'Andria MF, Turrin G, et al
PREVALENCE AND CLINICAL CORRELATES OF FRAILTY IN HYPERTENSIVE OLDER ADULTS.
J Hypertens. 2022;40.
PubMed Abstract available

SANCHEZ MS, Qin JC, Vinas-Esmel E, Mas MC, et al
AMBULATORY BLOOD PRESSURE MEASUREMENT AS A PREDICTOR OF HYPERTENSION MEDIATED TARGET ORGAN DAMAGE IN VERY ELDERLY POPULATION: THE MAPACHESS STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

LIAO CT, Toh HS, Yang CT, Wei D, et al
COST-EFFECTIVENESS OF INTENSIVE VERSUS STANDARD BLOOD-PRESSURE CONTROL IN OLDER PATIENTS WITH HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

LEE HY, Cho MC
CARDIOVASCULAR EVENTS ACCORDING TO FOLLOW-UP INTERVAL IN HYPERTENSIVE PATIENTS.
J Hypertens. 2022;40.
PubMed Abstract available

BURNIER M, Persu A, Azizi M, Prejbisz A, et al
PATIENT PERSPECTIVES ON TREATMENT ADHERENCE IN HYPERTENSION: PRELIMINARY RESULTS OF AN ESH SURVEY IN FIVE COUNTRIES.
J Hypertens. 2022;40.
PubMed Abstract available

KUZIOR A, Hernandez-Lazaro A, De Leon-Durango R, Rios-Gomez C, et al
INITIATION OF EMPAGLIFLOZIN THERAPY IS ASSOCIATED WITH A CLINICALLY RELEVANT DECREASE IN BLOOD PRESSURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND UNCONTROLLED HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

DE LA SIERRA A, Ruilope L, Martinez-Camblor P, Vinyoles E, et al
TIME DOSING OF ANTIHYPERTENSIVE TREATMENT AND PROGNOSIS.
J Hypertens. 2022;40.
PubMed Abstract available

HEISEL A, Vuurboom MD, Daams JG, De Rie MA, et al
INDIVIDUAL ANTIHYPERTENSIVE MEDICATION AND SKIN CANCER RISK: A SYSTEMATIC REVIEW AND META-ANALYSIS.
J Hypertens. 2022;40.
PubMed Abstract available

FRAGKOULIS C, Polyzos D, Mavroudis A, Dimitriadis K, et al
AGE AS A RISK FACTOR FOR CARDIOVASCULAR EVENTS IN PATIENTS WITH HYPERTENSIVE CRISES AFTER 12-MONTH FOLLOW-UP: A GREEK REGISTRY.
J Hypertens. 2022;40.
PubMed Abstract available

FORJAZ CLM, Oliveira-Silva LG, Silva-Junior ND, Pio-Abreu A, et al
ACUTE POST-DYNAMIC, ISOMETRIC AND COMBINED RESISTANCE EXERCISE HYPOTENSION IN PATIENTS WITH HYPERTENSION: A RANDOMIZED STUDY.
J Hypertens. 2022;40.
PubMed Abstract available

PATHAK A, Weber M, Poulos C, Coulter J, et al
PATIENT PREFERENCES FOR PHARMACEUTICAL AND INTERVENTIONAL HYPERTENSION TREATMENTS: RESULTS FROM A DISCRETE CHOICE EXPERIMENT.
J Hypertens. 2022;40.
PubMed Abstract available

ESLER M, Cao K, Lobo M, Sharp ASP, et al
CLINICAL EVENT REDUCTIONS IN HIGH-RISK HYPERTENSION PATIENTS TREATED WITH RENAL DENERVATION: 10-YEAR PROJECTIONS BASED ON 3-YEAR FOLLOW-UP FROM THE GLOBAL SYMPLICITY REGISTRY.
J Hypertens. 2022;40.
PubMed Abstract available

PERSU A, Georges CMG, Ritscher S, Pappaccogli M, et al
PSYCHOLOGICAL DETERMINANTS OF DRUG ADHERENCE AND SEVERITY OF HYPERTENSION IN PATIENTS WITH RESISTANT VS. CONTROLLED HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

POSTADZHIYAN A, Tochev S, Andreeva L, Rifai N, et al
EFFECT OF RENAL DENERVATION ON CARDIO ANKLE VASCULAR INDEX IN SUBJECTS WITH RESISTANT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

MISERQUE L, Boscaro M, Kotliar C, Obrego S, et al
HIDDEN CENTRAL HYPERTENSION AND SPURIOUS HYPERTENSION IN ELDERLY PEOPLE.
J Hypertens. 2022;40.
PubMed Abstract available

PECLY IMD, Fernandes ACTC, Bica RBDS, Flumingnan VSM, et al
KIDNEY SUBCLINICAL LESIONS IN HYPERTENSION PHENOTYPES DEFINED BY HOME BLOOD PRESSURE MONITORING AMONG YOUNG ADULTS ENROLLED IN A FAMILY HEALTH STRATEGY UNIT.
J Hypertens. 2022;40.
PubMed Abstract available

NORDB OP, Landolt L, Eikrem O, Scherer A, et al
COMPARATIVE TRANSCRIPTOMIC ANALYSIS IDENTIFIES EPITHELIAL-MESENCHYMAL TRANSITION AND INFLAMMATION AS COMMON PATHOGENETIC MECHANISMS IN HYPERTENSIVE AND DIABETIC NEPHROPATHY.
J Hypertens. 2022;40.
PubMed Abstract available

JENKINS S, Gupta P, Khunti K, Cross A, et al
THE EFFECT OF BIOFEEDBACK ON HYPERTENSION AND DIABETES: PRELIMINARY RESULTS FROM A SYSTEMATIC REVIEW.
J Hypertens. 2022;40.
PubMed Abstract available

SCHLAICH M, Sesa-Ashton J, Lee R, Lambert E, et al
CATHETER-BASED RENAL DENERVATION - LONG TERM SAFETY AND BLOOD PRESSURE REDUCTION IN PATIENTS WITH RESISTANT HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

LAZARIDIS A, Gavriilaki E, Dolgyras P, Koletsos N, et al
HIGH MOBILITY GROUP BOX-1 IS INCREASED IN NEWLY DIAGNOSED ESSENTIAL HYPERTENSIVES AND CORRELATES WITH HYPERTENSION-MEDIATED TARGET ORGAN DAMAGE.
J Hypertens. 2022;40.
PubMed Abstract available

ALOSAIMI H, Maffia P, Padmanabhan S, Guzik T, et al
ASSESSING THE IMPACT OF IMMUNOSUPPRESSIVE THERAPIES ON INCIDENCE OF HYPERTENSION IN PATIENTS WITH RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISEASES: A SYSTEMATIC REVIEW.
J Hypertens. 2022;40.
PubMed Abstract available

MERCADO-ASIS L, Ona DI, Bonzon D, Vilela G, et al
BURDEN OF DISEASE OF HYPERTENSION IN THE PHILIPPINES PROJECTED IN 2050.
J Hypertens. 2022;40.
PubMed Abstract available

TIMASHEVA Y, Balkhiyarova Z, Prokopenko I
DISENTANGLING THE SHARED HERITABILITY OF THE PREDISPOSITION TO HYPERTENSION AND TYPE 2 DIABETES.
J Hypertens. 2022;40.
PubMed Abstract available

GUERROT D, Hamzaoui M, Groussard D, Nezam D, et al
ENDOTHELIUM-SPECIFIC DEFICIENCY OF POLYCYSTIN-1 PROMOTES HYPERTENSION AND CARDIOVASCULAR DISORDERS.
J Hypertens. 2022;40.
PubMed Abstract available

GOMES J, Ferreira P, Adao R, Rocha C, et al
THERAPEUTIC EFFECTS OF NEBULIZATION- BASED DELIVERY OF ANTI-MIR-146A IN EXPERIMENTAL PULMONARY ARTERIAL HYPERTENSION.
J Hypertens. 2022;40.
PubMed Abstract available

May 2022

KHAN NA, Stergiou GS, Omboni S, Kario K, et al
Virtual management of hypertension: lessons from the COVID-19 pandemic-International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension.
J Hypertens. 2022 May 17. pii: 00004872-990000000-00001.
PubMed Abstract available

STOSCHITZKY K
Diuretics at bedtime hypertension treatment.
J Hypertens. 2022;40:1051.
PubMed

KREUTZ R, Brunstrom M, Thomopoulos C, Carlberg B, et al
Prescribing blood pressure lowering drugs irrespective of blood pressure?
J Hypertens. 2022;40:1050-1051.
PubMed

CHACHOO J, Mushtaq N, Jan S, Majid S, et al
Clinical variables accompanying salt-sensitive essential hypertension in ethnic Kashmiri population.
J Hypertens. 2022;40:916-923.
PubMed Abstract available

BLOK S, Haggenburg S, Collard D, Van Der Linden EL, et al
The association between socioeconomic status and prevalence, awareness, treatment and control of hypertension in different ethnic groups: the Healthy Life in an Urban Setting study.
J Hypertens. 2022;40:897-907.
PubMed Abstract available

PEI J, Wang X, Zheng K, Su W, et al
Effect of body size and intensive blood pressure management on cardiovascular and serious adverse events.
J Hypertens. 2022;40:878-887.
PubMed Abstract available

ITO H, Okamoto R, Ali Y, Zhe Y, et al
Cardiorenai protective effects of sodium-glucose cotransporter 2 inhibition in combination with angiotensin II type 1 receptor blockade in salt-sensitive Dahl rats.
J Hypertens. 2022;40:956-968.
PubMed Abstract available

PUTRA SED, Reichetzeder C, von Websky K, Neuber C, et al
Association between placental global DNA methylation and blood pressure during human pregnancy.
J Hypertens. 2022;40:1002-1009.
PubMed Abstract available

KREUTZ R, Brunstrom M, Thomopoulos C, Carlberg B, et al
Do recent meta-analyses truly prove that treatment with blood pressure-lowering drugs is beneficial at any blood pressure value, no matter how low? A critical review.
J Hypertens. 2022;40:839-846.
PubMed Abstract available

ZADEH SST, Moazzeni SS, Matsushita K, Hasheminia M, et al
Application of the 2017 American college of cardiology/American Heart Association Blood Pressure Guidelines for cardiovascular outcomes among Tehranian residents.
J Hypertens. 2022;40:924-932.
PubMed Abstract available

BOERSTRA BA, Soepnel LM, Nicolaou V, Kolkenbeck-Ruh A, et al
The impact of maternal hyperglycaemia first detected in pregnancy on offspring blood pressure in Soweto, South Africa.
J Hypertens. 2022;40:969-977.
PubMed Abstract available

April 2022

WANG Y, Jia H, Mu JJ
Reply to 'Plasma PAPP-A2 and genetic variations with hypertension'.
J Hypertens. 2022;40:837-838.
PubMed

SOOKAROMDEE P, Wiwanitkit V
Plasma PAPP-A2 and genetic variations with hypertension.
J Hypertens. 2022;40:837.
PubMed

BEN-ELTRIKI M, Cassels A, Erviti J, Wright JM, et al
Reply to 'Why we do not need a single independent international hypertension clinical practice guideline'.
J Hypertens. 2022;40:835-836.
PubMed

YOON SG, Lee SK, Kim SH, Shin C, et al
Differences in estimated glomerular filtration rate are associated with different patterns of 24-h ambulatory blood pressure in the general population.
J Hypertens. 2022;40:804-810.
PubMed Abstract available

LI J, Imano H, Kitamura A, Kiyama M, et al
Retinal microvascular abnormalities and risks of incident stroke and its subtypes: The Circulatory Risk in Communities Study.
J Hypertens. 2022;40:732-740.
PubMed Abstract available

SHAWKY NM, Dalmasso C, Ojeda NB, Zuchowski Y, et al
Consequences of hyperandrogenemia during pregnancy in female offspring: attenuated response to angiotensin II.
J Hypertens. 2022;40:712-722.
PubMed Abstract available

XU SK, Chen X, Sheng CS, Cheng YB, et al
Comparison of the mean of the first two blood pressure readings with the overall mean of three readings on a single occasion.
J Hypertens. 2022;40:699-703.
PubMed Abstract available

March 2022

SCHWILLENS EJM, Mostard GJM, Stifft F, van Twist DJL, et al
Exaggerated natriuresis after renal artery balloon angioplasty for flash pulmonary oedema: a potential complication in one-kidney renovascular hypertension.
J Hypertens. 2022 Mar 4. pii: 00004872-900000000-96476.
PubMed Abstract available

CAI A, Liu L, Zhou D, Tang S, et al
Influences of achieved SBP on age and sex-related left ventricular structural alteration in community hypertensive populations.
J Hypertens. 2022 Mar 2. pii: 00004872-900000000-96478.
PubMed Abstract available

AGOSTINUCCI K, Hutcheson R, Hossain S, Pascale JV, et al
Blockade of 20-hydroxyeicosatetraenoic acid receptor lowers blood pressure and alters vascular function in mice with smooth muscle-specific overexpression of CYP4A12-20-HETE synthase.
J Hypertens. 2022;40:498-511.
PubMed Abstract available

YADAV A, Beilin LJ, Huang RC, Vlaskovsky P, et al
The relationship between intrauterine foetal growth trajectories and blood pressure in young adults.
J Hypertens. 2022;40:478-489.
PubMed Abstract available

XIAO MZX, Whitney D, Guo N, Bentley J, et al
Trends in eclampsia in the United States, 2009-2017: a population-based study.
J Hypertens. 2022;40:490-497.
PubMed Abstract available

DE HAVENON A, Petersen N, Wolcott Z, Goldstein E, et al
Effect of dihydropyridine calcium channel blockers on blood pressure variability in the SPRINT trial: a treatment effects approach.
J Hypertens. 2022;40:462-469.
PubMed Abstract available

February 2022

GENG Q, Hou F, Zhang Y, Wang Z, et al
Effects of different doses of canagliflozin on blood pressure and lipids in patients with type 2 diabetes: a meta-analysis.
J Hypertens. 2022 Feb 25. pii: 00004872-900000000-96482.
PubMed Abstract available

HUCK DM, Rosenberg MA, Stauffer BL
Nebivolol and incident cardiovascular events in hypertensive patients compared with nonvasodilatory beta blockers.
J Hypertens. 2022 Feb 23. pii: 00004872-900000000-96483.
PubMed Abstract available

SHAKESPEAR-DRUERY J, De Cocker K, Biddle SJH, Bennie J, et al
Associations between duration and volume of muscle-strengthening exercise and clinically assessed hypertension among 10 519 UK adults: a cross-sectional study.
J Hypertens. 2022 Feb 21. pii: 00004872-900000000-96487.
PubMed Abstract available

SARNECKI J, Obrycki L, Feber J, Chelstowska S, et al
Isolated systolic hypertension is associated with increased left ventricular mass index and aortic stiffness in adolescents: a cardiac magnetic resonance study.
J Hypertens. 2022 Feb 21. pii: 00004872-900000000-96486.
PubMed Abstract available

BENOIT J, Gaudissard J, Doublet J, Boulestreauw R, et al
Adrenal BORDeAux reGistry: Bordeaux single-center study of hypertensive patients with primary hyperaldosteronism.
J Hypertens. 2022 Feb 18. pii: 00004872-900000000-96488.
PubMed Abstract available

RAHMAN M, Judah G, Murphy D, Garfield SF, et al
Which domains of the theoretical domains framework should be targeted in interventions to increase adherence to antihypertensives? A systematic review.
J Hypertens. 2022 Feb 11. pii: 00004872-900000000-96495.
PubMed Abstract available

VAN DER LINDEN EL, Meeks KAC, Klipstein-Grobusch K, Bahendeka S, et al
Hypertension determinants among Ghanaians differ according to location of residence: the Research on Obesity and Diabetes among African Migrants study.
J Hypertens. 2022 Feb 11. pii: 00004872-900000000-96494.
PubMed Abstract available

BREWSTER LM, Boermeester AS, Seedat YK, Van Montfrans GA, et al
Initial combination therapy for hypertension in patients of African ancestry: a systematic review and meta-analysis.
J Hypertens. 2022 Feb 7. pii: 00004872-900000000-96501.
PubMed Abstract available

MCGRATH B, McEvoy JW
Isolated diastolic hypertension in the UK Biobank: correspondence regarding Isolated systolic and diastolic hypertension by the 2017 American College of Cardiology/American Heart Association guidelines and risk of cardiovascular disease: a large prosp
J Hypertens. 2022;40:409-410.
PubMed

LI G, Shi C, Li T, Ouyang N, et al
A nomogram integrating non-ECG factors with ECG to screen left ventricular hypertrophy among hypertensive patients from northern China.
J Hypertens. 2022;40:264-273.
PubMed Abstract available

TSUJIMOTO Y, Kataoka Y, Banno M, Taito S, et al
Association of low birthweight and premature birth with hypertensive disorders in pregnancy: a systematic review and meta-analysis.
J Hypertens. 2022;40:205-212.
PubMed Abstract available

GAO M, Wells JCK, Li L
Secular trends in blood pressure trajectories in Chinese children and adolescents: the impact of changing physical growth.
J Hypertens. 2022;40:389-397.
PubMed Abstract available

ASAYAMA K, Ohkubo T, Rakugi H, Miyakawa M, et al
Direct comparison of the reproducibility of in-office and self-measured home blood pressures.
J Hypertens. 2022;40:398-407.
PubMed Abstract available

MEER R, Boateng D, Klipstein-Grobusch K, Norris SA, et al
Incidence and correlates of high blood pressure from childhood to adulthood: the Birth to Twenty study.
J Hypertens. 2022;40:274-282.
PubMed Abstract available

FISHER NDL, Kirtane AJ, Daemen J, Rader F, et al
Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial.
J Hypertens. 2022;40:221-228.
PubMed Abstract available

January 2022

TADIC M, Gherbesi E, Sala C, Carugo S, et al
Effect of long-term antihypertensive therapy on myocardial strain: a meta-analysis.
J Hypertens. 2022 Jan 31. pii: 00004872-900000000-96505.
PubMed Abstract available

WANG Y
Stage 1 hypertension and risk of cardiovascular disease mortality in United States adults with or without diabetes.
J Hypertens. 2022 Jan 31. pii: 00004872-900000000-96504.
PubMed Abstract available

HINDERLITER AL, Lin FC, Viera LA, Olsson E, et al
Hypertension-mediated organ damage in masked hypertension.
J Hypertens. 2022 Jan 31. pii: 00004872-900000000-96502.
PubMed Abstract available

KOVELL LC, Meyerovitz CV, Skaritanov E, Ayturk D, et al
Hypertension and contraceptive use among women of child-bearing age in the United States from 2001 to 2018.
J Hypertens. 2022 Jan 25. pii: 00004872-900000000-96509.
PubMed Abstract available

SEEMAN T, Blazik R, Fencl F, Blahova K, et al
Ambulatory blood pressure and hypertension control in children with autosomal recessive polycystic kidney disease: clinical experience from two central European tertiary centres.
J Hypertens. 2022 Jan 25. pii: 00004872-900000000-96507.
PubMed Abstract available

OJJI DB, Baldridge AS, Orji IA, Shedul GL, et al
Characteristics, treatment, and control of hypertension in public primary healthcare centers in Nigeria: baseline results from the Hypertension Treatment in Nigeria Program.
J Hypertens. 2022 Jan 14. pii: 00004872-900000000-96513.
PubMed Abstract available

FOTI K, Hardy ST, Chang AR, Selvin E, et al
BMI and blood pressure control among United States adults with hypertension.
J Hypertens. 2022 Jan 6. pii: 00004872-900000000-96517.
PubMed Abstract available

SAUNDERS A, Nuredini GN, Kirkham FA, Drazich E, et al
White-coat hypertension/effect is associated with higher arterial stiffness and stroke events.
J Hypertens. 2022 Jan 6. pii: 00004872-900000000-96516.
PubMed Abstract available

PEETERS LEJ, van der Net JB, Schoenmakers-Buis K, van der Meer IM, et al
Introducing the importance and difficulties of a three-step approach to improve nonadherence to antihypertensive drugs: a case series.
J Hypertens. 2022;40:189-193.
PubMed Abstract available

ZAFRIR B, Aker A, Asaf Y, Saliba W, et al
Blood pressure response during treadmill exercise testing and the risk for future cardiovascular events and new-onset hypertension.
J Hypertens. 2022;40:143-152.
PubMed Abstract available

PARK YJ, Yang PS, Yu HT, Kim TH, et al
Association of proteinuria and hypertension with incident atrial fibrillation in an elderly population: nationwide data from a community-based elderly cohort.
J Hypertens. 2022;40:128-135.
PubMed Abstract available

CUSPIDI C, Tadic M
Cardiovascular risk stratification: how important is the hypertensive response to exercise?
J Hypertens. 2022;40:27-29.
PubMed

ARDISSINO G, Perrone M, Ghiglia S, Salice P, et al
Fluid intake and blood pressure in children: the Salus per Aquam project.
J Hypertens. 2022;40:171-179.
PubMed Abstract available

CRAIG A, Gafane-Matemane L, Smith W, Mels C, et al
Elevated blood pressure positively associates with alpha-1 microglobulin in prepubescent children: the ExAMIN Youth SA study.
J Hypertens. 2022;40:136-142.
PubMed Abstract available

BAE E, Rocco MV, Lee J, Park JY, et al
Impact of DBP on all-cause and cardiovascular mortality: results from the National Health and Nutrition Examination survey, 1999-2014.
J Hypertens. 2022;40:108-116.
PubMed Abstract available

LIU W, Ye Y, Wang L, Gao C, et al
Central versus ambulatory blood pressure for predicting mortality and cardiovascular events in hemodialysis patients: a multicenter cohort study.
J Hypertens. 2022;40:180-188.
PubMed Abstract available

RYUZAKI M, Miyashita K, Sato M, Inoue H, et al
Activation of the intestinal tissue renin-angiotensin system by transient sodium loading in salt-sensitive rats.
J Hypertens. 2022;40:33-45.
PubMed Abstract available

December 2021

GAMBARO A, Lombardi G, Ribichini FL, Mantovani A, et al
Impact of early glomerular filtration rate decline in response to antihypertensive treatment on risk of end-stage kidney disease and cardiovascular outcomes: a systematic review and meta-analysis.
J Hypertens. 2021 Dec 20. pii: 00004872-900000000-96523.
PubMed Abstract available

BAPOLISI A, Maurage P, Pappaccogli M, Georges CMG, et al
Association between post-traumatic stress disorder and hypertension in Congolese exposed to violence: a case-control study.
J Hypertens. 2021 Dec 13. pii: 00004872-900000000-96524.
PubMed Abstract available

GORI M, Berzuini C, D'Elia E, Ghirardi A, et al
Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients.
J Hypertens. 2021 Dec 9. pii: 00004872-900000000-96525.
PubMed Abstract available

YUSUF SM, Norton GR, Peterson V, Libhaber CD, et al
Marked intrafamilial aggregation and heritability of aortic flow in a community with prevalent volume-dependent hypertension in Africa.
J Hypertens. 2021 Dec 7. pii: 00004872-900000000-96529.
PubMed Abstract available

YUN B, Sim J, Jeong I, Lee S, et al
Does severe subacute noise exposure increase risk of new onset hypertension beyond conventional risk factors? A 30 000 person-years cohort study.
J Hypertens. 2021 Dec 7. pii: 00004872-900000000-96527.
PubMed Abstract available

LI C, Ma L, Wang Q, Shao X, et al
Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension.
J Hypertens. 2021 Dec 2. pii: 00004872-900000000-96531.
PubMed Abstract available

EVERETT M, Setoguchi S, Visaria A
Considerations when assessing the effect of nightshifts on hypertension prevalence.
J Hypertens. 2021;39:2534.
PubMed

KIM BS, Kim HJ, Lyu M, Kim WD, et al
Clinical characteristics, practice patterns, and outcomes of patients with acute severe hypertension visiting the emergency department.
J Hypertens. 2021;39:2506-2513.
PubMed Abstract available

ABDALLA M, Sakhuja S, Akinyelure OP, Thomas SJ, et al
The association of actigraphy-assessed sleep duration with sleep blood pressure, nocturnal hypertension, and nondipping blood pressure: the coronary artery risk development in young adults (CARDIA) study.
J Hypertens. 2021;39:2478-2487.
PubMed Abstract available

SIAFI E, Andrikou I, Konstantinidis D, Kakouri N, et al
Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus.
J Hypertens. 2021;39:2470-2477.
PubMed Abstract available

MALAN N, Norton GR, Peterson VR, Yusuf SM, et al
Independent relationships between renal mechanisms and systemic flow, but not resistance to flow in primary hypertension in Africa.
J Hypertens. 2021;39:2446-2454.
PubMed Abstract available

MOORE MN, Climie RE, Otahal P, Schultz MG, et al
Exercise blood pressure and cardiovascular disease risk: a systematic review and meta-analysis of cross-sectional studies.
J Hypertens. 2021;39:2395-2402.
PubMed Abstract available

TSIRIMIAGKOU C, Karatzi K, Argyris A, Basdeki ED, et al
Dietary sodium and cardiovascular morbidity/mortality: a brief commentary on the 'J-shape hypothesis'.
J Hypertens. 2021;39:2335-2343.
PubMed Abstract available

TODKAR S, Padwal R, Cloutier L
Knowledge, perception and practice of Quebec nurses for ambulatory and clinic blood pressure measurement methods: are we there yet?
J Hypertens. 2021;39:2455-2462.
PubMed Abstract available

November 2021

BATTA D, Korosi B, Gyongyosi H, Nemcsik-Bencze Z, et al
Cross-sectional comparison of office and ambulatory pulse wave velocity by two methods, and their changes after lifestyle or medical interventions in hypertension.
J Hypertens. 2021 Nov 26. pii: 00004872-900000000-96534.
PubMed Abstract available

CARNAGARIN R, Nolde JM, Lee R, Lugo-Gavidia LM, et al
Renal denervation alters ambulatory blood pressure-derived salt sensitivity index in patients with uncontrolled hypertension.
J Hypertens. 2021 Nov 22. pii: 00004872-900000000-96535.
PubMed Abstract available

MENSAH EA, Daneshtalab N, Tabrizchi R
Differential biomechanics in resistance arteries of male compared with female Dahl hypertensive rats.
J Hypertens. 2021 Nov 18. pii: 00004872-900000000-96536.
PubMed Abstract available

BA DM, Gao X, Chinchilli VM, Liao D, et al
Red and processed meat consumption and food insecurity are associated with hypertension; analysis of the national health and nutrition examination survey data, 2003-2016.
J Hypertens. 2021 Nov 15. pii: 00004872-900000000-96539.
PubMed Abstract available

LIN M, Heizhati M, Gan L, Yao X, et al
Higher aldosterone is associated with increased renal impairment risk in patients with hypertension and abnormal glucose metabolism: a longitudinal study.
J Hypertens. 2021 Nov 15. pii: 00004872-900000000-96538.
PubMed Abstract available

PALMU J, Tikkanen E, Havulinna AS, Vartiainen E, et al
Comprehensive biomarker profiling of hypertension in 36 985 Finnish individuals.
J Hypertens. 2021 Nov 15. pii: 00004872-900000000-96537.
PubMed Abstract available

SILVA AA, Perilhao MS, Portes LA, Serra AJ, et al
Physical exercise attenuates stress-induced hypertension in rats but not the impairments on the myocardial mechanics.
J Hypertens. 2021 Nov 11. pii: 00004872-900000000-96542.
PubMed Abstract available

FUJIWARA A, Ozawa M, Sumida K, Hirawa N, et al
LPIN1 is a new target gene for essential hypertension.
J Hypertens. 2021 Nov 11. pii: 00004872-900000000-96540.
PubMed Abstract available

Aldosterone contributes to hypertension in male mice inducibly overexpressing human endothelin-1 in endothelium: Erratum.
J Hypertens. 2021;39:2333.
PubMed

GIUDICI A, Palombo C, Kozakova M, Morizzo C, et al
Noninvasive carotid pressure-diameter loops to identify viscoelastic properties in ageing, hypertension and type 2 diabetes.
J Hypertens. 2021;39:2307-2317.
PubMed Abstract available

LUNYERA J, Park YM, Ward JB, Gaston SA, et al
A prospective study of multiple sleep dimensions and hypertension risk among white, black and Hispanic/Latina women: findings from the Sister Study.
J Hypertens. 2021;39:2210-2219.
PubMed Abstract available

ZHAO Y, Liu Y, Sun Q, Han J, et al
Effects of blood pressure and heart rate circadian rhythms on left atrial function.
J Hypertens. 2021;39:2318-2324.
PubMed Abstract available

KRUGER R, Kruger HS, Monyeki MA, Pienaar AE, et al
A demographic approach to assess elevated blood pressure and obesity in prepubescent children: the ExAMIN Youth South Africa study.
J Hypertens. 2021;39:2190-2199.
PubMed Abstract available

GIUDICI A, Khir AW, Reesink KD, Delhaas T, et al
Five years of cardio-ankle vascular index (CAVI) and CAVI0: how close are we to a pressure-independent index of arterial stiffness?
J Hypertens. 2021;39:2128-2138.
PubMed Abstract available

SANTIAGO-HERNANDEZ A, Martin-Lorenzo M, Martinez PJ, Gomez-Serrano M, et al
Early renal and vascular damage within the normoalbuminuria condition.
J Hypertens. 2021;39:2220-2231.
PubMed Abstract available

ZHUO M, Yang D, Goldfarb-Rumyantzev A, Brown RS, et al
The association of SBP with mortality in patients with stage 1-4 chronic kidney disease.
J Hypertens. 2021;39:2250-2257.
PubMed Abstract available

SAITO K, Kurihara I, Itoh H, Ichijo T, et al
Subtype-specific trends in the clinical picture of primary aldosteronism over a 13-year period.
J Hypertens. 2021;39:2325-2332.
PubMed Abstract available

PAN F, He P, Pu X, Gao H, et al
Influence of aging and increased blood pressure on oscillometric cuff pressure waveform characteristics.
J Hypertens. 2021;39:2157-2163.
PubMed Abstract available

SUTHERLAND K, Dissanayake HU, Trzepizur W, Gagnadoux F, et al
Circadian blood pressure profile and blood pressure changes following oral appliance therapy for obstructive sleep apnoea.
J Hypertens. 2021;39:2272-2280.
PubMed Abstract available

ZHANG J, Song J, Zhou L, Zhou W, et al
Lower ambulatory nocturnal SBP is associated with less cardiovascular and renal damage in normotensive hospitalized patients with chronic kidney disease.
J Hypertens. 2021;39:2241-2249.
PubMed Abstract available

October 2021

KIM HJ, Jeon J, Song TJ, Kim J, et al
Association between oral health and cardiovascular outcomes in patients with hypertension: a nationwide cohort study.
J Hypertens. 2021 Oct 19. pii: 00004872-900000000-96549.
PubMed Abstract available

SONG Y, Nie L, Wei D, Liu P, et al
Serum cortisol-to-cortisone ratio and 11-deoxycortisol are associated with hypertension and blood pressure in Chinese rural population: a cross sectional study.
J Hypertens. 2021 Oct 19. pii: 00004872-900000000-96548.
PubMed Abstract available

SISO-ALMIRALL A, Kostov B, Blat E, Garcia N, et al
Validity and reliability of 1-h automated office blood pressure measurement for the diagnosis of hypertension.
J Hypertens. 2021 Oct 13. pii: 00004872-900000000-96551.
PubMed Abstract available

KAWADA T
Cancer, hypertension and risk for cardiovascular disease.
J Hypertens. 2021;39:2122.
PubMed

ZHOU Y, Liu L, Fan F, Hong-Yun Y, et al
Relation between elevated first SBP from baseline (delta SBP) and postoperative outcome.
J Hypertens. 2021;39:1982-1990.
PubMed Abstract available

HISAMATSU T, Ohkubo T, Hozawa A, Fujiyoshi A, et al
Association of self-measured home, ambulatory, and strictly measured office blood pressure and their variability with intracranial arterial stenosis.
J Hypertens. 2021;39:2030-2039.
PubMed Abstract available

OMBONI S, Ballatore T, Rizzi F, Tomassini F, et al
Feasibility of 24-h blood pressure telemonitoring in community pharmacies: the TEMPLAR project.
J Hypertens. 2021;39:2075-2081.
PubMed Abstract available

RIBBE M, Kern S, Wetterberg H, Ryden L, et al
Time trends in the relation between blood pressure and dementia in 85-year-olds.
J Hypertens. 2021;39:1964-1971.
PubMed Abstract available

NOTEN S, van den Berg-Emons RJG, Thorpe DE, Heyn PC, et al
Blood pressure in adults with cerebral palsy: a systematic review and meta-analysis of individual participant data.
J Hypertens. 2021;39:1942-1955.
PubMed Abstract available

PALLIKADAVATH S, Chambers L, Shepherd D, Sukhnani M, et al
The association of blood pressure variability with adverse outcomes in a primary care chronic kidney disease cohort.
J Hypertens. 2021;39:2067-2074.
PubMed Abstract available

DE HAAS S, Spaanderman MEA, van Kuijk SMJ, van Drongelen J, et al
Adaptation of left ventricular diastolic function to pregnancy: a systematic review and meta-analysis.
J Hypertens. 2021;39:1934-1941.
PubMed Abstract available

WIENER A, Goldstein P, Doenyas K, Okon-Singer H, et al
Abnormalities in emotional and motor reactions among young prehypertensive individuals: employing continuous blood pressure analysis.
J Hypertens. 2021;39:2040-2050.
PubMed Abstract available

September 2021

KOROGIANNOU M, Sarafidis P, Theodorakopoulou MP, Alexandrou ME, et al
Sex differences in ambulatory blood pressure levels, control, and phenotypes of hypertension in kidney transplant recipients.
J Hypertens. 2021 Sep 27. pii: 00004872-900000000-96554.
PubMed Abstract available

MIURA T, Sakuyama A, Xu L, Qiu J, et al
Febuxostat ameliorates high salt intake-induced hypertension and renal damage in Dahl salt-sensitive rats.
J Hypertens. 2021 Sep 7. pii: 00004872-900000000-96557.
PubMed Abstract available

VAN APELDOORN JAN, van der Linden EL, Bahendeka S, Beune E, et al
C-reactive protein and hypertension among Ghanaian migrants and their homeland counterparts: the Research on Obesity and Diabetes among African Migrants study.
J Hypertens. 2021 Sep 2. pii: 00004872-900000000-96560.
PubMed Abstract available

CUGLAN B, Atmaca H, Yalta K, Yetkin E, et al
Uterine fibroids in hypertension and pregnancy.
J Hypertens. 2021;39:1926.
PubMed

NOLDE JM, Frost S, Kannenkeril D, Lugo-Gavidia LM, et al
Capillary vascular density in the retina of hypertensive patients is associated with a non-dipping pattern independent of mean ambulatory blood pressure.
J Hypertens. 2021;39:1826-1834.
PubMed Abstract available

KONOPELSKI P, Konop M, Perlejewski K, Bukowska-Osko I, et al
Genetically determined hypertensive phenotype affects gut microbiota composition, but not vice versa.
J Hypertens. 2021;39:1790-1799.
PubMed Abstract available

COOK KL, Chappell MC
Gut dysbiosis and hypertension: is it cause or effect?
J Hypertens. 2021;39:1768-1770.
PubMed

SHI J, Ren Y, Liu S, Zhao Q, et al
Circulating miR-3656 induces human umbilical vein endothelial cell injury by targeting eNOS and ADAMTS13: a novel biomarker for hypertension.
J Hypertens. 2021 Sep 1. pii: 00004872-900000000-96566.
PubMed Abstract available

ZHAO W, Gao F, Lv L, Chen X, et al
The interaction of hypertension and homocysteine increases the risk of mortality among middle-aged and older population in the United States.
J Hypertens. 2021 Sep 1. pii: 00004872-900000000-96565.
PubMed Abstract available

GOULAS I, Farmakis I, Doundoulakis I, Antza C, et al
Comparison of the 2017 American Academy of Pediatrics with the fourth report and the 2016 European Society of Hypertension guidelines for the diagnosis of hypertension and the detection of left ventricular hypertrophy in children and adolescents: a sy
J Hypertens. 2021 Sep 1. pii: 00004872-900000000-96564.
PubMed Abstract available

BASSAREO PP
Magnitude and significance of interarm blood pressure differences in children and adolescents.
J Hypertens. 2021;39:1927-1928.
PubMed

CUSPIDI C, Tadic M, Grassi G
Blood pressure variability: a new therapeutic target on the horizon.
J Hypertens. 2021;39:1771-1773.
PubMed

CHANG HC, Wu CL, Lee YH, Gu YH, et al
Impact of dietary intake of sodium and potassium on short-term blood pressure variability.
J Hypertens. 2021;39:1835-1843.
PubMed Abstract available

CAI E, Chen L, Wang Y, An D, et al
Predictive value of within-visit and visit-to-visit blood pressure variability for all-cause mortality: the Minhang Study.
J Hypertens. 2021;39:1844-1851.
PubMed Abstract available

HILKENS NA, Klijn CJM, Richard E
Blood pressure, blood pressure variability and the risk of poststroke dementia.
J Hypertens. 2021;39:1859-1864.
PubMed Abstract available

August 2021

MARTINEZ-GARCIA MA
The effect of continuous positive airway pressure on patients with resistant and refractory hypertension: lessons from the HIPARCO programme.
J Hypertens. 2021 Aug 25. pii: 00004872-900000000-96574.
PubMed

THANGARAJ SS, Oxlund CS, Fonseca MPD, Svenningsen P, et al
The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-[gamma] and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension.
J Hypertens. 2021 Aug 23. pii: 00004872-900000000-96579.
PubMed Abstract available

PAINI A, Tarozzi L, Bertacchini F, Aggiusti C, et al
Cardiovascular prognosis in patients admitted to an emergency department with hypertensive emergencies and urgencies.
J Hypertens. 2021 Aug 20. pii: 00004872-900000000-96587.
PubMed Abstract available

KIM SM, Kim DH, Ryu DR, Lee S, et al
Optimal target blood pressure for major adverse cardiovascular and cerebrovascular events in hypertensive patients: a nationwide population-based study.
J Hypertens. 2021 Aug 20. pii: 00004872-900000000-96583.
PubMed Abstract available

LI Y, Hossain E, Arifen N, Srivastava AK, et al
Sirtuin-1 contributes to the overexpression of Gialpha proteins and hyperproliferation of vascular smooth muscle cells from spontaneously hypertensive rats.
J Hypertens. 2021 Aug 20. pii: 00004872-900000000-96582.
PubMed Abstract available

OZEKI A, Oogaki Y, Henmi Y, Karasawa T, et al
Elevated S100A9 in preeclampsia induces soluble endoglin and IL-1beta secretion and hypertension via the NLRP3 inflammasome.
J Hypertens. 2021 Aug 18. pii: 00004872-900000000-96588.
PubMed Abstract available

NEUFCOURT L, Zins M, Berkman LF, Grimaud O, et al
Socioeconomic disparities and risk of hypertension among older Americans: the Health and Retirement Study.
J Hypertens. 2021 Aug 13. pii: 00004872-900000000-96590.
PubMed Abstract available

LEMBO M, Manzi MV, Mancusi C, Morisco C, et al
Advanced imaging tools for evaluating cardiac morphological and functional impairment in hypertensive disease.
J Hypertens. 2021 Aug 12. pii: 00004872-900000000-96597.
PubMed Abstract available

POST A, Kremer D, Swarte JC, Sokooti S, et al
Plasma creatine concentration is associated with incident hypertension in a cohort enriched for the presence of high urinary albumin concentration: the Prevention of Renal and Vascular Endstage Disease study.
J Hypertens. 2021 Aug 9. pii: 00004872-900000000-96598.
PubMed Abstract available

BOULESTREAU R, Lucas L, Cremer A, Debeugny S, et al
Neurologically asymptomatic patients frequently present cerebral injuries during malignant hypertension: a MRI study.
J Hypertens. 2021 Aug 2. pii: 00004872-900000000-96606.
PubMed Abstract available

YU S, Zhang Y
The association between isolated systolic or diastolic hypertension and cardiovascular risk.
J Hypertens. 2021;39:1552-1554.
PubMed

BODER P, Mary S, Mark PB, Leiper J, et al
Mechanistic interactions of uromodulin with the thick ascending limb: perspectives in physiology and hypertension.
J Hypertens. 2021;39:1490-1504.
PubMed Abstract available

HISAMATSU T, Lloyd-Jones DM, Colangelo LA, Liu K, et al
Urinary sodium and potassium excretions in young adulthood and blood pressure by middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
J Hypertens. 2021;39:1586-1593.
PubMed Abstract available

WANG N, Harris K, Chalmers J, Harrap S, et al
Combination blood pressure lowering in the presence or absence of background statin and aspirin therapy: a combined analysis of PROGRESS and ADVANCE Trials.
J Hypertens. 2021;39:1689-1696.
PubMed Abstract available

YANNOUTSOS A, Lin F, Billuart O, Buronfosse A, et al
Low admission blood pressure as a marker of poor 1-year survival in patients with revascularized critical limb ischemia.
J Hypertens. 2021;39:1611-1620.
PubMed Abstract available

CUSPIDI C, Tadic M, Sala C, Carugo S, et al
Reverse dipping and subclinical cardiac organ damage: a meta-analysis of echocardiographic studies.
J Hypertens. 2021;39:1505-1512.
PubMed Abstract available

July 2021

KIFER D, Louca P, Cvetko A, Deris H, et al
N-glycosylation of immunoglobulin G predicts incident hypertension.
J Hypertens. 2021 Jul 19. pii: 00004872-900000000-96614.
PubMed Abstract available

LIU F, Hidru TH, Yang X, Xia Y, et al
Reply to 'Cancer, hypertension and risk for cardiovascular disease'.
J Hypertens. 2021 Jul 16. pii: 00004872-900000000-96618.
PubMed

DONG J, Dong H, Yan Y, Cheng H, et al
Prevalence of hypertension and hypertension phenotypes after three visits in Chinese urban children.
J Hypertens. 2021 Jul 16. pii: 00004872-900000000-96617.
PubMed Abstract available

PARATI G, Stergiou GS, Bilo G, Kollias A, et al
Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension.
J Hypertens. 2021 Jul 15. pii: 00004872-900000000-96622.
PubMed Abstract available

LIU J, Bu X, Wei L, Wang X, et al
Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019.
J Hypertens. 2021 Jul 15. pii: 00004872-900000000-96620.
PubMed Abstract available

SCHMIEDER RE, Mahfoud F, Mancia G, Azizi M, et al
European Society of Hypertension position paper on renal denervation 2021.
J Hypertens. 2021 Jul 13. pii: 00004872-900000000-96628.
PubMed Abstract available

CARRA MC, Fessi S, Detzen L, Darnaud C, et al
Self-reported periodontal health and incident hypertension: longitudinal evidence from the NutriNet-Sante e-cohort.
J Hypertens. 2021 Jul 13. pii: 00004872-900000000-96626.
PubMed Abstract available

SCHRADER B, Schrader J, Vaske B, Elsasser A, et al
Football beats hypertension: results of the 3F (Fit&Fun with Football) study.
J Hypertens. 2021 Jul 13. pii: 00004872-900000000-96625.
PubMed Abstract available

KIKUCHI Y, Tanaka F, Nakamura M, Tanno K, et al
Utility of urinary albumin excretion as an index for stratifying the residual cardiovascular risk in patients undergoing antihypertensive agents treatment.
J Hypertens. 2021 Jul 13. pii: 00004872-900000000-96623.
PubMed Abstract available

CHEN H, Wu W, Fang W, Chen Z, et al
Does an increase in estimated pulse wave velocity increase the incidence of hypertension?
J Hypertens. 2021 Jul 12. pii: 00004872-900000000-96629.
PubMed Abstract available

BELLO H, Woodiwiss AJ, Naran R, Peterson VR, et al
Impact of stroke work on the ability of left ventricular mass to account for pressure effects on function in a community with prevalent systemic flow-dependent hypertension.
J Hypertens. 2021 Jul 6. pii: 00004872-900000000-96634.
PubMed Abstract available

LOUTRADIS C, Sarafidis PA, Ekart R, Tsouchnikas I, et al
Ambulatory blood pressure changes with lung ultrasound-guided dry-weight reduction in hypertensive hemodialysis patients: 12-month results of a randomized controlled trial.
J Hypertens. 2021;39:1444-1452.
PubMed Abstract available

GOEL S, Jaswal N, Sharma S, Gill SS, et al
Development of integrated model of communication for implementing media strategy to prevent hypertension in a northern state of India.
J Hypertens. 2021;39:1333-1340.
PubMed Abstract available

SAEED S, Edvardsen T
Basal septal hypertrophy in hypertension; about time to introduce an objective and reproducible quantification.
J Hypertens. 2021;39:1316-1318.
PubMed

MANCUSI C
Aortic strain in hypertensive patients, are we ready for it?
J Hypertens. 2021;39:1314-1315.
PubMed

TADIC M, Grassi G
The interactions between antihypertensive drugs and novel anticancer therapy.
J Hypertens. 2021;39:1303-1305.
PubMed

KICHENADASSE G, Miners JO, Mangoni AA, Rowland A, et al
Effect of concomitant use of antihypertensives and immune check point inhibitors on cancer outcomessname.
J Hypertens. 2021;39:1274-1281.
PubMed Abstract available

SAEED S, Tadic M, Larsen TH, Grassi G, et al
Coronavirus disease 2019 and cardiovascular complications: focused clinical review.
J Hypertens. 2021;39:1282-1292.
PubMed Abstract available

KREUTZ R, Kjeldsen SE, Mancia G
Why we do not need a single independent international hypertension clinical practice guideline.
J Hypertens. 2021 Jul 1. pii: 00004872-900000000-96638.
PubMed

FAN WG, Wang WY, Meng YX, Sharman JE, et al
Within-visit and between-visit intra-individual blood pressure variability in an unselected adult population from rural China.
J Hypertens. 2021;39:1346-1351.
PubMed Abstract available

CLARKE MM, Harrington HA, Glenning JP, Zannino D, et al
Magnitude and significance of interarm blood pressure differences in children and adolescents.
J Hypertens. 2021;39:1341-1345.
PubMed Abstract available

MARCINIAK M, Gilbert A, Loncaric F, Fernandes JF, et al
Septal curvature as a robust and reproducible marker for basal septal hypertrophy.
J Hypertens. 2021;39:1421-1428.
PubMed Abstract available

NOLDE JM, Lugo-Gavidia LM, Kannenkeril D, Chan J, et al
Increased pulse wave velocity in patients with an orthostatic blood pressure rise independent of other cardiovascular risk factors.
J Hypertens. 2021;39:1352-1360.
PubMed Abstract available

SEIDEL M, Pagonas N, Seibert FS, Bauer F, et al
The differential impact of aerobic and isometric handgrip exercise on blood pressure variability and central aortic blood pressure.
J Hypertens. 2021;39:1269-1273.
PubMed Abstract available

June 2021

TUPPIN P, Denis P, Gastaldi C, Olie V, et al
Characteristics of people with severe hypertension in France and determinants of medication persistence after 6 years.
J Hypertens. 2021 Jun 23. pii: 00004872-900000000-96642.
PubMed Abstract available

TADIC M, Sala C, Carugo S, Mancia G, et al
Myocardial strain and left ventricular geometry: a meta- echocardiographic studies in systemic hypertension.
J Hypertens. 2021 Jun 14. pii: 00004872-900000000-96649.
PubMed Abstract available

BAROCHINER J, Aparicio LS, Martinez R, Alfie J, et al
Prognostic value of masked uncontrolled apparent resistant hypertension detected through home blood pressure monitoring.
J Hypertens. 2021 Jun 14. pii: 00004872-900000000-96648.
PubMed Abstract available

KASIAKOGIAS A, Rosei EA, Camafort M, Ehret G, et al
Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension.
J Hypertens. 2021 Jun 7. pii: 00004872-900000000-96653.
PubMed Abstract available

THOMOPOULOS C, Andrikou I, Konstantinidis D, Iliakis P, et al
Isolated diastolic vs. systolic hypertension phenotypes and outcomes: prospective cohort of newly diagnosed individuals with hypertension.
J Hypertens. 2021 Jun 4. pii: 00004872-900000000-96658.
PubMed Abstract available

LEE CH, Han KD, Yoo J, Kwak MS, et al
Synergistic harmful interaction between sustained physical inactivity and hypertension/diabetes mellitus on the risk of all-cause mortality: a retrospective observational cohort study.
J Hypertens. 2021 Jun 4. pii: 00004872-900000000-96655.
PubMed Abstract available

ZHU Y, Liu Y, Wu C, Li H, et al
Enterococcus faecalis contributes to hypertension and renal injury in Sprague-Dawley rats by disturbing lipid metabolism.
J Hypertens. 2021;39:1112-1124.
PubMed Abstract available

MURRAY E, Rossitto G, Delles C
Haemodynamic assessment in hypertension: the soloists and the orchestra.
J Hypertens. 2021;39:1109-1111.
PubMed

SCHLAICH MP, Kiuchi MG, Nolde JM, Lugo-Gavidia LM, et al
Therapeutic inertia in hypertension management - status quo in primary care.
J Hypertens. 2021;39:1107-1108.
PubMed

EGAN BM, Sutherland SE
Editorial commentary on 'Country of birth and mortality risk in hypertension with and without diabetes: the Swedish Primary Care Cardiovascular Database'.
J Hypertens. 2021;39:1104-1106.
PubMed

AGNIHOTHRI S, Cui L, Rajan B, Banerjee A, et al
Mobile health application usage and quality of care at a hypertension clinic: an observational cohort study.
J Hypertens. 2021 Jun 1. pii: 00004872-900000000-96660.
PubMed Abstract available

KAWADA T
Blood pressure and atrial fibrillation: a risk assessment.
J Hypertens. 2021;39:1261.
PubMed

Association of age and blood pressure among 3.3 million adults: insights from China PEACE million persons project.
J Hypertens. 2021;39:1143-1154.
PubMed Abstract available

ROSELEUR J, Gonzalez-Chica DA, Bernardo CO, Geisler BP, et al
Blood pressure control in Australian general practice: analysis using general practice records of 1.2 million patients from the MedicineInsight database.
J Hypertens. 2021;39:1134-1142.
PubMed Abstract available

ROUSH GC, Messerli FH
Chlorthalidone versus hydrochlorothiazide: major cardiovascular events, blood pressure, left ventricular mass, and adverse effects.
J Hypertens. 2021;39:1254-1260.
PubMed Abstract available

KIM W, Kim SH, Choi CU, Lee SK, et al
Role of arterial stiffness in the association between hand grip strength and cardiovascular events: the Korean Genome and Epidemiology Study.
J Hypertens. 2021;39:1203-1209.
PubMed Abstract available

May 2021

HALIMI JM, Ortiz A, Sarafidis PA, Mallamaci F, et al
Hypertension in kidney transplantation: a consensus statement of the 'hypertension and the kidney' working group of the European Society of Hypertension.
J Hypertens. 2021 May 28. pii: 00004872-900000000-96664.
PubMed Abstract available

TADIC M, Sala C, Carugo S, Mancia G, et al
Myocardial strain in hypertension: a meta-analysis of two-dimensional speckle tracking echocardiographic studies.
J Hypertens. 2021 May 28. pii: 00004872-900000000-96663.
PubMed Abstract available

BERILLO O, Coelho SC, Mahjoub N, Offermanns S, et al
Aldosterone contributes to hypertension in male mice inducibly overexpressing human endothelin-1 in endothelium.
J Hypertens. 2021 May 25. pii: 00004872-900000000-96665.
PubMed Abstract available

MANCUSI C, Trimarco V, Losi MA, Canciello G, et al
Impact of visit-to-visit blood pressure variability on hypertensive-mediated target organ damage and future cardiovascular events: the Campania salute network.
J Hypertens. 2021 May 17. pii: 00004872-900000000-96669.
PubMed Abstract available

CHAUDHARY P, Velkoska E, Wainford RD
An exploratory analysis of comparative plasma metabolomic and lipidomic profiling in salt-sensitive and salt-resistant individuals from The Dietary Approaches to Stop Hypertension Sodium Trial.
J Hypertens. 2021 May 17. pii: 00004872-900000000-96667.
PubMed Abstract available

IKEDA S, Shinohara K, Enzan N, Matsushima S, et al
Effectiveness of statin intensive therapy in type 2 diabetes mellitus with high visit-to-visit blood pressure variability.
J Hypertens. 2021 May 17. pii: 00004872-900000000-96668.
PubMed Abstract available

FAN J, Jia X, Wang Y, Zhao Y, et al
Birth weight, childhood obesity and risk of hypertension: a Mendelian randomization study.
J Hypertens. 2021 May 14. pii: 00004872-900000000-96673.
PubMed Abstract available

AJAMU S, Fenner RC, Grigorova YN, Cezayirli D, et al
Association of central arterial stiffness with hippocampal blood flow and N-acetyl aspartate concentration in hypertensive adult Dahl salt sensitive rats.
J Hypertens. 2021 May 14. pii: 00004872-900000000-96671.
PubMed Abstract available

LOUCA P, Nogal A, Wells PM, Asnicar F, et al
Gut microbiome diversity and composition is associated with hypertension in women.
J Hypertens. 2021 May 10. pii: 00004872-900000000-96678.
PubMed Abstract available

JOHANSSON MAK, Ostgren CJ, Engvall J, Swahn E, et al
Relationships between cardiovascular risk factors and white-coat hypertension diagnosed by home blood pressure recordings in a middle-aged population.
J Hypertens. 2021 May 10. pii: 00004872-900000000-96676.
PubMed Abstract available

ZHANG L, Li J, Li N, Sun N, et al
Trends in cause-related comorbidities in hospitalized patients with secondary hypertension in China from 2013 to 2016: a retrospective analysis of hospital quality monitoring system data.
J Hypertens. 2021 May 10. pii: 00004872-900000000-96675.
PubMed Abstract available

TURER CB, Doney A, Bowen ME, Menzies C, et al
Determining pediatric hypertension criteria: concordance between observed physician methods and guideline-recommended methods.
J Hypertens. 2021 May 6. pii: 00004872-900000000-96679.
PubMed Abstract available

VISARIA A, Raju P, Islam S, James J, et al
Understanding the impact of blood pressure guidelines and variability on hypertension diagnoses.
J Hypertens. 2021;39:1044-1045.
PubMed

WANG Y, Zhang T, Zhang Y, Yu Y, et al
Effects of inverted photoperiods on the blood pressure and carotid artery of spontaneously hypertensive rats and Wistar-Kyoto rats.
J Hypertens. 2021;39:871-879.
PubMed Abstract available

PULGAR VM
Uterine leiomyoma and hypertensive disorders in pregnancy.
J Hypertens. 2021;39:869-870.
PubMed

KYAW T, Bobik A
Is angiogenic CD4+ T-cell mediated inflammation responsible for endothelial dysfunction in essential hypertension?
J Hypertens. 2021;39:867-868.
PubMed

TOSELLO F, Guala A, D'ascenzo F, Bollati M, et al
Central pulse pressure is inversely associated with proximal aortic remodelling.
J Hypertens. 2021;39:919-925.
PubMed Abstract available

THOMOPOULOS C, Bazoukis G, Grassi G, Tsioufis C, et al
Monotherapy vs combination treatments of different complexity: a meta-analysis of blood pressure lowering randomized outcome trials.
J Hypertens. 2021;39:846-855.
PubMed Abstract available

CREMER A, Doublet J, Boulestreau R, Gaudissard J, et al
Short-term blood pressure variability, arterial stiffness, and cardiovascular events: results from the Bordeaux cohort.
J Hypertens. 2021;39:947-951.
PubMed Abstract available

LUCHI WM, Crajoinas RO, Martins FL, Castro PC, et al
High blood pressure induced by vitamin D deficiency is associated with renal overexpression and hyperphosphorylation of Na+-K+-2Cl- cotransporter type 2.
J Hypertens. 2021;39:880-891.
PubMed Abstract available

ESLER MD, Jennings G, Schlaich M, Lambert G, et al
The adrenal medulla in cardiovascular medicine: an untold story.
J Hypertens. 2021;39:819-829.
PubMed Abstract available

NEWTON J, Singh C, Sinha MD
Measurement of SBP at home by parents using hand-held Doppler device and aneroid sphygmomanometer: a single-centre experience.
J Hypertens. 2021;39:904-910.
PubMed Abstract available

April 2021

ABAD-GARCIA MF, Gonzalez-Teruel A, Bolanos-Pizarro M, Lurbe I Ferrer E, et al
Scientific mapping of the research output on hypertension in children and adolescents, 2010-2018.
J Hypertens. 2021 Apr 28. pii: 00004872-900000000-96681.
PubMed Abstract available

KOW CS, Hasan SS
Intensive blood pressure-lowering strategy should also be offered to older patients.
J Hypertens. 2021;39:812-813.
PubMed

ALSHAARAWY O, Vanderziel A
Visit-to-visit variability in blood pressure among cannabis users participating in the Third National Health and Nutrition Examination Survey.
J Hypertens. 2021;39:621-626.
PubMed Abstract available

HEFFERNAN KS, Jae SY, Loprinzi PD
Estimated pulse wave velocity is associated with residual-specific mortality: findings from the National Health and Nutrition Examination Survey.
J Hypertens. 2021;39:698-702.
PubMed Abstract available

COWELL OR, Mistry N, Deighton K, Matu J, et al
Effects of a Mediterranean diet on blood pressure: a systematic review and meta-analysis of randomized controlled trials and observational studies.
J Hypertens. 2021;39:729-739.
PubMed Abstract available

CUSPIDI C, Tadic M, Sala C, Quarti-Trevano F, et al
Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies.
J Hypertens. 2021;39:775-783.
PubMed Abstract available

March 2021

TODKAR S, Padwal R, Michaud A, Cloutier L, et al
Knowledge, perception and practice of health professionals regarding blood pressure measurement methods: a scoping review.
J Hypertens. 2021;39:391-399.
PubMed Abstract available

CAI P, Peng Y, Chen Y, Wang Y, et al
Blood pressure characteristics of subclinical hypothyroidism: an observation study combined with office blood pressure and 24-h ambulatory blood pressure.
J Hypertens. 2021;39:453-460.
PubMed Abstract available

February 2021

BOHM M, Schumacher H, Teo KK, Lonn EM, et al
Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk.
J Hypertens. 2021 Feb 3. pii: 00004872-900000000-96717.
PubMed Abstract available

OUYANG M, Munoz-Venturelli P, Billot L, Wang X, et al
Low blood pressure and adverse outcomes in acute stroke: HeadPoST study explanations.
J Hypertens. 2021;39:273-279.
PubMed Abstract available

MALOBERTI A, Bombelli M, Facchetti R, Barbagallo CM, et al
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study.
J Hypertens. 2021;39:333-340.
PubMed Abstract available

EDWARDS JJ, Taylor KA, Cottam C, Jalaludeen N, et al
Ambulatory blood pressure adaptations to high-intensity interval training: a randomized controlled study.
J Hypertens. 2021;39:341-348.
PubMed Abstract available

SALVETTI M, Paini A, Bertacchini F, Aggiusti C, et al
Myocardial mechano-energetic efficiency in primary aldosteronism.
J Hypertens. 2021;39:318-324.
PubMed Abstract available

January 2021

GIBBS J, Gaskin E, Ji C, Miller MA, et al
The effect of plant-based dietary patterns on blood pressure: a systematic review and meta-analysis of controlled intervention trials.
J Hypertens. 2021;39:23-37.
PubMed Abstract available

MATSUMOTO K, Jin Z, Homma S, Elkind MSV, et al
Office, central and ambulatory blood pressure for predicting incident atrial fibrillation in older adults.
J Hypertens. 2021;39:46-52.
PubMed Abstract available

CUSPIDI C, Tadic M, Sala C, Quarti-Trevano F, et al
Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis.
J Hypertens. 2021;39:4-11.
PubMed Abstract available

MUIESAN ML, Salvetti M, Virdis A, Masi S, et al
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study.
J Hypertens. 2021;39:62-69.
PubMed Abstract available

December 2020

THOMOPOULOS C, Bazoukis G, Tsioufis C, Mancia G, et al
Reply.
J Hypertens. 2020;38:2544-2545.
PubMed

SCHLAICH MP, Nolde JM, Carnagarin R, Schlaich LI, et al
Vascular compression of the rostral ventrolateral medulla: a relevant indicator of sympathetically driven blood pressure variability?
J Hypertens. 2020;38:2380-2381.
PubMed

May 2020

GRASSI G, Biffi A, Dell'Oro R, Quarti Trevano F, et al
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis.
J Hypertens. 2020 May 7. doi: 10.1097/HJH.0000000000002431.
PubMed Abstract available

February 2020

PAINI A, Aggiusti C, Bertacchini F, Stassaldi D, et al
Relationship between arterial stiffness and unattended or attended blood pressure values.
J Hypertens. 2020;38:243-248.
PubMed Abstract available

MEYER ML, Klein BE, Klein R, Palta P, et al
Central arterial stiffness and retinal vessel calibers: the Atherosclerosis Risk in Communities Study-Neurocognitive Study.
J Hypertens. 2020;38:266-273.
PubMed Abstract available

DENG AY, Menard A
Biological convergence of three human and animal model quantitative trait loci for blood pressure.
J Hypertens. 2020;38:322-331.
PubMed Abstract available

KAYSER A, Beck E, Hoeltzenbein M, Zinke S, et al
Neonatal effects of intrauterine metoprolol/bisoprolol exposure during the second and third trimester: a cohort study with two comparison groups.
J Hypertens. 2020;38:354-361.
PubMed Abstract available

DI STEFANO C, Sobrero G, Milazzo V, Vallelonga F, et al
Cardiac organ damage in patients with Parkinson's disease and reverse dipping.
J Hypertens. 2020;38:289-294.
PubMed Abstract available

TADIC M, Cuspidi C, Majstorovic A, Pencic B, et al
The association between 24-h blood pressure patterns and left ventricular mechanics.
J Hypertens. 2020;38:282-288.
PubMed Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: